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ABSTRACT 
SYNTHETIC STUDIES OF (+)-NODULISPORIC ACID A: DEVELOPMENT OF AN 
EFFICIENT ROUTE TO EASTERN HEMISPHERE SUB-TARGETS 
 
Stephen S. Gonzales 
Advisor: Amos B. Smith, III 
 
(+)-Nodulisporic Acid A (NsAA) is an indole diterpene of complex structure, 
isolated from the fungus nodulisporium sp., possessing potent insecticidal activity. 
Herein is described a new tactic for the construction of complex indoles employing a 
tandem palladium-mediated process between a haloindoline and a vinyl bromide or 
triflate. 
Chapter 1 of this work will review the efforts by Merck and Co. that lead to the 
isolation and discovery of potent analogs of NsAA, as well as briefly review the history of 
complex indole synthesis in the Smith Research Group.  
Chapter 2 will describe efforts to streamline the synthesis of the chiral, non-
racemic material used to make different variants of the eastern hemisphere sub-target, 
the development of a new tactic for bringing the two hemispheres together, and efforts to 
synthesize an eastern hemisphere sub-target that contains the sidechain of NsAA.  
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 1 
CHAPTER 1. (+)-NODULISPORIC ACID A – BACKGROUND 
 
1.1. ISOLATION AND BIOLOGICAL ACTIVITY OF THE NODULISPORIC ACIDS 
 
1.1.1 SUMMARY OF ISOLATION WORK BY MERCK 
 
The search for potent insecticidal agents with minimal mammalian toxicity led Merck 
and company to the discovery of (+)-nodulisporic acid A (1.1, NsAA, Figure 1.1) in 
1997.1 NsAA was isolated from Nodulisporium sp., an endophytic fungus that  
 
Figure 1.1. (+)-Nodulisporic Acid A Structure 
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typically infects woody plants and trees, and was found to have potent insecticidal 
activity in two different assays. One assay was a culture extract screen against the 
larvae of the mosquito Aedes aegypti,2 and another against larvae of the blowfly Lucilia 
seracata. NsAA also displays activity against the cat flea Ctenocephalides felis.3   
The gross structure of NsAA was established through a battery of NMR 
experiments as well as mass spectral analysis. Both 1D and 2D experiments, including 
COSY, TOCSY, HMQC, and HMBC, were performed. Relative stereochemistry was 
 2 
elucidated through ROESY and NOESY studies. Mosher ester studies of the C-7 
hydroxyl group established the absolute stereochemistry of NsAA by the assignment of 
the S configuration at this carbon. X-Ray analysis of a crystal of the C-7 4-
bromobenzoate derivative completed the spectral battery of experiments. 
 An interesting aspect of the structure of NsAA is the line broadening of the 
signals associated with the C-2’ isoprenyl group (Figure 1.2). These signals suggest 
restricted conformational mobility of this group. Interestingly, when the C-2’ stereocenter 
was inverted by treating the methyl ester of NsAA 1.2 with DMAP in a mixture of 
acetonitrile and methylene chloride, the line broadening of the isoproprenyl signals was 
not observed. These observations suggest that there is considerable congestion on the  
 
Figure 1.2. Steric Congestion on the !-Face of NsAA 
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!-face of NsAA in the solution conformation, a fact that has implications for the synthesis 
of this challenging ring system. 
 3 
 Observations of the chemical reactivity of NsAA revealed sensitivity to light and 
oxygen that seemed to be independent of solvent. During NMR studies, NsAA 
underwent an oxidative cleavage of the central ring, as well as isomerization of the C3”-
C4” bouble bond from E to Z (Scheme 1.1). Such reactivity has been observed for the 
tremorgenic alkaloid paxilline,4 and rigorous characterization of 1.4 and 1.5 helped to 
secure the structure of NsAA. 
 
Scheme 1.1. Oxidative Sensitivity of NsAA  
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1.1.2 SUMMARY OF THE BIOGENESIS WORK BY MERCK 
 
 In order to optimize the fermentation process by which Merck would obtain NsAA 
for medicinal chemistry studies, studies were conducted on the biogenetic pathway 
 4 
leading to NsAA.5 Two strains of the fungus, MF6244 and MF6299, were developed in 
order to produce material at a level that would support isotopic incorporation studies. On 
the basis of the similarity of NsAA’s structure with that of other indole alkaloids like 
paspaline or penitrem A, that the indole core of NsAA was postulated to derived from 
tryptophan or a tryptophan metabolite, and that the diterpene features were built from 
geranylgeranyl pyrophosphate (GGPP) (Figure 1.3). 
 Isotopic enrichment studies with 2-13C-acetate were conducted. Incorporation of  
 
Figure 1.3. 13C-labelling Studies of NsAA 
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 5 
this labeled actate into the mevalonic acid pathway, which was shown to be operating 
through 2-13C-mevalonolactone incorporation studies, results in enrichment at carbons 2, 
4, and 5 of isopentenylpyrophosphate (Figure 1.3) (IPP).6 The consequence of this 
labeling pattern is that, after incorporation into NsAA, no two labeled carbons should be 
adjacent to one another. However, coupling between C-11 and C-12 in 13C NMR 
spectrum, with a J = 34 Hz, was observed. The only way this could occur is through 
skeletal rearrangement of the carbon framework after the initial polycyclization event 
(Figure 1.4), analogous to a similar rearrangement that occurs during the biosynthesis of 
paxilline and penitrem A.7  
 
Figure 1.4. Carbon Skeleton Rearrangement During the Biosynthesis of 
Nodulisporic Acid A 
 
N
H
HO OH
OPO3-2
[O]
 glyceraldehyde-
3-phosphate
PPO
Indole-3-glycerol-phosphate geranylgeranyl
pyrophosphate
N
H
O N
H
OH
[O]
N
H OH
O
OH
12
11
 
 
 6 
1.1.3. BIOLOGICAL ACTIVITY OF NODULISPORIC ACID A 
 
The biological target of NsAA was found to be a glutamate-gated chloride channel 
(GluCl) that is specific to insects,8 with binding of an amide analog of NsAA determined 
to have a KD = 12 pM. A similar type of activity is known for the antihelmintic and 
insecticidal agent ivermectin (IVM). GluCl plays a key role in neuron signal propogation. 
Patch-clamp studies on grasshopper neurons showed that NsAA potentiates the effect 
of glutamate on GluCl opening (Figure 1.5). The Merck group found that while IVM and 
NsAA both bind to GluCl, NsAA is specific to one population of binding sites associated 
with GluCl, while IVM binds to two different sets of receptors, as determined by studies 
on C. elegans membranes. NsAA did not inhibit binding IVM on C. elegans tissues. 
 
Figure 1.5. NsAA Mechanism of Action.  
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The specificity of binding is interesting from a therapeutic standpoint, since the GluCl 
binding site of NsAA is specific to insects and is not found in vertabrates.9, 10 NsAA was 
found to be effective for flea and tick infestations in companion animals,11 and perhaps 
 7 
more interestingly, to have 10-fold greater activity against the bed bug Cimex lectularius 
than ivermectin, the latter being the standard treatment (NsAA, LD90 = 1 ppm; IVM, LD90 
= 10 ppm).3 Bed bug infestation has become a major problem in North America in recent 
years,12, 13 and effective methods of exterminating these pests are lacking. 
The nodulisporic acids lack the C-9 tertiary hydroxyl (Figure 1.6, red hydroxyl) that 
imparts tremorgenic activity7 found in other indole diterpenes like penitrems (1.6 and 
1.7), janthitrems (1.8 – 1.10), and the lolitrem B (1.11). Among the nodulisporic acids, 
only NsAA possesses the highly strained !-ketodihydropyrrole ring. Taken together, the  
 
Figure 1.6. Comparison of Structures of NsAA and Several Tremorgenic Alkaloids 
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specificity, effectiveness in killing certain insect species, and the lack of mammalian 
toxicity point to NsAA as a promising lead structure in the search for effective 
insecticides. 
 
1.2. SUMMARY OF MEDICINAL CHEMISTRY OF NODULISPORIC ACID A 
 
Initial studies aimed at exploring the structure-activity relationship (SAR) of NsAA 
targeted the sidechain and core ring system for modification.14 Esters and amides were 
made using standard conditions (Table 1.1). The results revealed that many amide 
analogs are superior in their anti-flea activity to 1.1, with the methyl amide 1.14 being 10-  
 
Table 1.1. Amide and Ester Substitution at C-6” of NsAA 
 
N
O
O
OHHO
CO2H
H
1.1
(+)-Nodulisporic Acid A
H
H
O
R
Condition
Compound
1.1
1.12
1.13
1.14
1.15
1.16
1.17
1.18
Condition
-
A
A
B
B
B
B
B
R
OH
OMe
OCH2CH2OCH2CH2OH
NHMe
NHC(Me)2C(O)NMe2
N-1-[(4-Me)Piperazinyl]
N-1-[(4-CO2Et)Piperazinyl]
N-1-[(4-SO2Me)Piperazinyl]
Anti-flea Activity (ppm)
1
10
0.1
~0.1
0.01
1
0.1
~0.01
Conditions: A = ROH, CH2Cl2, BOP, ! 20 °C - rt; B = R1R2NH, CH2Cl2, BOP, DIEA, 0 °C - rt.  
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fold more potent than NsAA. Amides with extended polar substitution (1.15 and 1.18) 
were one order of magnitude more potent still. Interestingly, the piperazine series 
showed increasing potency as the 4-substitution changed from methyl to ethyl 
carbamate to methyl sulfone (1.16 – 1.18). Esters were generally less potent than the 
parent, although the PEG-like ester 1.13 showed a 10-fold increase over the parent.  
 Further studies in which various changes were made to the core ring system 
revealed that this region is non-permissive to modification. Oxidation of the C-24 
hydroxyl to the ketone ablated activity, as did elimination of this same hydroxyl to form 
the extended conjugated system. Reduction of the 1’ carbonyl, epimerization of the 2’ 
isopropenyl group, and oxidation or acetylation of the C-7 hydroxyl also eliminated 
activity. These initial results guided further efforts. 
 
Figure 1.7. Initial SAR of NsAA 
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 At this juncture in Merck’s program, several modes of reactivity of NsAA had 
been revealed. Base-induced epimerization of C-2’ to the thermodynamically more 
stable !-configuration (see Figure 1.2), oxidative cleavage of the central indole double-
bond (Scheme 1.1), and dehydrative elimination of the C-24 hydroxyl group under acidic 
conditions are all processes which would need to be taken into account when planning 
any synthesis of more involved analogs. With the establishment of the sidechain as a 
permissive region, studies were undertaken to elucidate the SAR of this region. Merck 
found that the sidechain of NsAA could be degraded and modified to provide truncated 
analogs that could be used for further derivatization.15 Thus, after considerable 
experimentation, NsAA could be treated with KMnO4 adsorbed onto wet alumina in water 
and methylene chloride to give the truncated aldehyde 1.19 (Scheme 1.2). This 
aldehyde would prove to be useful synthon for sidechain studies. The corresponding 
acid 1.20 could be obtained by subjecting 1.19 to Lindgren-Pinnick oxidation conditions. 
 
Scheme 1.2. Sidechain Truncation of NsAA 
 
N
O
O
OHHO
CO2H
H
1.1
(+)-Nodulisporic Acid A
H
H
OH
H
OH
OH
O O
KMnO4, 
alumina (acidic)
water, CH2Cl2
25 °C, 20 min
(94%)
NaClO2, isobutylene
NaH2PO4, t-BuOH, H2O
25 °C, 12 h (76%)
1.19 1.20  
 11 
 In order to improve the pharmacokinetic performance of NsAA and the amide 
derivatives thereof, heterocycle incorporation (Scheme 1.3) into the sidechain was  
 
Scheme 1.3. Heterocycle Incorporation Into the Sidechain of NsAA 
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O
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N
O
O
N
1. 2M (CH3)NH/THF
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    CH2Cl2, 
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   (80%)
2. PPTS, EtOH
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        14h (90%)
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N
S
O
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investigated.16 Substitution of the oxazole and thiazole moieties for the dienamide group 
in the sidchain was predicted to improve PK on the basis of polarity modification and 
length approximation. Starting from acid 1.21 (Scheme 1.3), both the oxazole and 
thiazole congeners were synthesized. After coupling of either serine allyl ester or 
cysteine allyl ester, a dehydrative cyclization according the method of Wipf17 (using 
Burgess reagent) or Charette18 (activation of secondary amides with triflic anhydride) 
gave oxazoline 1.22 and thiazoline 1.25, respectively. Oxidation to the oxazole and 
thiazole was accomplished by the method of Williams19, 20 to give the aromatized 
heterocycles 1.23 and 1.26. Removal of the allyl ester, coupling of an amine to the acid, 
and final de-protection gave the desired analogs 1.24 and 1.27. The methyl oxazole was 
also made (not shown). The biological and pharmacokinetic data of heterocyclic amides 
1.24 and 1.27 revealed these compounds to be superior to NsAA, with 1.24 displaying a 
duration of action in dogs of 2 and 4 weeks (single po dose of 10 mg/kg) in the flea and 
tick assay, respectively. By comparison, NsAA displays a duration of 0.5 weeks in the 
flea/dog assay. The t1/2 in dogs of 1.24 was 2.8 days, up from 0.8 days for NsAA. The 
methyl oxazole displayed similar improvements in PK, but was 10-fold less active in the 
anti-flea assay. 
Further sidechain modifications were explored in which every position of the 
dienoate moiety was varied. By employing aldehyde 1.21 from the previous work, both 
1”,2”-dehydro and 2”,3”-dehydro truncated amide analogs 1.29 and 1.32 were 
synthesized (Scheme 1.4). Considerable difficulty was encountered in the route to 1.29, 
with extensive degradation resulting when attempts to homologate 1.21 were made. A 
solution to this issue was found by olefination of 1.21 to make aminonitrile 1.28. A 
sequence of hydrolysis/esterification, transesterification to the allyl ester, deprotection, 
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and amide coupling then gave the desired analog. A similar route was followed after a 
Cürtius reaction was performed on 1.21.  
As shown in Table 1.2, the 1”,2”-dehydro analogs had superior activity to 2”,3”-
dehydro analogs. In general, more extended amide groups like ethyl (1.37) or benzyl 
(1.38) caused a 10-fold drop in activity, while more compact groups like cyclopropyl 
(1.35) or t-butyl (1.36) gave activity on par with NsAA itself (NsAA flea activity = 1 ppm). 
 
Scheme 1.4. Synthesis of 1”,2”-Dehydro and 2”,3”-Dehydro Chain-truncated 
Analogs 
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CN
NNC Ph
PhLi
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Eventually, all of the above results led Merck to advance the tert-butyl amide of NsAA 
into development as a flea and tick treatment for companion animals.21 
 
Table 1.2. Activity of Chain-truncated Analogs of NsAA 
 
Compound
1.33
1.34
1.35
1.36
1.37
1.38
1.39
1.40
1.41
1.42
Unsaturation
1",2"
1",2"
1",2"
1",2"
1",2"
1",2"
1",2"
2",3"
2",3"
2",3"
R Group
OMe
Me
NH-cPr
NH-tBu
NHEt
NHBn
NMe2
OMe
NH-cPr
NMe2
Flea Activity (ppm)
~1
1
~1
~1
10
10
10
10
10
10
N
O
O
OHHO
O
R
H
H
H
1"
2"
3"
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1.3. EVOLUTION OF COMPLEX INDOLE SYNTHESIS IN THE SMITH RESEARCH 
GROUP 
 
1.3.1. THE MODIFIED MADELUNG INDOLE SYNTHESIS 
 
 An innovation that was introduced by the Smith group in 198622 that greatly 
expanded the ability to introduce an indole in a complex setting was the modified 
Madelung reaction (Figure 1.8). Thus, a silylated o-toluidine 1.43 is bis-metallated and 
treated with an ester to give, after addition to the carbon nucleophile, 1.45.  
Figure 1.8. The Modified Madelung Reaction 
 
NH
Si
R NLi
Si
R
Li
RLi
NLi
Si
R
O
R'
R' OR''
O
R N Si
O
R'
Li
R N
R'
R NH
R'
2.2 equiv
aza-Peterson
Olefination
tautomerization
1.43 1.44 1.45
1.46 1.47 1.48  
 
Intramolecular attack of the metallated nitrogen on the carbonyl then leads to an aza-
Peterson olefination (1.46 – 1.47). The corresponding indole 1.48 is obtained after 
tautomerization. The concept of forming the indole moiety itself in the fragment union 
was to become the predominant strategy for all the indole alkaloids that the Smith group 
would pursue for the next 25 years. 
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This method was showcased first in the synthesis of (+)-cinchonamine22 
(Scheme 1.5), and then later in the conquest of more complex indole alkaloids like the  
 
Scheme 1.5. Use of the modified Madelung Reaction in the Synthesis of 
Cinchonamines 
 
CH3
NH
Si
1) 2.2 equiv n-BuLi
2)
NCEtO HR
1.50, R = !-H, "-H
N
H
C N
HR N
H
C N
HR
OH
1.52, R = !-H, (+)-cinchonamine
1.53, R = "-H, (+)-epi-cinchonamine
1) CH3MgI
2) ethylene oxideO
1.49 1.51
 
 
penitrems (Scheme 1.6 and 1.7), in which a strategy of coupling two fragments of 
roughly equal size and complexity was envisioned. In the penitrem synthesis, the ester  
electrophile used was a lactone, 1.55. By adding bis-metallated western hemisphere 
1.54 to this lactone, an indole was obtained which possessed a hydroxymethyl group 
suitably poised for construction of the polycyclic framework. In the event, oxidation to the 
aldehyde, removal of the trimethylsilyl group, and treatment with scandium (III) triflate in 
benzene formed the complex ring system of penitrem D in satisfactory yield. One 
observation that was made during this work was that the second step of the reaction 
cascade, the aza-Peterson, did not proceed in more complex cases. This necessitated a 
second step in which the indole ring had to be closed either by heating or mild acid 
treatment. 
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Scheme 1.6. Synthesis of Penitrem D Through the Use of the Modified Madelung 
Reaction 
 
OH
O
O
H
OH H
OTES
NH2
H
H
TIPSO
H
OTMS
H
H
O
N
H
OH
OH H
OH
1.58
(!)-Penitrem D
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     DMSO-Et3N (4:1)
2) 1N aq. HCl
     THF-H2O (5:1)
3) Sc(OTf)3, benzene
(47%, three steps)
1.54 1.55
1.56 1.57
 
 
The effort to synthesize the nodulisporic acids was then initiated, with the goal of 
employing the modified Madelung reaction toward the construction of (+)-nodulisporic 
acid F (Scheme 1.7).23, 24 Pleasingly, the process accomplished the union of silylated o-  
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Scheme 1.7. The Smith Synthesis of (+)-Nodulisporic Acid F 
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H
H
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Br OMe
O
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    MeOH/THF, 25 °C; 87%
2. p-TsOH (10 mol%)
   MeOH, 25 °C, 1h; 92%
1.59 1.60
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toluidine and eastern hemisphere 1.59, although once again the reaction cascade did 
not go to completion, and a second ring-closing step had to be performed (1.60 to 1.61), 
which was accomplished with catalytic p-toluenesulfonic acid in benzene. Activation of 
the primary alcohol of 1.61 with methanesullfonyl chloride, followed by treatment with t-
butylmagnesium chloride and zinc (II) triflate accomplished the formation of the ring 
system of nodulisporic acid F. Hydroboration of the alkene, followed by Suzuki coupling 
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to E-3-bromo-methyl tiglate and final deprotection, provided (+)-nodulisporic acid F 1.64 
in 28 steps from Wieland-Miescher ketone in 0.6% overall yield. (+)-Nodulisporic acid F 
was the first member of the nodulisporic acid family to succumb to total synthesis. Efforts 
were then launched to attain the synthesis of other members of this family of natural 
products. 
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CHAPTER 2. SYNTHESIS OF THE EASTERN HEMISPHERE OF (+)-NODULISPORIC 
ACID A AND DEVELOPMENT OF A NEW FRAGMENT UNION TACTIC 
 
2.1 FIRST GENERATION RETROSYNTHETIC ANALYSIS 
2.1.1 PROBLEMS ENCOUNTERED WITH THE MODIFIED MADELUNG REACTION: 
EARLY STUDIES TOWARD (+)-NODULISPORIC ACID A 
 
Figure 2.1. First-generation Retrosynthetic Analysis of (+)-Nodulisporic Acid A 
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With the success of the modified Madelung reaction1 in constructing the indole core 
of nodulisporic acid F and D,2, 3 which in turn lead to the completion of the total synthesis of 
the former, attention was turned toward more complex members of the nodulisporic acid 
family. A strategy was adopted2, 4 (Figure 2.1) in which the D-ring of (+)-nodulisporic acid A 
(NsAA) would be installed at a late stage in the synthesis, and the central fused indole core 
of NsAA would be formed using the modified Madelung synthesis. Retrosynthetic analysis 
revealed intermediate 2.1, containing seven of NsAA’s eight rings. Further disconnection 
gave two main fragments, eastern hemisphere 2.3 and western hemisphere 2.2.  
It was at this point in the program that the limitations of the method began to be 
revealed.2 When a western hemisphere bearing the C-24 (NsAA numbering) hydroxyl group 
(–)-2.2 (Scheme 2.1) was subjected to the modified Madelung sequence with eastern  
 
Scheme 2.1 Problems Encountered with C-24 Hydroxyl Elimination 
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hemisphere (+)-2.4 (the synthesis of which will be discussed below), the product of coupling, 
amino alcohol 2.5, could indeed be obtained. However, all attempts to achieve cyclization of 
2.5 using Montmorillonite K20 or TFA-water gave only products of elimination of the 
corresponding C-24 hydroxyl group 2.7, albeit with the desired cyclization to the indole.2 
Nevertheless, hydroxyindole 2.7 could be cyclized to the fused indole through activation of 
the hydroxyl group followed by base-mediated ring closure to give (+)-2.8 (Scheme 2.2). 
 
Scheme 2.2. Synthesis of Heptacyclic Nodulisporic Acid Ring System 
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Another problem with the first-generation approach to NsAA was encountered when 
studies toward installation of the D-ring were conducted on model systems (Figure 2.2).4 
Thus, intramolecular formation of a carbon-nitrogen bond (bond b) from either bromoketone5 
2.9 or diazoketone6 2.11 failed to give the cyclized product 2.10. Furthermore, intra–
molecular Dieckmann condensation of diester 2.12 (to form bond c) failed to give any 
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cyclized product. Carbonylative cyclization7 to form the aryl-carbonyl bond (bond a) also did 
not occur under a variety of conditions. These results suggested that the strategy on which 
the first-generation approach was predicated, wherein the D-ring is formed at a late stage, 
was not tractable for the total synthesis.  
At this point in the project, a new strategy was formulated8, 9 wherein the fused indole 
core would be formed in a modular fashion, with all of the other rings of NsAA being present 
prior to the coupling of the two fragments. Such a modular approach would in principle avoid 
 
Figure 2.2. Attempted Formation of D-ring on Model Systems 
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the problems of forming the indole ring in a stepwise fashion that were outlined above. The 
new construct (Figure 2.3) involved disconnecting in a retrosynthetic fashion NsAA’s central 
indole ring to reveal a substrate (2.16) for an intramolecular Buchwald/Hartwig coupling, 
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which would in turn arise from a Stille coupling between an iodoenone eastern hemisphere 
2.18 and a stannylated indoline western hemisphere 2.17. In the forward sense, after joining 
of the two hemispheres, the resultant enone could then be converted to vinyl triflate 2.16 by 
conjugate reduction and trapping of the enolate. The concept was reduced to practice, with 
the effectiveness of the method demonstrated on several simple systems.8, 9 To this end, 
efforts were initiated to synthesize the two advanced fragments 2.17 and 2.18 needed to 
synthesize NsAA using this construct. 
 
Figure 2.3. Second-generation Strategy for the Synthesis of NsAA 
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The eastern hemisphere can be further analyzed (Figure 2.4) in retrosynthetic 
fashion to reveal enone 2.19, the direct precursor of the iodoenone. In the synthetic direction 
this enone could arise from diene 2.20 by way of ring-closing metathesis.10, 11 
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Figure 2.4. Retrosynthetic Analysis of the Eastern Hemisphere  
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Diene 2.20 in turn could be obtained by addition/alkylation of a suitable unsaturated 
carbonyl substrate like enal 2.21 (X = O). The enal can in turn be made from ketone 2.22, 
which would be fashioned from (+)-Wieland-Miescher ketone12 (WMK, (+)-2.23). All of the 
stereocenters present on the eastern hemisphere would thus arise from the direction of the 
central sterocenter of (+)-WMK in a stereochemical linear approach.13 
 
2.2 MODIFICATIONS TO THE EXISTING ROUTE TO THE EASTERN HEMISPHERE 
 
At the outset of the present synthetic effort, enantiopure Wieland-Miescher ketone 
(WMK), obtained from the Hajos-Parrish reaction14, was employed as the starting point of 
the synthetic route, in keeping with the earlier work of the group. Thus, triketone 2.26 
(Scheme 2.3), upon exposure to L-proline in DMSO over 6 days, suffered enantioselective 
cyclodehydration to give (+)-WMK in approximately 68% ee in a typical run. 
 30 
Scheme 2.3. Comparison of the Hajos-Parrish Reaction and the Shibasaki Modified 
Hajos-Parrish In the Production of Chiral, Non-racemic Starting Synthon 
 
O
O
L-Phe (30 mol %)
PPTS (50 mol %)
DMSO (1 equiv)
50 °C, sonication,1 day
(90%, 89% ee, 
 >95% ee after recrys.) (+)-2.30C-4-Methyl WMK
New Route - Shibasaki Modified Hajos/Parrish
OO
O
DABCO
DME, rt
16 h
(quant.)
O O
O
OO
O
OAcOH (cat.)
water
hydroquinone
75 °C, 6h
(quant.)
L-Proline
DMSO
rt, 6 days
(56%, ca. 68% ee) (+)-2.23
Wieland-Miescher Ketone
Old Route - Hajos/Parrish Reaction
One recrystallization required
to obtain optically pure material
Multiple recrystallizations
required to obtain optically 
pure material
O
OO
O
2.24
2.25
2.26
2.27
2.28
2.29
 
 
In order to enrich the optical purity to a higher level, serial recrystallizations had be 
performed, and as many as 100 such operations were carried out by L. Kurti in the early 
stages of the project.4   
It was clear from the outset that obtaining the requisite amount of chiral, non-racemic 
starting material in this manner was untenable due to the time consuming nature of both the 
Hajos-Parrish reaction and the subsequent recrystallization operations. A better method was 
sought for producing the enantioenriched feedstock necessary for the synthesis effort. A 
review of the literature revealed a report by Hagiwara and Uda15, in which the C-4 methyl 
analog of (+)-WMK (+)-2.30 was synthesized by employing L-phenylalanine as a catalyst in 
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the de-symmetrizing cyclization reaction of triketone 2.29 to give a product possessing 
approximately 90% ee. Importantly, only one recrystallization was then needed to enhance 
the optical purity to >95% ee. Approximately 17 years after this initial report, Shibasaki and 
co-workers reported an improved procedure16 in which L-phenylalanine is employed under 
sonication conditions to produce (+)-2.30 under nearly solvent-free conditions (1 equiv of 
DMSO). This procedure was chosen to produce the material needed for the total synthesis, 
and in our hands was used very effectively. The Shibasaki-modified Hajo-Parrish reaction 
could be scaled to as large as 100 g very easily due to the near solvent-free conditions. The 
16 h reaction time (cf. 6 days for previous procedures) also enabled a faster turnaround of 
material. Over 300 g of (+)-2.30 were produced in this manner.  
The fact that the C-4-methyl group is present in the new starting synthon is an 
additional bonus, as this carbon is present in the target compound. In the previous work, the 
corresponding carbon was installed using the Kirk-Petrow reaction17 (Scheme 2.4),  
 
Scheme 2.4 – (+)-C-4 Methyl WMK Streamlines Synthesis of Eastern Hemisphere 
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wherein unsaturated ketone (+)-2.31, the monoketal of (+)-WMK obtained by the action of p-
toluenesulfonic acid and ethylene glycol, was treated with thiophenol, formaldehyde, and 
triethylamine in ethanol to affect a Michael addition-alkylation reaction to install the requisite 
carbon, carrying a thiophenyl group (compound (+)-2.32).  Subjection of (+)-2.31 to 
dissolving metal reduction, followed by trapping of the intermediate lithium enolate as the 
trimethylsilyl enol ether, furnished 2.34, the product of protonation of the less hindered !-
face, along with thiophenol by-product that must be removed chromatographically. On the 
other hand, employment of C-4-methyl WMK in the analogous sequence obviates the need 
for the Kirk-Petrow step, and provides silyl enol ether 2.34 without the need for 
chromatography, a non-trivial operation on this moisture and acid-sensitive compound, since 
no thiophenol by-product is present. Because these changes are early in the sequence, the 
benefit reaped from the time and solvent savings can be appreciated. In the event, other 
benefits were realized from the elimination of the Kirk-Petrow step from the sequence (vide 
infra).  
 Another minor modification to the dissolving metal reaction involves removing the 
residual ammonia at the expungement phase using low vacuum (Figure 2.5). In the  
 
Figure 2.5 – Experimental Setup for Dissolving Metal Reaction 
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published procedure18 for this reaction, an inert gas sweep was used to expunge the 
ammonia from the reaction vessel prior to the enolate-trapping step. However, it was found 
to be preferable to use vacuum instead of an inert gas sweep, not only because of the time 
consideration (~2-3 h vs. 8 h), but because of the increased efficiency with which the last 
traces of ammonia could be removed. It is important to remove all the ammonia before 
proceeding to the enolate-trapping step, as residual ammonia will consume the 
chlorotrimethylsilane and cause unreacted enolate to remain. 
Another advantage of employing the C-4-methyl WMK is that the absence of 
thiophenol contaminant facilitates the next step in the sequence, namely, the scandium  
 
Scheme 2.5. Elaboration of Silyl Enol Ether to Unsaturated Aldehyde (+)-2.21 
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(III) triflate-catalyzed aldol of the enol silane with formaldehyde in aqueous milieu (Scheme 
2.5) to provide, stereoselectively, the hydroxymethyl ketone (–)-2.35. Thiophenol inhibits this 
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reaction by interfering with the Lewis acid catalyst. Following a Gribble-Evans diastereo-
selective reduction19 using tetra-methylammonium triacetoxyborohydride and acid-mediated 
removal of the ketal, the diol (–)-2.36 was protected as the bis-tert-butyldimethylsilyl ether (–
)-2.37. Kinetic enolization of the ketone, followed by trapping of the potassium enolate with 
N-phenyl-trifluoro-methylsulfonimide then provided enol triflate (–)-2.38, which was 
subjected to a Stille palladium-catalyzed carbonylation to furnish the enal (+)-2.21, ready for 
the installation of the C-3,C-12 stereo-diad of (+)-nodulisporic acid A. 
 In the previous work, the installation of the C-3,C-12 stereocenters in a 
stereoselective fashion was accomplished by the method of Koga20 (Scheme 2.6),  
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wherein an unsaturated aldehyde (+)-2.39 was condensed with enantioenriched (S)-tert-
butyl 2-amino-3,3-dimethylbutanoate to give the aldimine (+)-2.40. The aldimine was then 
treated with a Grignard reagent, whereupon a metalloenamine is formed in a stereoselective 
fashion, mediated by a chelation-controlled transition state (2.41). The metallo-enamine was 
next trapped by the in situ addition by an alkylating agent, to affect formation of a second 
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carbon-carbon bond, also in a stereoselective fashion. On simple systems like the one 
shown on Scheme 2.6, the product in which both appended groups are in the !-
configuration resulted, after acidic removal of the chiral auxiliary, to give (+)-2.44. 
Recognizing that the eastern hemisphere sub-target also possesses this 
configuration, the Koga protocol was chosen to install this feature (Scheme 2.7). In the 
event, the Koga reaction was performed on enal (+)-2.21 by previous workers on the  
 
Scheme 2.7 – Use of the Koga Reaction in the Synthesis of the Eastern Hemisphere 
 
OTBS
OTBSOHC
H
t-BuO2C NH2
t-Bu
cat. HCl, toluene
azeotrope OTBS
OTBS
Nt-BuO2C
t-Bu
MgBr
H
(87% BORSM)
(60%, 3 steps)
i.
 
     (4 equiv)
ii. MeI, HMPA, THF
    –15 oC to 23 oC
OTBS
OTBS
Nt-BuO2C
t-Bu
H
10% oxalic acid
OTBS
OTBSOHC
H
C-12 Stereochemistry
Undesired
C-3 Stereochemistry
Desired
12
3
(+)-2.21 (+)-2.45
2.46
(+)-2.47  
 
project.21 They found that, while the C-3 methyl group did indeed have the desired alpha 
configuration, the vinyl group in fact had added from the beta face to yield the undesired C-
12 stereoconfiguration. The reason for this result is unclear, but one possible explanation is 
that the inherent substrate selectivity of the bicyclic structure overrides the influence of the 
chiral auxiliary (Figure 2.6). There is literature precedence for axial addition of sterically 
undemanding nucleophiles to rigid ring systems,22 which in the present case agrees with the 
observed results. 
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Figure 2.6. Possible Rationale for the Outcome of the Koga Reaction 
 
H
Me Me
OTBSOTBSH
Nu
N H
Me Me
OTBS
OTBSH
Nu
NH H
Me Me
OTBS
OTBSH
Nu
NXC XC XC
M
 
 
The unexpected outcome of the Koga reaction did not initially present a problem for 
the synthetic effort.  Correction of the C-12 configuration was achieved via ozonolysis  
 
Scheme 2.8– Synthesis of First-Generation Eastern Hemisphere 
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to aldehyde 2.49 (Scheme 2.8) followed by epimerization to the preferred equatorial 
configuration (after adjusting the oxidation state of the aldehyde to the carboxylate) to 
furnish ester (+)- 2.50. This sequence only added one synthetic operation to the route (i.e., 
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epimerization) leading to the first-generation eastern hemisphere (+)-2.4, the synthesis of 
which was completed by reduction of the aldehyde (+)-2.50 and intramolecular cyclization 
with the ester.21 The reader should recall from earlier in the chapter (see Scheme 2.1) that 
lactone (+)-2.4 proved not to be a viable eastern hemisphere for the construction of NsAA. A 
new 2nd-generation synthetic strategy was therefore developed (see Figure 2.3) wherein (+)-
2.50 was viewed as a common advanced intermediate. 
Despite the minor problem presented by the unexpected outcome of the Koga 
reaction in the first generation work (Schemes 2.7 and 2.8), the inability of the Koga reaction 
to install selectively the C-12 stereogenic center with the desired configuration would have 
more troublesome implications for the present work (Scheme 2.9). In particular, to access 
the desired iodoenone eastern hemisphere sub-target 2.18 using  
 
Scheme 2.9. Inversion of C-12 Stereocenter 
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the ring-closing metathesis route outlined in the 2nd-generation retrosynthesis (Figure 2.3), 
the carbon that was excised in the ozonolysis of (+)-2.47  needed to be replaced after the 
epimerization of the aldehyde (cf. 2.50). Furthermore, the oxidation state of the ester (–)-
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2.51 needed to be re-adjusted to that of an aldehyde (cf. (–)-2.53), in order to construct the 
diene needed for the ring-closing metathesis, the key step for construction of the fused 5-
membered ring. 
Despite these shortcomings, the enone (+)-2.54 (Scheme 2.10) was initially 
synthesized using the Koga route. Diene 2.20 was made via reaction of aldehyde (–)-2.53 
with vinylmagnesium bromide, followed by ring-closing metathesis  
 
Scheme 2.10. Synthesis of Enone (+)-2.54 
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and oxidation of the intermediate alcohol in situ with PCC to furnish the desired enone. 
However, in order to provide sufficient material for: (a) completion of the eastern 
hemisphere, (b) support studies for coupling to the western hemisphere, and (c) studies to 
avoid the excision and replacement of carbons and adjustments of oxidation state in the 
route, a new strategy to access (+)-2.54 was required. 
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2.3 CONJUGATE ADDITION TO A 6,6,6-RING SYSTEM ENONE AS AN ALTERNATIVE 
TO THE KOGA REACTION TO ACCESS ENONE (+)-2.54 
 
In the search for an alternative method to install the critical C-3,C-12 stereocenters, 
inspiration was initially found in previous work from the Smith group23 in the area of 
tremorgenic alkaloid synthesis, namely, (–)-paspaline (–)-2.55 (Figure 2.7).  
 
Figure 2.7. Smith Synthesis of Paspaline: Retrosynthesis and Key Step 
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In the first generation synthesis of paspaline,24 the synthetic strategy centered 
around the installation of the 6a,12b stereocenters (analogous to the C-3,C-12 
stereocenters of nodulisporic acid A) by way of manipulation of unsaturated ketone 2.59. In 
the forward direction, this transformation would be accomplished via a dissolving metal 
reduction of the unsaturated ketone to give a silyl enol ether, followed by activation of the 
enol ether as the lithium enolate, which could then be trapped by an appropriate alkylating 
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agent to give ketone 2.58, which bears the required trans-5,6 ring fusion and !-methyl 
group. Precedence for this strategy was found in Trost’s synthesis of aphidicolin,25 in which 
 
Scheme 2.11. Precedent for installation of trans-5,6 Ring Fusion from Trost’s 
Aphidicolin Synthesis 
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unsaturated ketone 2.60 was transformed to ketone 2.62, possessing the requisite trans-5,6 
ring fusion (Scheme 2.11). 
In the event (Scheme 2.12), unsaturated ketone 2.59, produced in 8 steps from (+)-
WMK, was subjected to dissolving metal conditions followed by alkylation with methyl iodide. 
Unexpectedly, the cis-5,6 product 2.63 was isolated and not the expected trans-5,6 product. 
 
Scheme 2.12. Unexpected Outcome of Reduction/Alkylation Sequence 
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The reason for this result was not fully understood. Further studies were conducted to 
determine if the Trost observation arose from O-alkylation of the intermediate enolate 
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followed by Claisen rearrangement. These experiments also yielded only the cis products. 
Eventually, conditions were found in which the desired trans-fused product 2.58 could be 
obtained from the reduction/alkylation sequence in 15% yield. 
A second report23 was published later the same year by the Smith group in which a 
second-generation strategy was outlined to address the unsatisfactory outcome of the first 
strategy in fashioning the desired C-6a,C-12 stereoconfiguration. The new strategy involved 
pursuing ketone 2.65 (Figure 2.8), which was envisioned as a common intermediate for the 
synthesis of several different tremorgenic alkaloids like paspalicine,26 paspalinine,22 and 
 
Figure 2.8. Second-Generation Strategy for the Synthesis of Paspaline 
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paxilline. This ketone would in turn be derived from tricyclic enone 2.66, which would in turn 
be built up from (+)-WMK. In the synthetic direction, the requisite !-methyl group would be 
installed through a conjugate addition to enone 2.66, which would be directed by the central 
"-methyl group adjacent to the enone double bond. Enone (–)-2.66 was synthesized from 
ketal (+)-2.67 (Scheme 2.13), derived in two steps from (+)-WMK, via a Robinson annulation 
sequence. Thus, the enamine resulting from condensation of ketone (+)-2.67 with 
benzylamine was treated with methyl vinyl ketone to give diketone 2.68. This diketone was 
then cyclized with sodium hydride in benzene to give the key enone (–)-2.66. The C-6a 
stereocenter of this enone is set by way of thermodynamic equilibration to the more stable 
equatorial configuration through dienolate formation/pro–tonation under the basic conditions 
of the cyclization reaction. 
 
Scheme 2.13. Synthesis of Enone Precursor for Conjugate Addition in the Paspaline 
Total Synthesis 
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 The next task was to find an appropriate reagent for the conjugate addition. A 
number of different organometallic agents were explored, including lithium dimethylcuprate 
(which gave only 1,2-addition products), several different other types of cuprates (i.e., 
Noyori’s phosphinyl cuprates,27 Lipshutz’s higher-order cuprates28) and aluminum reagents, 
specifically, Nagata’s diethylaluminum cyanide.29 The latter gave satisfactory results, but the 
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complication of having to transform the cyano group into a methyl group detracted from the 
usefulness of this reagent.  In the end, a nickel-catalyzed addition of dimethylzinc30, 31 to (–)-
2.66 gave the product of methyl addition directly to provide the desired trans-fused 
configuration. The resulting silyl enol ether 2.69 was transformed into the desired 5,6,6-ring 
system (–)-2.65 through the route shown in Scheme 2.14. The success of this strategy 
provided the inspiration to apply a similar construct to the synthesis of the eastern 
hemisphere of nodulisporic acid A. 
 
Scheme 2.14. Synthesis of Key Intermediate in Smith’s Paspaline Total Synthesis 
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Application of this strategy to the retrosynthetic analysis of the eastern hemisphere of 
NsAA reveals enone 2.74 (Figure 2.9), which is in turn fashioned from the diol (–)-2.36, an 
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intermediate already in hand. In the synthetic direction, conjugate addition of a suitable 
organometallic agent, followed by a ring contraction sequence analogous to the one outlined 
in Scheme 2.15, gave ketone 2.73. At the outset of implementing the conjugate addition 
strategy, we recognized that there are distinct differences in the structural features of the 
substrate used in the paspaline synthesis     (–)-2.66 and the requisite substrate for the 
present work, 2.74. Namely, the presence of a double bond in the central ring of tricyclic 
enone (–)-2.66 appeared to impart a flatter molecular architecture compared to that of 2.74. 
 
Figure 2.9. Second Generation Retrosynthetic Analysis of the Eastern Hemisphere of 
NsAA 
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However, it was not clear how this difference would affect the stereochemical outcome of 
the conjugate addition, and so we resorted to experiment to assess the feasibility of this 
approach.  
The requisite enone for the second-generation approach was made according to  
Scheme 2.15. Diol (–)-2.36 was protected as the acetonide to give ketone (–)-2.75,which 
was subjected to imine formation/alkylation with methyl vinyl ketone to give diketone 2.76. 
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Base-induced cyclization with sodium hydride in benzene provided the enone (–)-2.74, the 
substrate for conjugate addition studies. 
Initially it was found that the same catalyst/organometal system used in the 
paspaline work, namely, nickel (II) acetylacetonate and dimethylzinc, did not react with 
enone (–)-2.74, and only starting material could be recovered. Pleasingly, an alternative 
 
Scheme 2.15. Synthesis of Enone (–)-2.74 
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method employing the same catalyst, but trimethylaluminum as the alkylmetal reagent,32 
provided the conjugate addition product, which, in initial studies was not trapped as the silyl 
enol ether but hydrolyzed to the ketone in order to ascertain the stereo-chemical outcome of 
the reaction (Scheme 2.16). Crystallization of the product and X-ray analysis revealed 
 
Scheme 2.16. Conjugate Addition of Methyl Group Takes Place from !-Face 
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that instead of the desired !-methyl product 2.78, the product of "-addition, (+)-2.77,  was 
instead formed (Figure 2.10). One possible reason for this outcome is the aforementioned 
difference in topology of enone (–)-2.74 compared with enone (–)-2.66, with (–)-2.74 having 
a puckered structure that shields the !-face, while (–)-2.66 has a flatter structure 
 
Figure 2.10. ORTEP of Compound (+)-2.77 with 30% Probability Thermal Ellipsoids  
 
 
 
that allows the central angular methyl group to dictate the facial selectivity, directing 
nucleophiles to the !-face. Calculated structures of both (–)-2.74 and (–)-2.66 using 
GAUSSIAN33 at the 6-31G(d) level support this notion (Figure 2.11). Note the overall 
puckered structure of (–)-2.74 (left structure), while (–)-2.66 has a flatter structure. 
Calculations on the LUMO of each structure also reveals that the accessibility of the #* on 
the !-face is much higher for (–)-2.66, due not only to the flat structure but also to the 
absence of axial protons on the adjacent ring blocking the approach of nucleophiles. The 
view shown in Figure 2.11B reveals that access to the #* (the LUMO) on the !-face (yellow 
lobe closest to viewer) is less obstructed for (–)-2.66 than for the corresponding orbital of (–
)-2.74. The puckered structure of (–)-2.74 is likely due to the 1,3-diaxial interaction between 
the two angular methyl groups. 
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Figure 2.11. Calculated Structures of (–)-2.74 (right) and (–)-2.66 (left) Using 
GAUSSIAN at 6-31G(d) Level of Theory. A) Geometry Optimized Structures, Top view 
is shown. B) Molecular Orbitals, !* (LUMO) is shown in green and yellow. 
 
A) 
                
B)                                 
 
 At this stage, we recognized that application of the 6,6,5-enone conjugate addition 
approach would not be viable as an efficient approach to the requisite Eastern Hemisphere 
of NsAA. 
 
2.4. THE USE OF CUPRATES TO INSTALL THE CRITICAL C-3,C-12 STEREOCENTERS 
OF EASTERN HEMISPHERE 2.18 
 
 The search for a stereoselective method to install the C-12 vinyl group continued, 
and after some reflection on the problem, the use of cuprates to accomplish this task was 
investigated. Cuprates are known to affect 1,4-addition on unsaturated carbonyl systems 
(usually unsaturated ketones) of various kinds. A search of the literature reveals that 
 48 
unsaturated aldehydes are not employed as often as unsaturated ketones. Consequently, 
this class of substrates is not as well studied and the substrate scope has not been fleshed 
out as much as the other classes. These limitations notwithstanding, we focused on the 
reports of adding cuprates to unsaturated aldehydes. Normant34-36 found that unsaturated 
aldehydes suffered 1,4-addition of cuprates through the use of copper (I) bromide 
dimethylsulfide and Grignard reagents in the presence of chlorotrimethylsilane to give the 
silyl enol ethers in good yield. Interestingly, the use of copper (I) bromide without dimethyl 
sulfide gave exclusively 1,2-addition products. The use of chlorotrimethylsilane was critical. 
It was initially thought that this reagent was acting simply as an enolate trapping agent or a 
Lewis acid activator of the unsaturated carbonyl pi-system. Subsequent to these studies, 
Kuwajima and Nakamura37 reported optimized conditions for adding cuprates to unsaturated 
aldehydes. 
An example of the use of cuprates with chlorotrimethylsilane and unsaturated 
aldehydes is found in Snider and co-worker’s synthesis of (+)-erinacine A (Figure 2.12).38 
They found that enal 2.79 underwent 1,4-addition smoothly with the Grignard-derived 
 
Figure 2.12. Use of Cuprate on Unsaturated Aldehyde in Snider’s  (+)-Erinacine A 
Synthesis 
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cuprate in the presence of chlorotrimethylsilane to give enol ether 2.80, which could be 
alkylated with methyl iodide using Ireland’s conditions39 (KOtBu, MeI) to give the formal 
addition/alkylation product 2.81. The latter was an important finding since an analogous 
process would need to be performed on NsAA’s eastern hemisphere intermediate (vide 
infra). Snider pointed out that the stereochemical outcome of this reaction could not be 
predicted on the basis of literature precedence, since there were examples of both !-40 and 
"-attack41 on bicyclic unsaturated ketone substrates bearing an angular methyl group.  
Some analysis of known data on the mechanism of the process was therefore in 
order, to assess whether or not cuprates would actually add in the preferred manner to enal 
(+)-2.21. Studies by Corey and Boaz,42, 43 and subsequently by Kuwajima and Nakamura,37 
suggested that chlorotrimethylsilane was not acting merely as a trapping agent or a 
 
Figure 2.13. Corey’s Cuprate Addition Experiment 
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Lewis acid, but instead was acting as an accelerant. In studies performed on unsaturated 
carbonyl compound 2.82 (Figure 2.13). Corey postulated that the initial complexes 2.84 and 
2.89 (arising from interaction of the d orbitals of the copper and the !3* of the enone) were in 
equilibrium with the uncomplexed starting materials. It was found that in the absence of 
chlorotrimethylsilane, the cis addition product 2.88 formed in preference to the trans product 
2.87 (92:8 cis/trans), while in the presence of chlorotrimethylsilane, the opposite was noted 
(1:99 cis/trans). The expectation had been that the trans product would predominate, base 
on the notion that complex 2.84 would predominate in the equilibrium mixture due to 
hyperconjugative stabilization by the C-O "* orbital of the cuprate coordination. These 
observations were rationalized by postulating that, in absence of TMSCl, complex 2.89 goes 
on to product faster than 2.84 due to sterics, even though it is the minor component of the 
equilibrium mixture. On the other hand, in the presence of TMSCl, the major component, 
2.84, rapidly interacts with TMSCl and is converted to product before it can revert back to 
starting materials, thus leading to trans product 2.87. NMR studies of mixtures of 
chlorotrimethylsilane and enone revealed that no shift of the enone protons occurred, 
suggesting that Lewis acid activation was not the reason behind these observations.  
The implications of the preceding results on the present work were compelling, and 
studies were carried out on the usefulness of cuprates in the formation of the C-3,C-12 
stereodiad. The rationale for selective addition of an #-vinyl group is outlined in Figure 2.14. 
The cuprate should preferentially form the initial complex from the #-face of the enal (2.92, 
shown with !* orbitals), due to the steric environment of the $-face, which is congested 
because of the angular methyl group. Such an event would lead in turn to the product 
bearing a #-vinyl group 2.98. 
In the event, the Normant-type cuprate derived from vinylmagnesium bromide and 
copper (I) bromide dimethylsulfide complex was found to add selectively to enal (+)-2.21 to 
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give the product bearing a !-vinyl group (Scheme 2.17). 1H NMR spectra of the silyl enol 
ether products 2.99 and 2.100 were difficult to interpret due to the presence not only of C-12 
diastereomers, but also E and Z olefin isomers about the enol ether itself. Further 
contamination by small amounts of 1,2-addition product added to the problem. The silyl enol 
ethers could in turn be converted to the C-3 methylated products (–)-2.53 and (+)-2.47, 
 
Figure 2.14. Rationale for Use of Cuprate in 1,4-Addition to Enal (+)-2.21 
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both of which had been made independently using the earlier route (vide supra, Schemes 
2.8 and 2.9). Silica chromatography gave a mixture of products (–)-2.53, (+)-2.47, and 
hydrolysis by-products 2.101, all of which co-eluted in 2% ethyl ether/hexanes. 1H NMR 
analysis was straightforward at this point, and an estimate of the product distribution could 
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be made from the different aldehyde peaks of the products. Unfortunately, the mixture of 
products could not be separated chromatographically at this point, even after considerable 
experimentation on purification conditions. 
 
Scheme 2.17. Normant-type Cuprate Adds Selectively to Enal (+)-2.21 To Yield 
Desired C-12 Stereoisomer 
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 A short optimization study of the cuprate conditions was carried out (Table 2.1). 
Catalytic copper was effective in the reaction, giving a ~2:1 ratio of the desired to undesired 
products as determined after their conversion to the methylated products (+)-2.47 and (–)-
2.53 (vide infra, see Table 2.2). The Normant-type cuprate gave a modest boost in 
selectivity to ~3:1 when a 5 minute addition period was employed to add the enal (+)-2.21 
and TMSCl to the reaction mixture. However, when a slower 30 minute addition period to 
add the enal was used, the selectivity increased to ~6:1. This was the maximum selectivity 
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achieved and varying other parameters like temperature or the organometallic reagent (the 
Gilman-type cuprate is shown in the last entry) did not improve the selectivity. It is 
interesting to note the low selectivity observed with the Gilman cuprate (Table 2.1, last 
entry). 
 
Table 2.1. Optimization of Cuprate Conditions 
 
OTBS
OTBSOHC H
OTBS
OTBSHTMSO
Conditions
Reagent CuBr·S(CH3)2/RM Time of Add./Enal Yield 2.99/2.100a
MgBr
MgBr
MgBr
Li
5:95
1:2
1:2
1:2
5 min
5 min
30 min
30 min
85%
85%
91%
47%
2.1:1
2.8:1
5.7:1
1:1.4
OTBS
OTBSHTMSO
2.99 2.100
MgBr 1:2 4.3:1–95 65%30 min
Temp. (°C)
–78
–78
–78
–78
(+)-2.21
a. Product ratio was inferred from 1H NMR of crude product of the alkylation of 2.99/2.100 in next step.  
 
 Optimization of the alkylation conditions of the silyl enol ether products of the cuprate 
reaction (Table 2.2) proved to be the most challenging aspect of the synthesis of the eastern 
hemisphere. Initially, the method of Stork44 was investigated, wherein methyllithium-
mediated conversion of the silyl enol ether to the lithium enolate is employed. At -78 °C, this 
method gave the desired product in 23% yield (as determined by 1H NMR), whereas higher 
temperatures (-40 °C) resulted in lower yield (entries 1 and 2). Ireland’s protocol39, 45, 46 using 
potassium tert-butoxide as well as variants using potassium ethoxide gave yields ranging 
from 18-29%, with the balance being products of O-alkylation. Finally, the method of 
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Kuwajima and Nakamura47 involving benzyltrimethyl ammonium fluoride (BTAF)-mediated 
activation of the silyl enol ether gave 32% when performed at 0 °C in THF and 10 equiv of 
methyl iodide. 
 
Table 2.2. Optimization of Alkylation Conditions 
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All of the methods tested gave varying amounts of hydrolysis products 2.101, even when 
careful precautions were taken to exclude water.  
The Kuwajima-Nakamura method was used to advance the material through the 
route, but it should be noted that the reproducibility of this protocol is highly variable owing 
to the difficulty of drying the fluoride reagent. Even when the reagent is dried in the 
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prescribed manner (heating at 70 °C under high vacuum for 16 h), the reaction can yield as 
much as 40-50% of hydrolysis products. In light of this difficulty, it may be preferable to use 
the Stork method (methyllithium-mediated activation of the silyl enol ether) since this method 
gave almost no hydrolysis, owing to the use of excess base (which scavenges adventitious 
water), even though the yield is slightly lower when this procedure is employed.  
 At this point in the synthetic route, a method of separating the desired product of 
addition/alkylation (–)-2.53 from the undesired diastereomer and the hydrolysis products 
was required. We postulated that switching the protecting group on the primary alcohol of (–
)-2.53 from a TBS-ether to a different group might alter the chromatographic behavior of the 
material enough to enable the separation. Additionally, this protecting group switch would be 
necessary for any future efforts to attach the sidechain of NsAA, since previous workers on 
the project noted that a primary-selective removal of the TBS group was not feasible.2 A 
benzyl group was chosen for this task. 
 To this end (Scheme 2.18), the mixture of products (–)-2.53/(+)-2.47 was subjected 
to TBS removal conditions (TBAF, THF) to give the corresponding diols 2.102, which were 
also not separable chromatographically. Silver (I) oxide-mediated alkylation of the primary 
alcohol selectively gave the mono-protected diols 2.103 in good yield, although this mixture 
of products also resisted separation on silica gel. Finally, after conversion of the secondary 
hydroxyl to the TBS ether with TBS-triflate and 2,6-lutidine, the material yielded to 
chromatographic separation and aldehyde (–)-2.104 could be obtained as a single 
diastereomer. 
 
 
 
 
 56 
Scheme 2.18. Protecting Group Switch Enables Purification of Aldehyde (–)-2.53 
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Advancement of aldehyde (–)-2.104 to the second-generation eastern hemisphere 
(Scheme 2.19) was carried out by treatment with vinyl magnesium bromide to give diene 
2.105 as an inconsequential mixture of diastereomers. Diene 2.105 underwent ring-closing 
metathesis smoothly under the influence of Grubbs’ first-generation catalyst to give alcohol 
2.106, which was not isolated, but instead oxidized in the same pot using PCC buffered with 
sodium acetate, to provide the key enone (+)-2.107 in good yield for the two trans–
formations. Finally, treatment of the enone with iodine in pyridine/carbon tetrachloride 
(Johnson’s conditions48) gave the second-generation eastern hemisphere (+)-2.108 in a total 
of 19 steps and 2% overall yield. In all, 7 synthetic steps were eliminated from the route by 
employing C-4-Me-WMK (+)-2.30. In addition, the use of a Normant-type cuprate in an 
addition/alkylation sequence that selectively installs the desired C-3 and C-12 stereocenters 
could be introduced. 
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Scheme 2.19. Completion of the Second-Generation Eastern Hemisphere of (+)-
Nodulisporic Acid A 
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2.5. PROBLEMS ENCOUNTERED WITH SECOND-GENERATION STRATEGY AND 
DEVELOPMENT OF TANDEM PALLADIUM-CATALYZED INDOLE FORMATION-BASED 
STRATEGY 
 
Concurrent with the work outlined above which culminated in the synthesis of 
eastern hemisphere (+)-2.108, Dr. Vladimir Simov49 and later Dr. Junha Jeon50 carried out 
studies to assess the feasibility of the second generation fragment coupling strategy. They 
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employed the iodoenone derived from estrone methyl ether,9 (–)-2.110 (Scheme 2.20), as a 
surrogate eastern hemisphere, owing to the similar structural features possessed by this 
compound. These workers found that (–)-2.110 would undergo Stille coupling to western 
hemisphere (+)-2.109 to give advanced intermediate (–)-2.111. The latter could be 
transformed to vinyl triflate 2.112, the intramolecular palladium-catalyzed carbon-nitrogen 
bond-forming (Buchwald-Hartwig coupling) substrate, through a  sequence of 1,4-reduction, 
vinyl triflate formation, and removal of the tert-butyloxycarbonyl protecting group. 
Unfortunately, 2.112 was found to be highly unstable, having a half-life of 24 h at -20 °C. 
Furthermore, when 2.112 was subjected to Buchwald-Hartwig coupling conditions, an 
unexpected triflate ejection product (+)-2.113 was isolated. A survey of the literature  
 
Scheme 2.20. Problem with Second-generation Fragment Coupling Strategy 
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revealed precedence for this type of reactivity in the work of Overman51 (Scheme 2.21), who 
showed that enones could be formed through base-mediated elimination of vinyl triflates like 
2.114 to give the corresponding enone 2.115. 
 
Scheme 2.21. Overman’s Precedent for Triflate Ejection 
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 All efforts to achieve cyclization of (+)-2.113 under acid- or base-mediated conditions 
lead to decomposition of the starting material, with no fused indole products being observed. 
These problems precipitated a new effort to re-design the synthetic plan to overcome the 
problems inherent with the 2nd-generation union strategy. We realized that the order of 
events of the fragment-coupling process was key to the success of any strategy. It occurred 
to us that the carbon-nitrogen bond forming reaction may need to take place first (Figure 
2.15), followed by carbon-carbon bond formation to form the highly strained fused-ring 
indole system, in order to circumvent any problems of the type outlined in Scheme 2.19.  
 
Figure 2.15. Revised Fragment Union Strategy  
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After formation of the carbon-nitrogen bond, a second bond-forming reaction would close 
the final ring of the fused indole system. The latter reaction could in theory be a discrete 
reaction performed on the isolated enamine-type product of the first event, or could take 
place in a tandem fashion in the same reaction pot. We performed some initial studies on 
simple systems and found that enamine intermediates of the type shown on Figure 2.15 
were highly unstable, and only hydrolysis products could be obtained from Buchwald 
Hartwig coupling reactions (not shown). We therefore chose to pursue the tandem 
approach. 
 A number of metal-mediated processes for forming indoles in the context of 
polycyclic frameworks have been reported in recent years,52-54 but the one that attracted out 
attention in this context was that of Barluenga,55 in which an o-haloanaline and a vinyl halide 
could be joined in a tandem palladium-catalyzed process to give indoles (Scheme 2.22). As 
an example, 2-bromoaniline 2.116 and bromostyrene 2.117 could be fashioned into indole 
2.118 through subjection to palladium catalysis under the influenceof DavePhos,56 a ligand 
 
Scheme 2.22. Barluenga’s Tandem Palladium-catalyzed Indole Synthesis 
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of the biaryl phosphine class advanced by the Buchwald group recently.57 The indole was 
formed in 64% yield. The process presumably involves an initial Buchwald-Hartwig coupling, 
followed by a Heck-type process or intramolecular attack of the nucleophilic enamine on the 
electrophilic palladium (II) center of the oxidative insertion product, followed by reductive 
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elimination with carbon-carbon bond formation. It was notable that in this report, only 
primary anilines and simple vinyl halides lacking 2-substitution were shown to participate in 
the reaction. Clearly, some work was in order to expand the substrate scope of the process 
for employment in the context of the nodulisporic acid A total synthesis. 
To this end, estrone methyl ether was again chosen as a model system for the 
eastern hemisphere. The requisite vinyl bromide derived from estrone methyl ether58 (+)-
2.121 (Scheme 2.23) was synthesized by employing the method of Myers,59 in which the 
ketone (+)-2.119 was condensed with bis-TBS-hydrazine under scandium (III) triflate-
catalysis to give the TBS hydrazone (+)-2.120. The hydrazone was then treated with N-
bromosuccinimide in pyridine to give the vinyl bromide (+)-2.121. The use of TBS-protected  
 
Scheme 2.23. Synthesis of the Vinyl Bromide Derived From Estrone Methyl Ether for 
Studies of Tandem Buchwald-Hartwig/Heck Reaction  
 
 
H H
H
OMe
O
H H
H
OMe
NN
TBS
H
H H
H
OMe
Br
NN
TBS
H TBS
H
Sc(OTf)3
50 °C, CHCl3
(67%)
NBS
pyridine, 0 °C
(97%)
(+)-2.119 (+)-2.120
(+)-2.121  
hydrazones is reported to circumvent many of the known complications of using unprotected 
hydrazones, chiefly the formation of dimers. 
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With vinyl bromide (+)-2.121 in hand, studies employing 7-chloro indoline 2.122, 
synthesized according to literature60 procedures, were initiated. To this end, vinyl bromide 
(+)- 2.121 and 2.122 were subjected to palladium-catalyzed coupling conditions employing a 
number of different ligands (Scheme 2.24).  The biarylphosphane ligand XPhos61 (2.125) 
was effective in forming the fused indole (+)-2.124 in 41% yield. Bidentate ligands like 
Xantphos62 (2.128) gave only homocoupled by-products of 2.122, and other biaryl–
phosphane ligands gave the desired product along with proto-dehalogenated vinyl bromide 
as a by-product. 
 
Scheme 2.24. Tandem Coupling Demonstrated on Model System 
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Union of 2.122 and (+)-2.121 represents a major advance of the scope of the 
Barluenga process, and supports the hypothesis that a tandem Buchwald-Hartwig/Heck-
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type process can be used to forge fused indoles within the context of complex molecule 
synthesis. Possible mechanisms for this process are shown in Figure 2.16. The first step in 
the process is expected to be a Buchwald-Hartwig coupling to form intermediate enamine 
2.129. Oxidative insertion of palladium (0) into the carbon-chlorine bond gives 2.130, which  
 
Figure 2.16. Possible Mechanistic Pathways of Tandem Indole-forming Reaction 
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can follow a few possible pathways. One such path is an intramolecular Heck coupling to 
provide the observed product. Another path involves intramolecular attack of the enamine 
on the electrophilic palladium (II) center, followed by reductive elimination and loss of a 
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proton to give the same fused indole product. The former is less likely due to the locked 
trans orientation of the palladium and !-hydrogen in the carbopalladation intermediate, 
precluding !-hydride elimination (a syn process) on this substrate. 
These findings were expanded upon by postdoctoral associate Dr. Junha Jeon, who 
demonstrated the tandem coupling on a still more complex system (Scheme 2.25). Fully  
 
Scheme 2.25. Tandem Coupling by Dr. Junha Jeon to form Advanced Intermediate of 
Estrone analog of NsAA 
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elaborated western hemisphere (–)-2.131, containing all of the carbons of the western half 
of NsAA, was successfully coupled to estrone-derived vinyl bromide (+)-2.121 in 40-45% 
yield, demonstrating that the method was viable on fragments approaching the complexity of 
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those needed for the total synthesis of NsAA. On the basis of these results, a new synthetic 
strategy toward NsAA was formulated. 
 
2.6. SYNTHESIS OF THIRD-GENERATION EASTERN HEMISPHERES BASED ON 
TANDEM BUCHWALD-HECK PROCESS 
 
On the basis of the success of the tandem Buchwald-Hartwig/Heck-type process in 
assembling fused indoles in our model systems, a new strategy was formulated (Figure 
2.17).  Thus, a western hemisphere consisting of chloroindoline (–)-2.131 and vinyl 
 
Figure 2.17. Retrosynthetic Analysis Based on Tandem Buchwald-Hartwig/Heck-type 
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bromide eastern hemisphere 2.133, where PG and PG’ are orthogonal protecting groups to 
enable installation of the sidechain at a future point. The eastern hemisphere sub-target was 
now 2.133. 
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To access vinyl bromide 2.133, enone (+)-2.107, an intermediate in the route to the 
iodoenone eastern hemisphere (+)-2.108 (vide supra), was treated with L-Selectride to 
affect 1,4-reduction to the ketone (–)-2.134 (Scheme 2.26). X-ray analysis of ketone (–)-
2.134 confirmed the structure and stereochemical assignments (Figure 2.18). The vinyl 
bromide target (–)-2.133 was then obtained by employing the aforementioned method of 
Myers, and treatment of ketone (–)-2.134 with TBS-hydrazine and scandium (III) triflate 
catalyst in chloroform gave hydrazone (+)-2.135, which was transformed to the target 
compound by subjection to N-bromosuccinimide in pyridine to give vinyl bromide eastern 
hemisphere (–)-2.133 in good yield. 
 
Scheme 2.26. Synthesis of Vinyl Bromide Eastern Hemisphere Sub-target 
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Figure 2.18.  ORTEP of Ketone (–)-2.134 With 30% Probability Thermal Ellipsoids 
 
 
 
 Vinyl triflates were also recognized as potentially useful intermediates in the tandem 
Buchwald-Hartwig/Heck process (Figure 2.19). We thought that the conditions used to install 
a vinyl triflate, rather than those used to install a vinyl bromide, would perhaps be more 
amenable in the context of eastern hemispheres with the attached sidechain of NsAA, since 
the bis-TBS-hydrazone used in the Myers method (vide supra) might be prone to addition to 
the !,",#,$-unsaturated sidechain (cf. 2.134 to 2.135, Scheme 2.25). Also, Buchwald 
recently published a report58 describing the palladium-catalyzed conversion of vinyl triflates 
to vinyl bromides, so in theory the vinyl bromide of the type 2.139 could still be accessed 
from the vinyl triflate 2.138. This approach offers flexibility in the choice of electrophile on 
the eastern hemisphere. 
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Figure 2.19. Analysis of Vinyl Triflate and Vinyl Bromide Eastern Hemispheres in 
Fragment Coupling 
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To this end, we began by synthesizing aldehyde (–)-2.141 (Scheme 2.27), 
possessing a 3,4-dimethoxybenzyl (DMB) acetal protecting group, which could be  
 
Scheme 2.27. Synthesis of DMB-acetal Aldehyde (–)-2.141 
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converted later to a 3,4-dimethoxybenzyl ether on the secondary alcohol by the action of 
diisobutylaluminum hydride, giving an intermediate that would be suitably disposed for future 
studies of sidechain attachment. In the event, diols 2.103, synthesized via the cuprate 
addition/alkylation sequence outlined previously (Scheme 2.17), was treated with 3,4-
dimethoxy-benzaldehyde in methylene chloride with magnesium sulfate to give the desired 
aldehyde in 23% yield. The low yield of the reaction reflects the fact that 2.103 is a mixture 
 
Figure 2.20. ORTEP Drawing of Aldehyde (–)-2.141 With 30% Probability Thermal 
Ellipsoids 
 
 
of diastereomers and C-3 H impurities (vide supra). Aldehyde (–)-2.141 could be purified by 
crystallization, and X-ray analysis confirmed the structure of this key aldehyde (Figure 2.20). 
The vinyl triflate sub-target was then synthesized according to Scheme 2.28. Thus, 
aldehyde (–)-2.141 was treated sequentially with vinyl-magnesium bromide, and Grubbs 1st 
generation catalyst to give the alcohol 2.142 as an inconsequential mixture of  
diastereomers. Unlike the previous employment of this sequence with the benzyl ether/tert-
butyldimethylsilyl ether protecting group protocol, the DMB acetal protecting group proved 
problematic in the vinylmagmagnesium addition step, giving an unidentified impurity along 
with the desired allylic alcohols. The impurity may arise from addition of the Grignard 
reagent to the methine of the acetal, but this has not as yet been confirmed. 
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Scheme 2.28. Synthesis of Vinyl Triflate Eastern Hemisphere (–)-2.144 
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This impurity could be efficiently removed from 2.142 via silica gel chromatography. Dess-
Martin periodinane treatment provided enone (+)-2.143. Attempted conjugate reduction and 
trapping of the intermediate enolate by sequential treatment with L-Selectride and N-
phenyltriflimide gave a mixture of desired vinyl triflate  (–)-2.144 and ketone (–)-2.145, the 
latter being converted to the desired product by kinetic deprotonation with potassium 
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hexamethyldisilylamide and trapping with N-phenyl triflimide in 87% yield. Thus, advanced 
enol triflate (–)-2.144 has been prepared for the first time. 
 
2.7. STUDIES DIRECTED AT ATTACHING THE SIDECHAIN TO THE EASTERN 
HEMISPHERE SUB-TARGET 
 
 We recognized that any strategy involving attachment of the sidechain to an 
intermediate possessing the core ring system of NsAA has many pitfalls, due to the labile 
nature of the structure (see Chapter 1 of this work). In particular, the use of bases, either in 
a Wittig63 or Horner-Wadsworth-Emmons64, 65 reaction, or in a metal-catalyzed process such 
as a Suzuki,66 was precluded due to the sensitive nature of the C-24 hydroxyl goup. Since 
attachment of the sidechain was likely to proceed through one of  
the aforementioned reactions, it was determined that the sidechain should be in place on the 
eastern hemisphere sub-target prior to the fragment-coupling event. Such a strategy would 
also increase the convergency of the route.  
In order to study sidechain attachment conditions, ketone (–)-2.134 was subjected to 
hydrogenation conditions to remove the benzyl group of the primary alcohol (Scheme 2.29). 
Alcohol (–)-2.146 was then oxidized to the aldehyde (–)-2.147, the key intermediate for 
these studies. At the outset of these studies, we thought that ketoaldehyde (–)-2.147, which 
possesses two reactive carbonyls, may react preferentially at the aldehyde, since both are 
handicapped with an adjacent quaternary center. In the event, subjection of (–)-2.147 to 
Horner-Wadsworth-Emmons olefination conditions using phosphonate 2.148 failed to 
provide any desired product, with starting material being the only identifiable product in each 
case. Apparently, the neo-pentyl aldehyde with an adjacent tert-butyldimethylsilyl-protected 
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secondary alcohol is too sterically hindered to undergo reaction with phosphonate 2.14867 
under these conditions. 
 
Scheme 2.29. Attempted Attachment of the Sidechain to the Eastern Hemisphere Sub-
target 
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An examination of the literature revealed some precedence for the inertness of 
aldehydes typified by (–)-2.147. In Snapper’s synthesis of cacospongiolonide B analogs 
(Figure 2.21),68 the aldehyde 2.150 failed to suffer olefination under a variety of conditions. 
The solution to the problem was found in fashioning the aldehyde into an alkyne using 
Ohira-Bestmann69 conditions, followed by hydrozirconation of the alkyne with zirconocene 
hydrochloride (Schwartz’s reagent70) and subsequent iodination to give vinyl iodide 2.151. 
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The vinyl iodide was then coupled to boronate 2.152 under palladium catalysis to give 
intermediate 2.153, and thus successful chain extension was achieved. The 
conformationally restricted analog of cacospongionolide B 2.154 was then obtained by 
further advancement of 2.153. Compound 2.154 was found to possess inhibitory 
 
Figure 2.21. Snapper’s Cacospongionolide B Analog Synthesis 
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activity against the pro-inflammatory enzyme secretary phospholipase A2 (sPLA2) that 
rivaled that of the natural product (IC50 = 5 µM vs. 10 µM for cacospongionolide B). 
 In light of this information, a potential solution to the problem at hand would be a 
direct application of this strategy (Figure 2.22). Thus, ketoaldehyde (–)-2.147 or a ketone-
protected variant 2.155 would be reacted with the Ohira-Bestmann reagent under  
standard conditions to give the alkyne 2.156. Treatment with Schwartz’s reagent would then 
provide vinyl zirconium intermediate 2.157, which could be trapped with iodine to provide 
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vinyl iodide 2.158. Subsequent coupling of 2.158 to boronate 2.159 using Suzuki-Miyaura 
conditions will then provide the compound 2.160, an intermediate possessing all of the 
carbons of the eastern hemisphere of NsAA. Studies toward this end are ongoing in the 
Smith laboratory. 
 
Figure 2.22. Proposed Application of Alkynylation/Hydrometallation/Palladium 
Catalyzed Coupling Strategy to NsAA Eastern Hemisphere 
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2.8. CONCLUSIONS AND FUTURE DIRECTIONS 
 
2.8.1 SUMMARY AND ANALYSIS OF CHANGES MADE TO EXISTING SYNTHETIC 
ROUTE 
 
 An efficient route to several different eastern hemispheres of (+)-nodulisporic acid A 
has been developed. This new route makes use of the C-4-methyl Wieland-Miescher ketone 
(C-4-methyl-WMK), which is produced from an organocatalytic process that is very scalable 
(up to 100 g, ca. 0.5 mol). The C-4-methyl-WMK thus produced is of  
a very high enantiomeric purity (~89% ee) and can be crystallized to >95% ee in one 
operation. The presence of the C-4-methyl group obviates the need for a discrete  
synthetic step to install this carbon, which is present in the natural product, and facilitates 
two of the reactions in the early part of the route, the dissolving metal reduction of enone 
2.33 (vide supra) and the scandium (III) triflate-catalyzed aldol reaction of silyl enol ether 
2.34. Two chromatographic operations were eliminated from this part of the route. An 
improvement in the efficiency of the installation of the critical C-3,C-12 stereodiad was also 
realized through the use of a cuprate addition.  
An analysis of the differences in the old route and the new is illustrated in Scheme 
2.30. In all, a total of 9 steps were eliminated in the transformation of enal (+)-2.21 to vinyl 
aldehyde (–)-2.53, with the overall yield being improved from ca. 13% to ca. 37%. 
One disadvantage to the new route is the formation of several  diastereomeric and 
hydrolysis impurities during installation of the C-3 methyl group (2.99 to (–)-2.53, Scheme 
2.18) that are difficult to remove, causing these impurities to be carried through subsequent 
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synthetic operations. Ongoing work on the optimization of the alkylation process is also 
ongoing in the Smith group. 
 
Scheme 2.30. Analysis of Modification to the Old Synthetic Route to Key Aldehyde 
Intermediate (–)-2.53 
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2.8.2. PROPOSED ENDGAME EMPLOYING EASTERN HEMISPHERE IN TANDEM 
BUCHWALD-HARTWIG/HECK CASCADE 
 
One possible endgame scenario for the total synthesis of (+)-nodulisporic acid is 
shown in Scheme 2.31. A strategy in which the sidechain is attached to the eastern  
 
Scheme 2.31. Proposed Endgame for the Total Synthesis of (+)-Nodulipsoric Acid A 
Employing the Tandem Buchwald-Hartwig/Heck-type Process 
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hemisphere prior to the fragment coupling is preferred over any strategy in which the 
sidechain would need to be attached after the fragment coupling, owing to increased 
convergency and the avoidance of manipulating the sensitive ring system of NsAA. Thus, 
2.139 and a western hemisphere typified by 2.161 will be joined using the RuPhos71 pre-
catalyst developed by the Buchwald group. The resulting intermediate 2.162, possessing the 
carbon skeleton of NsAA, will be de-protected on the D-ring oxygen, and the resulting 
alcohol will be oxidized using Ley’s conditions.72 (+)-Nodulisporic acid A will then be 
revealed following removal of the protecting groups from the hydroxyls at C-24 and C-7, and 
subsequent transesterification of the methyl ester to an allyl ester to enable palladium-
catalyzed transformation to the acid, a sequence Merck has employed for the synthesis of 
NsAA analogs.73 The exact protecting groups that will be employed for the protection of the 
C-24 and C-7 hydroxyls have not yet been determined. The choices available for this task 
are of course limited due to the highly sensitive nature of NsAA’s ring system (see Chapter 1 
of this work).  
 
2.4. REFERENCES FOR CHAPTER 2 
 
1. Smith III, A. B.; Visnick, M.; Haseltine, J. N.; Sprengeler, P. A., Organometallic 
reagents in synthesis : A new protocol for construction of the indole nucleus. Tetrahedron 
1986, 42, (11), 2957-2969. 
2. Smith, A. B.; Davulcu, A. H.; Cho, Y. S.; Ohmoto, K.; Kurti, L.; Ishiyama, H., Indole 
Diterpene Synthetic Studies. Total Synthesis of (+)-Nodulisporic Acid F and Construction of 
the Heptacyclic Cores of (+)-Nodulisporic Acids A and B and (-)-Nodulisporic Acid D. J. Org. 
Chem. 2007, 72, (13), 4596-4610. 
 79 
3. Smith, A. B.; Davulcu, A. H.; Kurti, L., Indole Diterpenoid Synthetic Studies. 
Construction of the Heptacyclic Core of (-)-Nodulisporic Acid D. Org. Lett. 2006, 8, (8), 1669-
1672. 
4. Kurti, L. Indole Diterpenoid Synthetic Studies. Part 1. Optimization of the Synthetic 
Sequence Leading to the Eastern Hemisphere Sub-Target of Nodulisporic Acids A, D, and 
F. Part 2. Construction of the Highly Strained CDEF Parent Tetracycle of Nodulisporic Acids 
A and B. University of Pennsylvania, Philadelphia, 2006. 
5. Erian, A. W.; Sherif, S. M.; Gaber, H. M., The Chemistry of a-haloketones and their 
Utility in Heterocyclic Synthesis. Molecules 2003, 8, 793-865. 
6. Gibe, R.; Kerr, M. A., Convenient Preparation of Indolyl Malonates via Carbenoid 
Insertion. J. Org. Chem. 2002, 67, (17), 6247-6249. 
7. Sheffy, F. K.; Godschalx, J. P.; Stille, J. K., Palladium-catalyzed cross coupling of 
allyl halides with organotin reagents: a method of joining highly functionalized partners 
regioselectively and stereospecifically. J. Am. Chem. Soc. 1984, 106, (17), 4833-4840. 
8. Smith, A. B.; Kurti, L.; Davulcu, A. H., A New Modular Indole Synthesis. Construction 
of the Highly Strained CDEF Parent Tetracycle of Nodulisporic Acids A and B. Org. Lett. 
2006, 8, (10), 2167-2170. 
 80 
9. Smith, A. B.; Kurti, L.; Davulcu, A. H.; Cho, Y. S.; Ohmoto, K., Indole Diterpene 
Synthetic Studies: Development of a Second-Generation Synthetic Strategy for (+)-
Nodulisporic Acids A and B. J. Org. Chem. 2007, 72, (13), 4611-4620. 
10. Grubbs, R. H.; Trnka, T. M., The development of L2X2Ru=CHR olefin metathesis 
catalyst: an organometallic success story. Acc. Chem. Res. 2001, 34, 18. 
11. Grubbs, R. H.; Trnka, T. M., Ruthenium-Catalyzed Olefin Metathesis. In Ruthenium 
in Organic Synthesis, Wiley-VCH Verlag GmbH & Co. KGaA: 2005; pp 153-177. 
12. Wieland, P.; Miescher, K., Über die Herstellung mehrkerniger Ketone. Helv. Chim. 
Acta 1950, 33, (7), 2215-2228. 
13. Smith, A. B.; Fukui, M., Total synthesis of (+)-phyllanthocin. J. Am. Chem. Soc. 
1987, 109, (4), 1269-1272. 
14. Hajos, Z. G.; Parrish, D. R., Asymmetric synthesis of bicyclic intermediates of natural 
product chemistry. J. Org. Chem. 1974, 39, (12), 1615-1621. 
15. Hagiwara, H.; Uda, H., Optically pure (4aS)-(+)- or (4aR)-(-)-1,4a-dimethyl-4,4a,7,8-
tetrahydronaphthalene-2,5(3H,6H)-dione and its use in the synthesis of an inhibitor of 
steroid biosynthesis. J. Org. Chem. 1988, 53, (10), 2308-2311. 
 81 
16. Shigehisa, H.; Mizutani, T.; Tosaki, S.-y.; Ohshima, T.; Shibasaki, M., Formal total 
synthesis of (+)-wortmannin using catalytic asymmetric intramolecular aldol condensation 
reaction. Tetrahedron 2005, 61, (21), 5057-5065. 
17. Kirk, D. N.; Petrow, V., Modified steroid hormones. Part XXVII. A new route to 4-
methyl-3-oxo-!-4-steroids. J. Chem. Soc. 1962, 1091-1096. 
18. Smith, A. B.; Kurti, L.; Davulcu, A. H.; Cho, Y. S., Development of a Scalable 
Synthesis of a Common Eastern Tricyclic Lactone for Construction of the Nodulisporic 
Acids. Org. Process Res. Dev. 2007, 11, (1), 19-24. 
19. Evans, D. A.; Chapman, K. T.; Carreira, E. M., Directed reduction of .beta.-hydroxy 
ketones employing tetramethylammonium triacetoxyborohydride. J. Am. Chem. Soc. 1988, 
110, (11), 3560-3578. 
20. Hashimoto, S.-i.; Kogen, H.; Tomioka, K.; Koga, K., Asymmetric synthesis of 2-
substituted cycloalkanecarboxaldehydes. Tetrahedron Lett. 1979, 20, (32), 3009-3012. 
21. Smith, A. B.; Cho, Y. S.; Ishiyama, H., Nodulisporic Acid A Synthetic Studies. 2. 
Construction of an Eastern Hemisphere Subtarget. Org. Lett. 2001, 3, (24), 3971-3974. 
22. Wu, Y. D.; Houk, K. N.; Trost, B. M., Origin of enhanced axial attack by sterically 
undemanding nucleophiles on cyclohexenones. J. Am. Chem. Soc. 1987, 109, (18), 5560-
5561. 
 82 
23. Smith, A. B.; Leenay, T. L., Indole diterpene synthetic studies. 5. Development of a 
unified synthetic strategy; a stereocontrolled, second-generation synthesis of (-)-paspaline. 
J. Am. Chem. Soc. 1989, 111, (15), 5761-5768. 
24. Mewshaw, R. E.; Taylor, M. D.; Smith, A. B., Indole diterpene synthetic studies. 2. 
First-generation total synthesis of (-)-paspaline. J. Org. Chem. 1989, 54, (14), 3449-3462. 
25. Trost, B. M.; Nishimura, Y.; Yamamoto, K., A total synthesis of aphidicolin. J. Am. 
Chem. Soc. 1979, 101, (5), 1328-1330. 
26. Smith, A. B.; Kingery-Wood, J.; Leenay, T. L.; Nolen, E. G.; Sunazuka, T., Indole 
diterpene synthetic studies. 8. The total synthesis of (+)-paspalicine and (+)-paspalinine. J. 
Am. Chem. Soc. 1992, 114, (4), 1438-1449. 
27. Suzuki, M.; Suzuki, T.; Kawagishi, T.; Noyori, R., Organocopper conjugate addition 
revisited. Tetrahedron Lett. 1980, 21, (13), 1247-1250. 
28. Lipshutz, B. H.; Wilhelm, R. S.; Kozlowski, J., Chemistry of higher order, mixed 
organocuprates. reactions of α,β-unsaturated ketones. Tetrahedron Lett. 1982, 23, (37), 
3755-3758. 
29. Nagata, W.; Yoshioka, M., Alkylaluminum cyanides as potent reagents for 
hydrocyanation. Tetrahedron Lett. 1966, 7, (18), 1913-1918. 
 83 
30. Greene, A. E.; Lansard, J. P.; Luche, J. L.; Petrier, C., Efficient syntheses of (.+-.)-!-
cuparenone. Conjugate addition of organozinc reagents. J. Org. Chem. 1984, 49, (5), 931-
932. 
31. Luche, J.-L.; Petrier, C.; Lansard, J. P.; Greene, A. E., Ultrasound in organic 
synthesis. 4. A simplified preparation of diarylzinc reagents and their conjugate addition to "-
enones. J. Org. Chem. 1983, 48, (21), 3837-3839. 
32. Flemming, S.; Kabbara, J.; Nickisch, K.; Neh, H.; Westermann, J. r., Nickel-
Catalysed Conjugate Addition of Trimethylaluminum to Sterically Hindered ",!-Unsaturated 
Ketones. Synthesis 1995, (03), 317-320. 
33. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; 
Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; 
Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. 
L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; 
Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A.; Peralta, J. E. J.; Ogliaro, F.; 
Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; 
Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, 
M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; 
Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, 
C.; Ochterski, J. W.; Martin, R. L.; Mororkuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, 
P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; 
Cioslowski, J.; Fox, D. J. Gaussian 09, Revision A.1, Wallingford, CT, 2009. 
 84 
34. Bourgain-Commerçon, M.; Foulon, J.-P.; Normant, J. F., Regioselectivite de la 
reaction des dialkyl cuprates de magnesium sur des aldehydes !,"-ethyleniques. J. 
Organomet. Chem. 1982, 228, (3), 321-326. 
35. Chuit, C.; Foulon, J. P.; Normant, J. F., Réactivité des dérivés organocuivreux vis-a-
vis des aldéhydes !,"-éthyléniques. Tetrahedron 1981, 37, (7), 1385-1389. 
36. Chuit, C.; Foulon, J. P.; Normant, J. F., Action des dialkylcuprates de lithium sur les 
aldéhydes !," -éthylénioues. Tetrahedron 1980, 36, (16), 2305-2310. 
37. Matsuzawa, S.; Horiguchi, Y.; Nakamura, E.; Kuwajima, I., Chlorosilane-accelerated 
conjugate addition of catalytic and stoichiometric organocopper reagents. Tetrahedron 1989, 
45, (2), 349-362. 
38. Snider, B. B.; Vo, N. H.; O'Nei, S. V.; Foxman, B. M., Synthesis of (±)-Allocyathin B2 
and (+)-Erinacine A. J. Am. Chem. Soc. 1996, 118, (32), 7644-7645. 
39. Ireland, R. E.; Mander, L. N., Experiments directed toward the total synthesis of 
terpenes. XI. The total synthesis of (.+-.)-rimuene and (.+-.)-13-epi-rimuene. J. Org. Chem. 
1967, 32, (3), 689-696. 
40. Boeckman, R. K.; Silver, S. M., Total synthesis of (+-)-.beta.-gorgonene. J. Org. 
Chem. 1975, 40, (12), 1755-1759. 
 85 
41. Ziegler, F. E.; Wallace, O. B., The Total Synthesis of (.+-.)-Scopadulcic Acids A and 
B and (.+-.)-Scopadulciol. J. Org. Chem. 1995, 60, (12), 3626-3636. 
42. Corey, E. J.; Boaz, N. W., d-orbital stereoelectronic control of the stereochemistry of 
SN2' displacements by organocuprate reagents. Tetrahedron Lett. 1984, 25, (29), 3063-
3066. 
43. Corey, E. J.; Boaz, N. W., Evidence for a reversible d, [pi]-complexation, [beta]-
cupration sequence in the conjugate addition reaction of Gilman reagents with [alpha],[beta]-
enones. Tetrahedron Lett. 1985, 26, (49), 6015-6018. 
44. Stork, G.; Hudrlik, P. F., Generation, nuclear magnetic resonance spectra, and 
alkylation of enolates from trialkylsilyl enol ethers. J. Am. Chem. Soc. 1968, 90, (16), 4464-
4465. 
45. Duhamel, P.; Cahard, D.; Poirier, J.-M., Unprecedented route to enolates from silyl 
enol ethers and enol acetates: reaction with hard and soft electrophiles. J. Chem. Soc., 
Perkin Trans. 1 1993, (21), 2509-2511. 
46. Yu, W.; Jin, Z., A facile generation of enolates from silyl enol ethers by potassium 
ethoxide. Tetrahedron Lett. 2001, 42, (3), 369-372. 
47. Kuwajima, I.; Nakamura, E.; Shimizu, M., Fluoride-mediated reactions of enol silyl 
ethers. Regiospecific monoalkylation of ketones. J. Am. Chem. Soc. 1982, 104, (4), 1025-
1030. 
 86 
48. Johnson, C. R.; Adams, J. P.; Braun, M. P.; Senanayake, C. B. W.; Wovkulich, P. M.; 
Uskokovic, M. R., Direct !-iodination of cycloalkenones. Tetrahedron Lett. 1992, 33, (7), 
917-918. 
49. Simov, V. Part 1. Total Synthesis of (-)-Clavosolide A; Part 2. Synthesis of the 
Western Hemisphere of (+)-Nodulisporic Acid A. University of Pennsylvania, Philadelphia, 
2009. 
50. Smith III, A. B.; Jeon, J., In University of Pennsylvania: Philadelphia, 2010. 
51. Hynes, J.; Nasser, T.; Overman, L. E.; Watson, D. A., Preparation of !-Sulfenyl 
Enones by Thermal Fragmentation of "-Sulfenyl Enol Triflates. Org. Lett. 2002, 4, (6), 929-
931. 
52. Ye, S.; Ding, Q.; Wang, Z.; Zhou, H.; Wu, J., Tandem addition-cyclization reactions 
of 2-alkynylbenzenamines with isocyanates catalyzed by PdCl2. Org. Biomol. Chem. 2008, 
6, (23), 4406-4412. 
53. Fu, W.; Xu, C.; Zou, G.; Hong, D.; Deng, D.; Wang, Z.; Ji, B., AuCl3-Catalyzed 
Tandem Reaction of N-(o-Alkynylphenyl)imines: A Modular Entry to Polycyclic Frameworks 
Containing an Indole Unit. Synlett 2009, 2009, (EFirst), 763,766. 
54. Suzuki, Y.; Ohta, Y.; Oishi, S.; Fujii, N.; Ohno, H., Efficient Synthesis of 
Aminomethylated Pyrroloindoles and Dipyrrolopyridines via Controlled Copper-Catalyzed 
 87 
Domino Multicomponent Coupling and Bis-cyclization. J. Org. Chem. 2009, 74, (11), 4246-
4251. 
55. Barluenga, J.; Fernandez, M. A.; Aznar, F.; Valdes, C., Cascade Alkenyl 
Amination/Heck Reaction Promoted by a Bifunctional Palladium Catalyst: A Novel One-Pot 
Synthesis of Indoles from o-Haloanilines and Alkenyl Halides. Chem. Eur. J. 2005, 11, (8), 
2276-2283. 
56. Harris, M. C.; Huang, X.; Buchwald, S. L., Improved Functional Group Compatibility 
in the Palladium-Catalyzed Synthesis of Aryl Amines. Org. Lett. 2002, 4, (17), 2885-2888. 
57. Surry, D. S.; Buchwald, S. L., Biaryl Phosphane Ligands in Palladium-Catalyzed 
Amination. Angew. Chem. Int. Ed. 2008, 47, (34), 6338-6361. 
58. Shen, X.; Hyde, A. M.; Buchwald, S. L., Palladium-Catalyzed Conversion of Aryl and 
Vinyl Triflates to Bromides and Chlorides. J. Am. Chem. Soc. 2010, 132, (40), 14076-14078. 
59. Furrow, M. E.; Myers, A. G., Practical Procedures for the Preparation of N-tert-
Butyldimethylsilylhydrazones and Their Use in Modified Wolff-Kishner Reductions and in the 
Synthesis of Vinyl Halides and gem-Dihalides. J. Am. Chem. Soc. 2004, 126, (17), 5436-
5445. 
60. Iwao, M.; Kuraishi, T., Directed Lithiation of 1-(tert-Butoxycarbonyl)indolines. A 
Convenient Route to 7-Substituted Indolines. Heterocycles 1992, 34, (5), 1031-1038. 
 88 
61. Huang, X.; Anderson, K. W.; Zim, D.; Jiang, L.; Klapars, A.; Buchwald, S. L., 
Expanding Pd-Catalyzed C‚N Bond-Forming Processes: The First Amidation of Aryl 
Sulfonates, Aqueous Amination, and Complementarity with Cu-Catalyzed Reactions. J. Am. 
Chem. Soc. 2003, 125, (22), 6653-6655. 
62. Kranenburg, M.; van der Burgt, Y. E. M.; Kamer, P. C. J.; van Leeuwen, P. W. N. M.; 
Goubitz, K.; Fraanje, J., New Diphosphine Ligands Based on Heterocyclic Aromatics 
Inducing Very High Regioselectivity in Rhodium-Catalyzed Hydroformylation: Effect of the 
Bite Angle. Organometallics 1995, 14, (6), 3081-3089. 
63. Wittig, G.; Schöllkopf, U., Über Triphenyl-phosphin-methylene als olefinbildende 
Reagenzien I. Mitteil. Chem. Ber. 1954, 87, (9), 1318-1330. 
64. Horner, L.; Hoffmann, H. M. R.; Wippel, H. G.; Klahre, G., Chem. Ber. 1959, 92, 
2499-2505. 
65. Wadsworth, W. S., Synthetic Applications of Phosphoryl-Stabilized Anions. In 
Organic Reactions, John Wiley & Sons, Inc.: 2004. 
66. Oh-e, T.; Miyaura, N.; Suzuki, A., Palladium-Catalyzed Cross-Coupling Reaction of 
Aryl or Vinylic Triflates with Organoboron Compounds. Synlett 1990, 1990, (04), 221,223. 
67. Löffler, A.; Pratt, R. J.; Rüesch, H. P.; Dreiding, A. S., Die Wohl-Ziegler-Bromierung 
von Tiglin- und Angelika-säureestern. Helv. Chim. Acta 1970, 53, (2), 383-403. 
 89 
68. Murelli, R. P.; Cheung, A. K.; Snapper, M. L., Conformationally Restricted (+)-
Cacospongionolide B Analogues. Influence on Secretory Phospholipase A2 Inhibition. J. 
Org. Chem. 2006, 72, (5), 1545-1552. 
69. Müller, S.; Liepold, B.; Roth, G. J.; Bestmann, H. J., An Improved One-pot Procedure 
for the Synthesis of Alkynes from Aldehydes. Synlett 1996, 1996, (06), 521,522. 
70. Hart, D. W.; Schwartz, J., Hydrozirconation. Organic synthesis via organozirconium 
intermediates. Synthesis and rearrangement of alkylzirconium(IV) complexes and their 
reaction with electrophiles. J. Am. Chem. Soc. 1974, 96, (26), 8115-8116. 
71. Biscoe, M. R.; Fors, B. P.; Buchwald, S. L., A New Class of Easily Activated 
Palladium Precatalysts for Facile C‚N Cross-Coupling Reactions and the Low Temperature 
Oxidative Addition of Aryl Chlorides. J. Am. Chem. Soc. 2008, 130, (21), 6686-6687. 
72. Ley, S. V.; Norman, J.; Griffith, W. P.; Marsden, S. P., Tetrapropylammonium 
Perruthenate, Pr4N+RuO4-, TPAP: A Catalytic Oxidant for Organic Synthesis. Synthesis 
1994, 1994, (07), 639,666. 
73. Chakravarty, P. K.; Shih, T. L.; Colletti, S. L.; Ayer, M. B.; Snedden, C.; Kuo, H.; 
Tyagarajan, S.; Gregory, L.; Zakson-Aiken, M.; Shoop, W. L.; Schmatz, D. M.; Wyvratt, M.; 
Fisher, M. H.; Meinke, P. T., Nodulisporic acid side-Chain modifications: access to the 2'', 
3'', 4'', and 6'' registers. Bioorg. Med. Chem. Lett. 2003, 13, (1), 147-150. 
 
 
 90 
CHAPTER 3. EXPERIMENTAL SECTION 
 
3.1 MATERIALS AND METHODS 
All solvents used were reagent grade.  Diethyl ether (Et2O), tetrahydrofuran (THF), 
methylene chloride, and toluene were obtained from a PurSolv™ PS-400.  TMEDA and tert-
butanol were freshly distilled over CaH2 prior to use. All reagents were purchased from 
Aldrich or Acros and used as received, except for benzyltrimethylammonium fluoride, which 
was dried under vacuum at 70 °C overnight prior to use. Reactions were magnetically stirred 
in oven-dried glassware under an argon atmosphere and monitored by thin layer 
chromatography (TLC) with 0.25 mm E. Merck pre-coated silica gel plates.  All starting 
materials were azeotroped with benzene (3x) and dried under vacuum prior to use.  Flash 
chromatography was performed with silica gel 60 (particle size 0.040 – 0.062 mm) supplied 
by Silicycle and Sorbent Technologies.  Yields refer to chromatographically and 
spectroscopically pure compounds, unless otherwise stated.  Infrared spectra were recorded 
on a Jasco Model FT/IR-480 Plus spectrometer.  Proton and carbon NMR spectra were 
recorded on a Bruker AMX-500 and Bruker Avance III 500 MHz spectrometer.  Chemical 
shifts are reported relative to either chloroform (! !7.27) or benzene (! 7.16) for 1H NMR and 
either chloroform (! 77.2) or benzene (! 128.4) for 13C NMR.  Optical rotations were 
measured on a Perkin-Elmer model 241 polarimeter or a Jasco polarimeter.  High resolution 
mass spectra were measured at the University of Pennsylvania Mass Spectrometry Service 
Center. 
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3.2 EXPERIMENTAL PROCEDURES 
 
O
O  
 
Diketone (+)-2.30, (+)-C-4-Methyl Wieland-Miescher Ketone: The triketone substrate 2.29 
for the catalytic Robinson Annulation was synthesized by the procedure of Zeigler (J. Org. 
Chem. 1986, 51, 4573). To a solution of 2-methylcyclohexane-1,3-dione (60 g, 476 mmol) 
and ethyl vinyl ketone (freshly distilled, 52 ml, in 1,2-dimethoxyethane (240 ml) stirring under 
argon in a round-bottomed flask was added DABCO (60 g, 535 mmol, recrystallized from 
ethyl ether) in one portion. The resulting mixture was stirred at room temperature for 16 h, 
cooled to 0 °C, and treated with 20% HCl (aq, 400 ml) dropwise (NOTE: this step must be 
performed slowly and cautiously, as side-products can form resulting from intramolecular 
aldol reactions if the acid is added too fast). The mixture was stirred for 15 min at 0 °C, then 
extracted with ethyl ether (3 X 300 ml). The organic layers were combined, dried (MgSO4), 
filtered, and concentrated under vacuum to give an amber oil (98 g, >95%). The 1H NMR 
was consistent with that of the published data: m.p.: 48-50 °C; 1H NMR (500 MHz, CDCl3) ! 
2.76 - 2.70 (m, 4H), 2.65 - 2.59 (m, 4H), 2.38 (q, 2H, J = 14.6, 7.3 Hz), 2.32 (t, 2H, J = 7.2 
Hz), 2.08 – 2.00 (m, 3H), 1.94 – 1.85 (m, 1H), 1.24 (s, 3H), 1.02 (t, J = 7.3 Hz). 
 
Organocatalytic Sonication-Mediated Robinson Annulation: The procedure of Shibasaki 
(Tetrahedron 2005, 61, 5057) was employed: The crude Michael addition product was 
placed in a round-bottomed flask equipped with a stir bar. The flask was further charged 
with L-Phenylalanine (23.1 g, 140 mmol), PPTS (58.6 g, 233 mmol), and anhydrous DMSO 
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(33 ml, 466 mmol). The mixture was briefly pumped and back-filled with argon, then the 
flask was sealed and placed in a sonicator water bath. The mixture was sonicated for 16 h. 
Note: water should be continuously and slowly dripped into the water bath to offset 
evaporation, or the bath will go dry. The bath attained a temperature of ca. 50 °C during this 
time. Sonication was ceased and the mixture was cooled to room temperature, diluted with 
ethyl acetate (300 ml), and poured into saturated sodium bicarbonate (500 ml). The layers 
were separated, and the aqueous layer back-extracted with ethyl acetate. The combined 
organic layer was washed with brine, dried (MgSO4), filtered and concentrated in vacuo to 
an orange oil (45.8 g). The crude product was purified by flash chromatography (silica gel, 
25% ethyl acetate/hexanes, 15 X 9 cm) to give 36.9 g of an oil. The oil was dissolved in 
hexanes with ethyl ether added to assist in dissolution (approx. 15:1 hexanes/ether, ~ 10 
ml/g of enone). The optical rotation of the purified product was found to be [!]25D = + 122 ° (c 
1.0, CHCl3), corresponding to approximately 90% ee (literature: [!]25D = + 136 ° (c 1.0, 
CHCl3) (Hagiwara and Uda, J. Org. Chem. 1988, 53, 2308). The resulting solution was 
placed in a -20 °C freezer for 16 h, and the crystalline product was harvested via filtration. 
The crystals were washed with a small amount of cold hexanes to give the desired product 
as a crystalline solid (55 g in the first crop ([!]25D = + 144.6 ° (c 1.18, CHCl3)), 7.5 g in the 
second crop). The mother liquors could be purified by silica chromatography as describe 
above and the resulting product recrystallized to give another 4.7 g of product for a total 
yield of 67.2 g, 75%. The spectroscopic data for this material was in agreement with 
published data: 1H NMR (500 MHz, CDCl3) " 2.86 (dddd, J = 11.17, 4.99, 4.99, 1.12 Hz, 1H), 
2.67 (ddd, J = 16.07, 10.45, 6.04 Hz, 1H), 2.53-2.45 (m, 3H), 2.42 (dddd, J = 12.16, 5.55, 
1.18 Hz, 1H), 2.17-2.02 (m, 3H), 1.80 (d, J = 1.35, 3H), 1.75 (m, 1H), 1.41 (s, 3H). 
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Silyl Enol Ether 2.34, Modified Procedure for the Dissolving Metal Reduction of C-4-
methyl Wieland-Meischer Ketone Monoketal: While the dissolving metal reduction of C-4-
methyl WMK mono-ketal is known in the literature (Jung and Duclos, Tetrahedron 2006, 62, 
9321-9334), a detailed procedure is provided here to reflect some innovations that were 
developed in order to facilitate scale-up. A flame-dried, 2 L, 4-necked Morton flask equipped 
with a cold finger condenser containing dry ice and acetone (sealed at the joint with parafilm 
and wrapped with a paper towel at the base), mechanical overhead stirrer, and rubber septa 
on the remaining necks, and sitting in a -78 °C bath, was charged with ammonia, which was 
condensed from the inlet of the cold finger. The vessel should be sealed during this step, 
and the rate of condensation of ammonia should be carefully adjust until ~ 1 drop/second is 
attained. Ammonia was allowed to condense until ~500 ml had collected, and the ammonia 
supply was replaced with an argon line with positive pressure. Stirring was commenced, and 
lithium metal (bead, 6.94 g, 328 mmol) was added portionwise through one of the open 
necks. The resulting deep blue solution was allowed to stir for 1 h to ensure complete 
dissolution of the lithium, and then was treated with a solution of C-4-Methyl Wieland-
Miescher Ketone Monoketal (15.5 g, 65.6 mmol) and freshly distilled t-BuOH (CaH2) (6.27 
ml, 65.6 mmol) in THF (225 ml) via canula at a fast drip. Once the addition was complete, 
the resulting mixture was allowed to stir for 45 min at –78 °C. Isoprene (19.7 ml, 197 mmol) 
was then added slowly dropwise (CAUTION: this step must be performed slowly in order to 
prevent a runaway reaction!). Once the blue color of the lithium has dissipated, the cooling 
bath was removed, the cold finger was replaced with a gas inlet, and a gas outlet was 
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placed on one of the other necks. A strong sweep of argon was started. After ~30 min, a 
room temperature water bath was placed on the flask to facilitate expungement of the 
ammonia from the reaction vessel. After the most of the ammonia has evaporated, the 
remaining ammonia was removed by placing a low vacuum (150 torr – 30 torr) on the vessel 
(Note: it is important to remove as much of the ammonia as possible as it will interfere with 
the enolate trapping step (vide infra)). This can be accomplished either with a good water 
aspirator or a rotovap pump with a dry ice/acetone cold finger trap to catch the expunged 
ammonia (see figure 2.5, chapter 2). After the mixture has been concentrated to a thick 
gray-colored slurry, the vacuum was ceased and the vessel was back-filled with argon. THF 
(180ml) was added to the lithium enolate slurry, and the resulting mixture was cooled to 0 
°C. A solution of chlorotrimethylsilane (45 ml, 361 mmol) and triethylamine (50 ml, 361 
mmol), both of which had been distilled from CaH2, was prepared, the resulting solid 
triethylamine hydrochloride was allowed to settle, and the supernatant solution was 
dropwise. The gray, turbid mixture became clear and pale-colored several minutes into the 
addition. After the addition, the mixture was allowed at stir at 0 °C for 15 minutes. TLC at this 
time indicated completion, and the mixture was poured into a 2L separatory funnel 
containing ethyl ether (500 ml) and saturated aqueous NaHCO3 (500 ml). The layers were 
separated, and the aqueous layer was back-extracted with ethyl ether (2 x 200 ml). The 
combined organic layer was dried (MgSO4), filtered, and concentrated in vacuo to a oil (19.9 
g, >95%). Upon standing overnight, this crude product would occasionally become hazy, 
and the problem could be remedied by dissolving the crude product in ethyl ether and 
filtering through paper before use in the next step. The 1H NMR was in agreement with 
published data: 1H NMR (500 MHz, CDCl3) ! 3.98-3.85 (m, 4H), 2.36 (bd, J = 13.21 Hz, 1H), 
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2.15-1.95 (m, 3H), 1.81-1.62 (m, 5H), 1.58 (m, 1H), 1.54-1.41 (m, 4H), 0.94 (s, 3H), 0.16 (s, 
9H). 
 
 
O H
O
O
 
 
Ketone (–)-2.75: To a solution of alcohol (–)-2.36 (1.5 g, 6.63 mmol) in acetone (30 ml) 
stirring under argon was added 2,2-dimethoxypropane (6.5 ml, 53.03 mmol) and d,l-
camphorsulfonic acid (155 mg, 0.66 mmol). The resulting solution was stirred for 4 hours, at 
which time TLC (60% ethyl acetate/hexanes) indicated completion. Triethylamine (2 ml) was 
added and the solution was concentrated in vacuo, and the resulting residue was partitioned 
between water (20 ml) and ethyl ether (50 ml). The aqueous layers were back-extracted with 
ethyl ether (2 X 50 ml) and the combined organic layer was dried with sodium sulfate, 
filtered, and concentrated in vacuo to a crystalline solid (1.75 g, 99%): m.p.: 110-112 °C; 
[!]25D = – 6.40 ° (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) " 3.49 (dd, J = 36.9, 10.7 Hz, 
2H), 3.46 (dd, J = 15.4, 4.3 Hz, 1H), 2.55 (ddd, J = 14.0, 14.0, 6.9 Hz, 1H), 2.20 (app ddt J = 
8.4, 3.4, 1.8, 1.8 Hz, 1H), 2.06 (m, 1H), 1.47-1.78 (m, 6H), 1.41 (app d, J = 3.3 Hz, 6H), 1.18 
(s, 3H), 1.16 (m, 1H), 1.15 (s, 3H); 13C NMR (125 MHz, CDCl3) " 214.4, 99.1, 76.8, 72.2, 
48.9, 48.5, 37.8, 37.6, 31.5, 29.9, 26.2, 23.4, 20.2, 19.8, 19.2, 12.8; IR (neat) 2990 (s), 2940 
(s), 2867 (s), 1707 (s), 1462 (br m), 1380 (s), 1344 (m), 1260 (s), 1227 (m), 1204 (s), 1168 
(m), 1146 (m), 1105 (s), 1066 (m), 1037 (m), 966 (m), 943 (m), 860 (s), 748 (w), 668 (w); 
HRMS (CI+) m/z 267.1938 [(M+H)+; calcd. for C16H27O3+:  267.1960].  
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Diketone 2.76: A 25 ml round-bottomed flask was charged with ketone (–)-2.75 (700 mg, 
2.6 mmol), p-toluenesulfonic acid (5 mg, 0.03 mmol, 0.01 equiv), and benzylamine (319 µl, 
2.9 mmol, 1.1 equiv). The flask was fitted with a Dean-Stark apparatus, and the mixture was 
heated at reflux for 48 h. The mixture was cooled to room temperature, concentrated in 
vacuo, and checked by 1H NMR, which indicated complete conversion to the corresponding 
imine. The imine was then dissolved in ethanol (200 proof, 5 ml) and treated with freshly 
distilled methyl vinyl ketone (MVK, 262 µl, 3.2 mmol, 1.2 equiv) and stirred for 1 h at room 
temperature. TLC (40% ethyl acetate/hexanes) showed incomplete reaction, so another 
portion of MVK (1.2 equiv) was added and stirring was continued for 16 h. The solvent was 
removed in vacuo and the residue thus obtained was partitioned between ethyl acetate (50 
ml) and 1:1 brine/water (100 ml). The layers were separated, and the aqueous layer was 
back-extracted with ethyl acetate (3 x 50 ml). The combined organic layers were dried 
(MgSO4), filtered, and concentrated in vacuo to give the crude product as an amber oil (1.4 
g), which was purified by silica flash chromatography (25-40% ethyl acetate/hexanes) to 
give the desired product as an oil (623 mg, 70%). This material is a mixture of 
diastereomers in approximately 2:1 ratio, which could be partially separated by silica 
chromatography to give the major diastereomer: 1H NMR (500 MHz, CDCl3) ! 3.53 – 3.44 
(m, 3H), 2.48 (m, 2H), 2.41 (m, 1H), 2.12 (s, 3H), 1.94-1.83 (m, 3H), 1.76-1.67 (m, 1H), 
1.65-1.49 (m, 6H), 1.41 (ad, J = 6.47 Hz, 6H), 1.39 (m, 1H), 1.12 (ad, J = 7.91 Hz, 6 H) ; 13C 
NMR (125 MHz, CDCl3) ! 218.2, 208.8, 99.32, 77.1, 72.1, 47.4, 44.4, 42.8, 41.4, 37.4, 33.2, 
30.1, 30.0, 25.0, 24.9, 23.5, 20.2, 19.3, 16.9, 12.6; IR (thin film, neat) 2942 (s), 1713 (s), 
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1448 (w), 1379 (m), 1364 (m), 1261 (m), 1202 (s), 1105 (m), 1063 (w), 1035 (w), 947 (w), 
862 (m) cm-1; HRMS (CI-MS) m/z 337.2390 [(M+H)+; calcd. for C20H32O4+: 337.2379]. 
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Enone (–)-2.74: To a slurry of sodium hydride (95%, 133 mg, 5.6 mmol) in benzene (6 ml) 
was added a solution of diketone 2.76 (623 mg, 1.85 mmol) in benzene (6 ml). NOTE: the 
benzene used in this procedure should be degassed with nitrogen or argon prior to use, 
otherwise oxidation of the enone to the corresponding phenol will occur as a side reaction. 
The resulting mixture was heated to 65 °C under argon for 45 minutes, at which time TLC 
indicated completion (40% ethyl acetate/hexanes, where the desired product has an Rf of 
0.17). The mixture was cooled to 0 °C and water (45 ml) was cautiously added dropwise. 
The resulting mixture was extracted with ether (3 x 50 ml), and the combined organic layer 
was dried (MgSO4), filtered, and concentrated in vacuo to a solid (620 mg). The crude 
product was purified by silica flash chromatography (25% ethyl acetate/hexanes) to give the 
desired product as a white solid (498 mg): [!]25D =      – 3.70 ° (c 1.0, CHCl3); 1H NMR (500 
MHz, CDCl3) " 5.80 (s, 1H), 3.48 (dd, J = 10.7, 48.8 Hz, 2H), 3.49 (m, 1H), 2.54 (m, 1H), 
2.37 (dt, J = 16.2, 4.99 Hz, 1H), 2.25 (m, 1H), 2.09 (m, 1H), 2.00 (m, 1H), 1.79-1.68 (m, 3H), 
1.68-1.52 (m, 4H), 1.41 (s, 6H), 1.23-1.14 (m, 1H), 1.17 (s, 3H), 1.14-1.07 (m, 1H), 1.12 (s, 
3H); 13C NMR (125 MHz, CDCl3) " 201.1, 175.0, 119.9, 99.2, 72.5, 48.5, 40.8, 37.6, 36.0, 
35.2, 34.7, 34.3, 29.9, 29.4, 24.0, 22.6, 20.6, 20.5, 19.3, 12.7; IR (thin film, neat) 2939 (s), 
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2857 (s), 1668 (s), 1451 (m), 1380 (m), 1263 (m), 1200 (m), 1114 (w), 862 (m), 738 (w) cm–
1; HRMS (CI-MS) m/z 319.1807 [(M+H)+; calcd. for  C20H31O3+: 319.2273]. 
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Conjugate Addition Product (+)-2.77: To a 5 ml round-bottomed flask was added enone (–
)-2.74 (100 mg, 0.31 mmol), THF (500 µL), and Ni(acac)2, and the vessel was flushed with 
argon. The resulting solution was cooled to 0 °C, and a solution of trimethylaluminum (2.0M 
in hexanes, 171 µL, 0.34 mmol) was added dropwise via syringe. The ice bath was removed 
and the mixture was allowed to stir at room temperature for 24 h while being monitored by 
TLC (the desired product has an Rf of 0.55 in 40% ethyl acetate/hexanes). The reaction 
mixture was quenched by the addition of 3 drops sat. NH4Cl (aq), followed by a spatula tip of 
MgSO4 and silica gel each. The mixture was stirred for 2 h, filtered, and concentrated in 
vacuo to give an oil (120 mg) which crystallized from ethyl acetate/hexanes to give the 
desired product (67 mg, 65%) as a crystalline solid: m.p. 222-225 °C;  [!]25D = + 1.00 ° (c 
1.0, CHCl3); 1H NMR (500 MHz, CDCl3) " 3.54 (d, J = 10.55 Hz, 1H), 3.42 (d, J = 11.13 Hz, 
1H), 3.38 (dd, J = 11.82, 3.68 Hz, 1H), 2.64 (d, J = 14.12 Hz, 1H), 2.36 (ddd, J = 14.48, 
14.48, 7.29 Hz, 1H), 2.20 (m, 2H), 2.01 (dddd, J = 13.81, 13.81, 4.79, 4.79 Hz, 1H), 1.84 (m, 
1H), 1.75 (ddd, J = 12.86, 12.86, 12.86, 4.19 Hz, 1H), 1.68 – 1.56 (m, 3H), 1.55 – 1.44 (m, 
3H), 1.42 (ad, J = 9.88 Hz, 6H), 1.38 – 1.30 (m, 3H), 1.11 (s, 3H), 1.06 (s, 3H), 0.82 (s, 3H); 
13C NMR (125 MHz, CDCl3) " 213.4, 99.1, 73.1, 45.5, 44.8, 42.5, 40.4, 37.1, 36.6, 35.8, 
30.7, 30.0, 27.9, 27.6, 23.8, 21.2, 20.5, 19.4, 16.5, 12.9; IR (thin film, neat) 2937 (s), 1706 
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(s), 1653 (w), 1558 (w), 1456 (w), 1378 (m), 1257 (w), 1201 (m), 1119 (m), 1081 (s), 865 (w) 
cm–1; HRMS (ES-MS) m/z 335.2682 [(M+H)+; calcd. for C21H35O3: 335.2581]. 
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Ester (–)-2.51. A 10 mL round-bottomed flask was charged with methyl–
triphenylphosphonium iodide (231 mg, 0.571 mmol, 1.7 equiv.) and dry THF (5.7 mL). To 
this mixture was added NaHMDS (1.0 M, 505 µL, 0.505 mmol, 1.5 equiv.) dropwise. After 
stirring at 23 oC for 30 minutes, the flask was cooled to -78 oC, and a solution of aldehyde 
(+)-2.50 (182 mg, 0.336 mmol, 1.0 equiv) in dry THF (3.4 mL) was added dropwise.  The 
reaction stirred at -78 oC for 5 minutes, then was allowed to warm to 23 oC and was 
monitored by tlc.  After 1.5 h all of the starting material had been consumed and hexane (20 
mL) was added and the solution sat at 23 oC for 5 minutes.  The precipitate was filtered via a 
Büchner funnel and the precipitate was washed with hexane (5 mL).  The filtrate was 
concentrated and a crude 1H NMR taken.  The residue was purified by flash column 
chromatography (1% Et2O/hexanes) to give 141 mg (78 %) of the vinyl ester as a film. Rf = 
0.6 (10% Et2O/hexanes); [!]25D = – 11.82 (c 0.17, CHCl3); 1H NMR (500 MHz, CDCl3) " 5.68 
(ddd, J = 16.0, 10.5, 1.5, Hz, 1H), 4.99 (dd, J = 16.0, 1.5 Hz, 2H), 3.69 (dd J = 10.2, 5.0 Hz, 
1H), 3.63 (s, 3H), 3.36 (d, J = 9.8 Hz, 1H), 3.13 (d, J = 9.8 Hz, 1H), 3.03 (m, 1H), 1.92 (dd, J 
= 11.9, 2.9 Hz, 1H), 1.69 (m, 1H), 1.51-1.82 (m, 4H), 1.19-1.40 (m, 4H), 1.13 (s, 3H), 1.07 
(s, 3H), 0.93 (s, 9H), 0.87 (s, 9H), 0.63 (s, 3H), 0.05 (s, 12H); 13C NMR (125 MHz, CDCl3) " 
175.7, 141.5, 115.3, 71.7, 64.4, 55.5, 51.1, 43.9, 40.9, 39.7, 36.0, 32.5, 27.7, 26.7, 26.2, 
26.1, 21.1, 18.3, 18.2, 17.9, 13.1, 12.3, -3.5, -4.7, -5.1, -5.5; IR (thin film, neat) 2952 (s), 
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2857 (m), 1725 (s), 1471 (m), 1389 (m), 1361 (w), 1251 (m), 1087 (s), 1004 (w), 891 (m), 
836 (s), 774 (s), 672 (w) cm-1; No HRMS ESI found.    
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Alcohol (–)-2.52: A 10 mL round-bottomed flask was charged with the methyl ester (–)-2.51 
(78 mg, 0.145 mmol, 1.0 equiv.) in dry CH2Cl2 (2 mL) was cooled to -78 oC.  Next, DIBAL-H 
in hexanes (435 µL of a 1 M solution, 0435 mmol, 1.1 equiv.) was slowly added dropwise to 
the -78 oC solution.  After stirring 30 min at -78 oC, the reaction was complete as seen by tlc. 
The reaction was allowed to warm to 0 °C and was then quenched with a mixture of MeOH 
(1 mL), ethyl ether (5 mL), and sat. aq Rochelle’s Salt (5 mL). The mixture was stirred 
vigorously for 20 min, and the layers were separated. The aqueous layer was back-
extracted with ethyl ether (2 x 10 mL), and the combined organic layers were dried 
(Na2SO4), filtered, and concentrated in vacuo to give the desired compound as a white solid 
(70 mg, >95%). Usually the crude product was clean enough to use as-is, but if desired, the 
residue could be purified by silica gel flash column chromatography (10% Et2O/hexanes), Rf 
= 0.2 (10% Et2O/hexanes): [!]25D = – 24.26 ° (c 0.19, CHCl3);  1H NMR (500 MHz, CDCl3) " 
5.93 (ddd, J = 17.1, 10.5, 2.0, Hz, 1H), 5.14 (dd, J = 17.1, 2.0 Hz, 2H), 5.01 (dd J = 10.1, 2.1 
Hz, 1H), 3.63-3.68 (m, 2H), 3.44 (m, 1H), 3.34 (d, J = 9.8 Hz, 1H),  3.11 (d, J = 9.7 Hz, 1H), 
2.48 (m, 1H), 1.93 (dd, J = 12.0, 2.6 Hz, 1H), 1.53-1.65 (m, 3H), 1.28-1.48 (m, 5H), 1.06 (s, 
3H), 0.92 (s, 9H), 0.90 (s, 3H), 0.87 (s, 9H), 0.61 (s, 3H), 0.04 (s, 3H), 0.03 (s, 6H), 0.02 (s, 
3H); 13C NMR (125 MHz, CDCl3) " 144.0, 115.2, 71.8, 68.4, 64.4, 45.9, 45.5, 43.8, 39.9, 
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37.4, 30.9, 29.9, 27.7, 26.1, 21.6, 18.3, 18.2, 16.2, 13.3, 12.2, – 3.4, – 4.7, –5.1, –5.5; IR 
(thin film, neat) 3454 (b), 2953 (s), 2857 (s), 1635 (w), 1472 (m), 1388 (m), 1360 (w), 1252 
(s), 1089 (s), 1035 (m), 1006 (w), 932 (w), 910 (m), 890 (m), 857 (s), 836 (s), 773 (s) cm-1; 
HRMS (ES+) m/z 533.3817 [(M+Na)+; Calcd for C29H54O3Si2H: 533.3822]. 
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Aldehyde (–)-2.53: To a 25 mL round-bottomed flask charged with alcohol (2 mg, 0.0039 
mmol, 1.0 equiv.) was added dry CH2Cl2 (3 mL) followed by NaHCO3 (1 mg, 0.0117 mmol, 
3.0 equiv.) and Dess-Martin periodinane (5 mg, 0.0117 mmol, 3.0 equiv.).  The reaction was 
stirred at 23 oC for 80 min and the tlc showed complete consumption of the starting material 
to a less polar spot.  The CH2Cl2 was concentrated with a stream of argon gas and the 
residue was taken up in 1% Et2O/hexanes and purified by flash column chromatography 
(10% Et2O/hexanes) to yield the desired aldehyde as a film.  Rf = 0.2 (2% Et2O/hexanes): 
[!]25D = – 31.6 ° (CHCl3, c = 1.32); 1H NMR (500 MHz, CDCl3) " 9.70 (s, 1H), 5.56 (ddd, J = 
16.5, 10.5, 2.0, Hz, 1H), 5.00-5.05 (m, 2H), 3.69 (m, 1H), 3.37 (d, J = 9.8 Hz, 1H),  3.13 (d, J 
= 9.8 Hz, 1H), 3.04 (m, 1H), 1.90 (dd, J = 11.6, 3.1 Hz, 1H), 1.90 (dd, J = 12.8, 3.9 Hz, 1H), 
1.30-1.62 (m, 7H), 1.21 (s, 3H), 1.03 (s, 3H), 0.92 (s, 9H), 0.87 (s, 9H), 0.64 (s, 3H), 0.05 
(m, 12H); 13C NMR (125 MHz, CDCl3) " 209.3, 140.2, 116.0, 71.6, 64.3, 55.9, 43.9, 40.9, 
40.7, 36.6, 32.1, 27.2, 27.1, 26.2, 26.1, 21.2, 18.3, 18.2, 17.3, 13.2, 10.3, – 3.4, –4.7, – 5.1, 
–5.5; IR (thin film, neat) 2927 (s), 2857 (s), 1712 (s), 1471 (w), 1386 (w), 1254 (m), 1084 (s), 
919 (w), 888 (w), 857 (s), 836 (s), 772 (s), 668 (m); No HRMS ESI found. 
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Enone (+)-2.54. Vinylmagnesium Bromide Addition: A 0.5-2.0 mL microwave reaction vial 
was charged with aldehyde (+)-2.53 (7 mg, 0.013 mmol) and dry THF (2.0 mL), and was 
cooled to -78 oC.  Next, excess vinyl magnesium bromide in THF (1.0 M, 500 µL, 0.500 
mmol) was added to the reaction flask via syringe.  The solution stirred at -78 oC for 2 h and 
the dry ice bath was removed and the solution was allowed to warm to 23 oC and stirred for 
2 h. The reaction was cooled to 0 oC and saturated NH4Cl was added (1 mL).  Saturated 
NaCl (10 mL) was added and the aqueous layer was extracted with Et2O (3 x 30 mL).  The 
organic layers were combined and dried with Na2SO4, filtered and concentrated on a rotary 
evaporator.  The material thus obtained is a mixture of diastereomers in approximately 3:1 
ratio, along with some product of aldehyde reduction. The residue was purified by flash 
column chromatography (2.8% Et2O/hexanes) to give the desired products (4 mg, 57%):  Rf 
= 0.2 (4% Et2O/hexanes). Major diastereomer: 1H NMR (500 MHz, CDCl3) ! 5.98 (m, 1H), 
5.12 (dd, J = 17.1, 1.8 Hz, 1H), 5.02 (m, 3H), 4.19 (t, J = 7.3 Hz, 1H), 3.67 (dd, J = 11.8, 4.4 
Hz, 1H), 3.31 (d, J = 9.8 Hz, 1H), 3.12 (d, J = 9.8 Hz, 1H), 2.89 (m, 1H) 2.05 (m, 1H), 1.96 
(dd, J = 11.4, 2.8 Hz, 1H), 1.95-1.44 (m, 5H), 1.68-1.54 (m, 3H), 1.21 (s, 3H), 0.92 (s, 9H), 
0.88 (s, 9H), 0.86 (s, 3H), 0.63 (s, 3H), 0.08 (s, 3H), 0.05 (s, 6H), 0.03 (s, 3H). No HRMS 
ESI found. The aldehyde reduction product (2 mg, 30%) was also isolated. 
 
Ring-Closing Metathesis/Oxidation: To a 10 mL round-bottomed flask charged with allylic 
alcohol (3 mg, 0.006 mmol) was added dry CH2Cl2 (6.0 mL) followed by a solution of Grubbs 
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1st generation catalyst (1 mg) in dry CH2Cl2 (2.0 mL).  The reaction was stirred for 4 h a gave 
a spot to spot conversion by tlc (acyclic allylic alcohol starting material Rf = 0.2 (4% 
Et2O/hexanes); 5-membered allylic alcohol intermediate Rf = 0.025 (4% Et2O/hexanes).  
After 4 h at 23 oC solid NaOAc (excess) and PCC (excess) were added to the reaction flask.  
The contents were stirred for 18 h at 23 oC. Next, NaHCO3 (5 mg) was added to the reaction 
flask and stirred for 3.5 h.  After that period, a 50% Et2O/hexanes solution (20 mL) was 
added and the contents of the flask were run through a silica gel plug (20 mL of silica gel).  
The product was eluted through the silica gel plug with more 50% Et2O/hexanes solution 
(150 mL) and the filtrate was concentrated on the rotary evaporator.  The residue was 
purified by flash column chromatography (7% Et2O/hexanes) and gave the desired enone as 
a white crystalline solid (2.6 mg, 92%), Rf = 0.33 (10% Et2O/hexanes): [!]25D = + 43.2 ° 
(CHCl3, c = 0.1);  1H NMR (500 MHz, CDCl3) " 7.4 (dd, J = 6.9, 1.6 Hz, 1H), 5.90 (dd, J = 
5.8, 2.0 Hz, 1H), 3.69 (dd, J = 11.1, 5.0 Hz, 1H), 3.43 (d, J = 11.3 Hz, 1H), 3.12 (m, 1H), 
3.09 (d, J = 9.6 Hz, 1H), 2.12-2.03 (m, 3H), 1.86-1.83 (m, 1H), 1.70-1.45 (m, 5H), 1.18 (s, 
3H), 1.06 (s, 3H), 0.92 (s, 9H), 0.88 (s, 9H), 0.61 (s, 3H), 0.06 (s, 3H), 0.05 (s, 9H); 13C NMR 
(125 MHz, CDCl3) " 213.6, 162.9, 132.1, 72.1, 64.5, 59.6, 47.2, 44.0, 38.8, 37.9, 30.4, 27.7, 
26.2, 26.1, 23.4, 23.1, 20.1, 18.9, 18.3, 18.2, 12.5, –3.3, –4.7, –5.0, –5.6; IR (thin film, neat) 
2953 (s), 2933 (s), 2856 (s), 1701 (s), 1471 (w), 1443 (w), 1385 (w), 1254 (m), 1087 (s), 932 
(w), 878 (w), 854 (m), 835 (s), 772 (s), 668 (m) cm–1; HRMS (ES+) m/z 507.3687 [(M+H)+; 
Calcd for C29H54O3Si2H: 507.3689]. 
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Procedure for the Synthesis of Aldehyde (–)-2.53 by Cuprate Addition to Aldehyde 
(+)-2.21: Cuprate Addition: To a suspension of copper (I) bromide dimethylsulfide complex 
(123 mg, 0.6 mmol, previously re-crystallized from dimethylsulfide according to the 
procedure of House et al. (J. Org. Chem. 1975, 40, 1460-1469)) in THF (1.4 ml) stirring at -
78 °C was added a solution of vinylmagnesium bromide (0.73M in THF, 1.2 mmol, prepared 
according to the procedure of Fuson and Mon ( J. Org. Chem. 1960, 25, 756-758)) 
dropwise. The resulting dark green suspension was allowed to stir for 15 minutes, during 
which time the color became a lighter. HMPA (150 µl, 0.86 mmol) was added, followed by a 
solution of enal (+)-2.21 (200 mg, 0.43 mmol) and TMSCl (110 µl, 0.86 mmol) in THF (1.2 
ml) dropwise over 30 minutes via syringe pump. The mixture was stirred for 1 hour further at 
-78 °C after the addition was complete, then was warmed to room temperature over 1.5 h. 
The mixture was then treated with triethylamine (120 µl), diluted with hexanes (30 ml), and 
water (1 ml). The copper salts became heterogenous and clumpy, and were removed by 
filtration through celite. The filtrate was washed with water (2 x 10 ml), the aqueous layers 
were back-extracted with hexanes (2 x 10 ml), and the combined organic layers were 
washed with brine, dried (MgSO4), filtered, and concentrated in vacuo to an oil (240 mg). 
The oil was azeotroped with benzene twice to give the intermediate silyl enol ether vinyl 
addition product 2.99 and 2.100 as a mixture of diastereomers (ca. 6:1 resp.), which was 
carried into the next step without purification. 
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Fluoride-mediated alkylation of silyl enol ether: The alkylation of the silyl enol ether product 
of the cuprate addition was carried out according to the procedure of Kuwajima and 
Nakamura (J. Am. Chem. Soc., 1982, 104 (4), 1025-1030): To a suspension of 
benzyltrimethylammonium fluoride (BTAF, 40 mg, 0.24 mmol, previously dried overnight 
under vacuum at 90 °C) and 4Å molecular sieves (100 mg, previously flame-dried under 
vacuum) in THF (250 µl) that had pre-stirred for 30 minutes at room temperature was added 
methyl iodide (50 µl, 0.76 mmol). Note: it is best to vacuum dry the BTAF in the same flask 
that the experiment is performed in, so that manipulation of this extremely hygroscopic 
reagent is kept to a minimum. To the BTAF/4Å MS/MeI slurry was added a solution of silyl 
enol ethers 2.99/2.100 (42 mg, 0.08 mmol, ca. 6:1 mixture) in THF  (150 µl + 100 µl rinse) 
dropwise. The resulting mixture was allowed to stir at 0 °C for 1.5 h while being monitored 
by TLC (2% ethyl ether/hexanes), at which time the reaction was judged to be complete. 
The mixture was diluted with ethyl ether (10 ml) and filtered through celite. The filtrate was 
concentrated in vacuo to an oil (40 mg) which was purified by silica flash chromatography 
(50:1 ethyl ether/hexanes) to give the desired product as an inseparable mixture with the C-
12 vinyl diastereomer and C-3 H product resulting from hydrolysis of the starting material 
(17 mgs, 46% by 1H NMR). The balance of the material was diastereomeric products and 
hydrolysis products that were not characterized. The fraction containing the desired product 
was carried into the next step. 
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Aldehyde (–)-2.104: De-silylation of bis-TBS diol: To a solution of bis-TBS-diols (+)-2.54 
and (+)-2.47 (200 mg, 0.39 mmol), as a 4:1 mixture resp., in THF (2 ml) stirring at 0 °C was 
added tetrabutylammonium fluoride (1.18 ml of 1.0M solution in THF, 1.18 mmol) dropwise. 
The resulting mixture was treated with 4Å molecular sieves (previously flame-dried under 
vacuum, 20 mg) and allowed to warm slowly to room temperature. After stirring 48 h at room 
temperature, TLC indicated completion. The mixture was diluted with ethyl acetate and 
filtered through celite, the filtrate was concentrated in vacuo, and the residue purified by 
flash silica chromatography (3%  methanol/methylene chloride, 2 x 12 cm) to give the 
intermediate diol 2.102 (89 mg, 81%), which was carried directly into the next step.  
 
Selective Benzylation of Primary Alcohol: To a solution of the diols 2.102 (18 mgs, 0.06 
mmol) in methylene chloride (2 mls) at room temperature was added freshly distilled benzyl 
bromide (76 µl, 0.64 mmol), followed by silver (I) oxide (25 mg, 0.11 mmol). The mixture was 
vigorously stirred for 3.5 h at which time TLC indicated completion. If the reaction progress 
stalls, additional portions of silver (I) oxide may be added to drive to completion. The mixture 
was then concentrated in vacuo, and the resulting residue was loaded onto a flash silica gel 
column (1.3 x 15 cm) and eluted with 20% ethyl acetate/hexanes to give the desired diols 
2.103 (21 mg, 90%) as an oil. The product thus obtained was carried directly into the next 
step. 
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Silylation of Secondary Alcohol: To a solution of the secondary alcohols 2.103 (300 mg, 0.81 
mmol, ca. 4:1 mixture of diastereomers) in methylene chloride (24 ml) was added freshly 
distilled 2,6-lutidine (236 µl, 2.02 mmol). The mixture was cooled to 0 °C, and then treated 
with tert-butyldimethylsilyl trifluoromethanesulfonate (205 µl, 0.89 mmol) dropwise. The 
mixture was warmed to room temperature over 15 minutes then stirred to 1 h at room 
temperature at which time the reaction was judged to be complete by TLC, poured into a 
separatory funnel containing saturated aqueous ammonium chloride (80 ml). The layers 
were separated, and the aqueous phase was back-extracted with methylene chloride (3 x 50 
ml), and the combined organic layers were washed with brine, dried (MgSO4), filtered, and 
concentrated in vacuo to give the crude product as an oil (440 mg). Purification was 
accomplished by two flash silica columns (3% ethyl ether/hexanes) to give the desired 
product (203 mg, 52%) as a single diastereomer: [!]25D = – 17.33 ° (CHCl3, c = 0.38); 1H 
NMR (500 MHz, CDCl3) " 9.69 (s, 1H), 7.37-7.26 (m, 5H), 5.59 (ddd, J = 17.32, 10.47, 6.99 
Hz, 1H), 5.02 (m, 2H), 4.56 (d, J = 12.21 Hz, 1H), 4.29 (d, J = 12.21 Hz, 1H), 3.75 (m, 1H), 
3.24 (d, J = 9.14 Hz, 1H), 3.01 (m, 1H), 3.02 (d, J = 9.10 Hz, 1H), 1.98 (m, 1H), 1.73-1.50 
(m, 5H), 1.38 (m, 3H), 1.19 (s, 3H), 1.06 (s, 3H), 0.87 (s, 9H), 0.65 (s, 3H), 0.04 (ad, 6H); 
13C NMR (125 MHz, CDCl3) " 209.4, 140.1, 139.1, 128.5, 128.4, 127.5, 115.9, 72.7, 72.1, 
72.0, 55.8, 43.4, 40.8, 40.7, 37.3, 32.1, 26.9, 26.1, 21.1, 18.2, 17.2, 13.3, 10.4, –3.7, –5.0; 
IR (thin film, neat) 2951 (s), 2856 (s), 2709 (w), 1720 (s), 1455 (m), 1385 (m), 1254 (m), 
1108 (s), 1004 (w), 915 (w), 890 (m), 836 (s) cm–1; HRMS (ES+) m/z 507.3263 [(M+Na)+; 
Calcd for C30H48NaO3Si: 507.3270]. 
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Enone (+)-2.107. Vinylmagnesium Bromide Addition: To a solution of aldehyde (–)-2.104 
(18 mg, 0.04 mmol) in THF (300 µl) stirring at -78 °C was added vinylmagnesium bromide 
(0.7M in THF, 270 µl, 0.19 mmol, 5 equiv) dropwise. The resulting mixture was stirred at -78 
°C for 5 minutes, then the bath was removed and stirring continued at room temperature 
with TLC monitoring. At 45 minutes, the reaction was judged to be complete. Saturated aq. 
ammonium chloride was added (1 ml) and the mixture was partitioned between saturated 
ammonium chloride and ethyl acetate (20 ml each). The layers were separated and the 
aqueous layer was back-extracted (2 x 10 ml ethyl acetate), the combined organic layer was 
dried (Na2SO4), filtered, and concentrated in vacuo to an oil (24 mg). The crude product was 
purified by flash silica gel chromatography (5% etyl ether/hexanes) to give the desired 
product (14 mg, 75%) as a clear oil. This product is a mixture of inseparable diastereomers 
by 1H NMR. 
 
Ring-Closing Metathesis/Oxidation: A solution of the allylic alcohols (14 mg, 0.03 mmol) in 
methylene chloride (3 ml, 0.01M) was treated with Grubbsʼ 1st generation catalyst (2.2 mg, 
0.003 mmol, 10%) and the vessel was flushed with argon. The purple solution slowly 
became dark green over 1 h, at which time TLC indicated complete conversion to a lower Rf 
spot (0.12 in 10% ethyl ether/hexanes). Sodium acetate (5 mg, 0.06 mmol) and pyridinium 
chlorochromate (9 mg, 0.04 mmol) were then added to the reaction mixture, and the 
progress of the reaction was monitored by TLC. The mixture was allowed to stir overnight, at 
which time complete conversion to a new spot with Rf = 0.19 in 10% ethyl ether/hexanes 
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was observed. The reaction was quenched by the addition of a spatula tip of solid sodium 
bicarbonate, and 1:1 ethyl ether/hexanes (5 ml) was added. The mixture was filtered through 
a small pad of silica gel and the filtrate was concentrated in vacuo. The crude product was 
purified by flash silica gel chromatography (10% ethyl ether/hexanes) to give the desired 
product (10 mg, 75%) as a crystalline solid: [!]25D = + 78.32 ° (CHCl3, c = 0.81); 1H NMR 
(500 MHz, CDCl3) " 7.40 (dd, J = 5.95, 1.89 Hz, 1H), 7.36-7.26 (m, 5H), 5.90 (dd, J = 5.95, 
3.17 Hz, 1H), 4.56 (d, J = 12.09 Hz, 1H), 4.30 (d, J = 12.08 Hz, 1H), 3.76 (dd, J = 11.41, 
4.94 Hz, 1H), 3.31 (d, J = 9.05 Hz, 1H), 3.08 (dddd, J = 12.90, 2.86, 2.86, 2.86 Hz, 1H), 2.99 
(d, J = 9.03 Hz, 1H), 2.11 (m, 2H), 1.79 (dddd, J = 10.14, 4.91, 4.91, 2.62 Hz, 1H), 1.74-1.64 
(m, 1H), 1.64-1.54 (m, 2H), 1.54-1.47 (m, 2H), 1.33-1.22 (m, 1H), 1.20 (s, 3H), 1.04 (s, 3H), 
0.88 (s, 9H), 0.64 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H); 13C NMR (125 MHz, CDCl3) " 213.5, 
162.9, 139.0, 131.9, 128.3, 127.5, 127.4, 72.7, 72.4, 59.5, 47.0, 43.5, 38.7, 38.5, 30.3, 27.4, 
25.9, 23.3, 22.9, 20.1, 19.1, 18.1, 12.5, – 3.7, – 5.2; IR (thin film, neat) 2951 (s), 2856 (s), 
1706 (s), 1471 (m), 1453 (m), 1386 (m), 1365 (m), 1253 (m), 1091 (s), 1032 (m), 1004 (w), 
929 (w), 837 (s), 775 (m) cm–1; HRMS (ES+) m/z 505.3101 [(M+Na)+; Calcd for 
C30H46NaO3Si+: 505.3114]. 
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Iodoenone Eastern Hemisphere (+)-2.108. A solution of enone (+)-2.107 (5 mg, 0.014 
mmol) in carbon tetrachloride (100 µl) was treated with pyridine (100 µl) and cooled to 0 °C. 
A separate solution of iodine (4.4 mg, 0.017 mmol) in 1:1 CCl4/pyridine (200 µl) was 
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prepared, and 100 µl of the iodine solution was added dropwise to the enone solution at 0 
°C. The resulting mixture was stirred for 30 minutes at 0 °C, then warmed to room 
temperature and stirred an additional 4 h, at which time TLC indicated near complete 
conversion to a new higher Rf spot (0.6 in 10% ethyl ether/hexanes). The mixture was 
diluted with ethyl ether (20 ml) and washed successively with water, saturated NH4Cl, water, 
and 20% aq. Na2S2O4 (10 ml each). The organic layer was dried (MgSO4), filtered, and 
concentrated in vacuo to a solid (8 mg), which was revealed to be a 5.7:1 mixture of desired 
product and starting material, respectively. Purification was accomplished by flash silica gel 
chromatography (3% ethyl ether/hexanes) to give the pure desired product (5 mg, 78%) as a 
glass: [!]25D = + 98.0 ° (CHCl3, c = 0.42); 1H NMR (500 MHz, CDCl3) " 7.76 (d, J = 2.11 Hz, 
1H), 7.36-7.26 (m, 5H), 4.56 (d, J = 12.09 Hz, 1H), 4.29 (d, J = 12.08 Hz, 1H), 3.75 (dd, J = 
11.32, 5.10 Hz, 1H), 3.31 (d, J = 9.12 Hz, 1H), 3.10 (ddd, J = 13.02, 2.66, 2.66 Hz, 1H), 2.97 
(d, J = 9.18 Hz, 1H), 2.11 (m, 2H), 1.79 (dddd, J = 9.92, 4.93, 4.93, 2.71 Hz, 1H), 1.74-1.57 
(m, 2H), 1.55-1.45 (m, 2H), 1.32-1.25 (m, 2H), 1.22 (s, 3H), 1.03 (s, 3H), 0.88 (s, 9H), 0.63 
(s, 3H), 0.05 (s, 3H), 0.03 (s, 3H); 13C NMR (125 MHz, CDCl3) " 206.4, 168.5, 139.2, 128.5, 
127.7, 127.6, 101.6, 72.9, 72.6, 72.5, 58.4, 49.6, 43.6, 39.0, 38.6, 30.6, 30.3, 26.1, 23.5, 
22.8, 20.3, 19.4, 18.3, 12.7,  
–3.6, –4.9; IR (thin film, neat) 2950 (s), 2928 (s), 2855 (s), 1716 (s), 1554 (w), 1454 (m), 
1385 (m), 1255 (m), 1092 (s), 929 (w), 879 (m), 836 (s) cm–1; HRMS (ES+) m/z 631.2064 
[(M+Na)+; Calcd for C30H45INaO3Si+: 631.2080]. 
 
 
 
 111 
OCH3
H
H
N
H
N
H
TBS  
 
TBS-hydrazone of Estrone Methyl Ether (+)-2.120: A green-capped 2-dram vial was 
charged with estrone methyl ether (50 mg, 0.176 mmol) and scandium (III) triflate (1 mg, 
0.018 mmol). The vessel was flushed with argon, then a solution of bis-tert-butyldimethylsilyl 
hydrazine (101 mg, 0.39 mmol) in chloroform (450 µl) was added by syringe. The vial was 
capped and the mixture heated to 55 °C for 16 h. TLC (3:2 ethyl acetate/hexanes with 1% 
triethylamine spike) indicated completion. The mixture was diluted with hexanes (2 ml) and 
filtered through a glass wool plug in a pipet. The filtrate was concentrated in vacuo, and the 
resulting residue was purified by silica gel chromatography (pre-treated silica with 1% 
triethylamine/hexanes, 0.5% ethyl acetate/hexanes) to give the desired product (49 mg, 
67%) as a white solid: [!]25D = + 60.14 ° (CHCl3, c = 0.25); 1H NMR (500 MHz, CDCl3) " 7.24 
(d, J = 8.61 Hz, 1H), 6.74 (dd, J = 8.58, 2.78 Hz, 1H), 6.65 (d, J = 2.70 Hz, 1H), 4.66 (bs, 
1H), 3.80 (s, 3H), 2.96-2.84 (m, 2H), 2.40-2.31 (m, 1H), 2.30-2.23 (m, 2H), 2.16 (quint., J = 
8.68 Hz, 1H), 2.07 (m, 1H), 1.96 (m, 2H), 1.57-1.47 (m, 4H), 1.47-1.40 (m, 1H), 1.36-1.27 
(m, 1H), 0.93 (s, 9H), 0.86 (s, 3H), 0.16 (s, 3H), 0.15 (s, 3H); 13C NMR (125 MHz, CDCl3) " 
159.2, 157.6, 138.1, 133.1, 126.5, 114.0, 111.6, 55.4, 53.1, 44.6, 44.2, 38.5, 34.9, 30.0, 
27.5, 26.7, 26.6, 23.7, 23.5, 18.5, 17.5, –5.5; IR (thin film, neat) 2932 (s), 1613 (m), 1504 
(m), 1470 (m), 1446 (m), 1365 (m), 1323 (w), 1246 (s) cm–1; HRMS (CI+) not found. 
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Vinyl Bromide of Estrone Methyl Ether (+)-2.121: To a 25 ml round-bottomed flask was 
added TBS-hydrazone (+)-2.120 (46 mg, 0.11 mmol) and pyridine (distilled, 4 ml) under 
argon. The resulting solution was cooled to 0 °C and treated with a solution of N-
bromosuccinimide (40 mg, 0.22 mmol) in pyridine (4 ml), during which time gas evolution 
was observed. The mixture was stirred for 10 min at 0 °C, at which time TLC (8% ethyl 
acetate/ hexanes, product Rf = 0.71) indicated completion. The mixture was poured into 
water (40 ml) and extracted with ethyl ether (3 x 10 ml). The combined organic layer was 
washed with 1M aq HCl (2 x 10 ml), sat aq sodium bicarbonate (10 ml), dried (Na2SO4), 
filtered and concentrated in vacuo to give the desired product (37 mg, 97%) as a white, 
semi-crystalline solid. Due to the lability of the vinyl bromide, the crude product was usually 
used as is, but purification could be achieved by careful silica gel chroma-tography 
(triethylamine-deactivated silica, 1% triethylamine/hexanes): [!]25D = + 51.20 ° (CHCl3, c = 
0.20); 1H NMR (500 MHz, C6D6) " 7.19 (d, J = 8.83 Hz, 1H), 6.72 (dd, J = 8.67, 2.82 Hz, 1H), 
6.64 (d, J = 2.83 Hz, 1H), 5.87 (dd, J = 3.26, 1.73 Hz, 1H), 3.78 (s, 3H), 2.95-2.83 (m, 2H), 
2.43-2.36 (m, 1H), 2.32-2.26 (m, 1H), 2.23 (ddd, J = 14.69, 6.47, 3.35 Hz, 1H), 2.00 (ddd, J 
= 14.63, 11.23, 1.61 Hz, 1H), 1.92 (dddd, J = 11.12, 5.53, 5.53, 2.53 Hz, 1H), 1.89-1.84 (m, 
1H), 1.65-1.55 (m, 2H), 1.55-1.39 (m, 3H), 0.86 (s, 3H); 13C NMR (125 MHz, C6D6) " 158.7, 
138.0, 136.6, 132.9, 129.5, 126.8, 114.6, 112.3, 55.3, 55.2, 49.5, 44.8, 38.2, 35.3, 32.0, 
30.2, 27.9, 26.9, 15.7; IR (thin film, neat) 2928 (s), 2852 (m), 1609 (m), 1498 (s), 1454 (m), 
1373 (w), 1285 (m), 1256 (s), 1155 (w), 1049 (m), 808 (m) cm–1; HRMS (ES+) m/z 347.1011 
[(M+H)+; Calcd for C19H24BrO: 347.1011]. 
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Ketone (–)-2.134: A 10 ml round-bottomed flask was charged with THF (700 µl) and cooled 
to -78 °C, then L-Selectride® (1.0M in THF, 155 µl, 0.155 mmol) was added to the vessel. To 
this mixture was added a solution of enone (+)-2.107 (68 mg, 0.141 mmol) in THF (700 µl + 
200 µl to quantitate transfer) dropwise. The resulting green-yellow solution was allowed to 
warm to room temperature, and after stirring for 10 min at room temperature, TLC indicated 
completion (8% ethyl acetate/hexanes, where the desired product has an Rf = 0.47). The 
mixture was diluted with ethyl ether, treated with 2N NaOH (aq), and the mixture was 
allowed to stir 10 min. The layers were separated, and the aqueous layer was back-
extracted with ethyl ether. The combined organic layers were dried (Na2SO4), filtered, and 
concentrated in vacuo to a pale yellow solid (77 mg). Flash silica chromatography (10% 
ethyl acetate/hexanes) gave the desired product (59 mg, 87%) as a crystalline solid: m.p. 
149-151 °C; [!]25D = – 30.15 ° (CHCl3, c = 0.88); 1H NMR (500 MHz, CDCl3) " 7.37-7.28 (m, 
5H), 4.57 (d, J = 12.45 Hz, 1H), 4.29 (d, J = 12.34 Hz, ,1H), 3.74 (dd, J = 11.32, 4.73 Hz, 
1H), 2.18 (m, 1H), 2.07 (ddd, J = 13.84, 3.75, 3.75, 1H), 2.04-1.94 (m, 2H), 1.80 (dddd, J = 
12.20, 9.44, 5.80, 0 Hz, 1H), 1.71-1.61 (m, 2H), 1.61-1.50 (m, 3H), 1.43-1.32 (m, 2H), 1.29-
1.19 (m, 4H), 1.00 (s, 3H), 0.96 (s, 3H), 0.89 (s, 9H), 0.62 (s, 3H), 0.05 (s, 3H), 0.04 (s, 3H); 
13C NMR (125 MHz, CDCl3) " 221.6, 139.4, 128.4, 127.6, 127.5, 72.9, 72.7, 56.4, 43.6, 40.6, 
39.3, 38.7, 37.8, 30.6, 27.5, 26.2, 26.0, 24.1, 22.3, 18.3, 18.0, 12.7, 10.8, –3.6, –4.9; IR (thin 
film, neat) 2953 (s), 2925 (s), 2854 (s), 1732 (s), 1471 (m), 1387 (w), 1253 (m), 1090 (s), 
925 (w), 896 (w), 874 (w), 836 (m) cm–1; HRMS (ES+) m/z 507.3253 [(M+H)+; Calcd for 
C30H48NaO3Si: 507.3270]. 
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TBS-hydrazone (+)-2.135: To a 1 dram green-capped vial was added ketone (–)-2.134 (43 
mg, 0.089 mmol), 1,2-bis-tert-butyldimethylsilyl hydrazine (100 µl), and scandium (III) triflate 
(5 mol %, 2.2 mg). The vessel was flushed with argon, sealed, and heated to 100 °C for 48 
h. After cooling to room temperature, the mixture was diluted with hexanes and filtered 
through glass wool, followed by two hexanes rinses. The filtrate was concentrated in vacuo 
and pumped on the high vacuum pump at 80 °C for 48 h. Purification of the resulting residue 
on basic alumina (2% ethyl acetate/hexanes) gave the desired product (43 mg, 79%) as an 
oil: [!]25D = + 6.18 ° (CHCl3, c = 0.17); 1H NMR (500 MHz, CDCl3) " 7.37-7.25 (m, 5H), 4.56 
(d, J = 12.16 Hz, 1H), 4.38 (bs, 1H), 4.30 (d, J = 12.13 Hz, 1H), 3.74 (dd, J = 11.57, 4.78 Hz, 
1H), 3.29 (d, J = 8.99 Hz, 1H), 3.00 (d, J = 8.98 Hz, 1H), 2.08 (m, 1H), 1.98-1.85 (m, 3H), 
1.79 (m, 1H), 1.68 (m, 1H), 1.53-1.12 (m, 11H), 1.03 (s, 3H), 0.93 (s, 9H), 0.89 (s, 9H), 0.62 
(s, 3H), 0.17 (s, 3H), 0.15 (s, 3H), 0.07 (s, 3H), 0.04 (s, 3H); 13C NMR (125 MHz, CDCl3) " 
165.4, 139.9, 135.7, 126.0, 100.5, 73.4, 54.1, 44.3, 43.6, 39.7, 39.4, 33.0, 32.0, 31.0, 30.6, 
28.6, 26.6, 26.3, 25.9, 23.7, 18.7, 18.7, 18.6, 13.2, 13.0, 1.8, –3.3, –4.2, –4.6 ; IR (thin film, 
neat) 2928 (s), 2857 (s), 2710 (w), 1737 (m), 1615 (s), 1471 (s), 1385 (m), 1301 (m), 1256 
(s), 1091 (s), 835 (s) cm–1; HRMS (CI+) m/z 499.3720 [(M–TBS)+; Calcd for C30H48NaO3Si: 
499.3714]. Some recovered starting material (4 mg) was also obtained. 
 
 
 115 
OTBS
OBn
H
H
Br
 
 
Vinyl Bromide Eastern Hemisphere (–)-2.133: A 2-dram vial was charged with TBS-
hydrazone (+)-2.135 (6.3 mg, 0.01 mmol) and freshly distilled pyridine (100 µl), and the 
vessel was flushed with argon and cooled to 0 °C. To the TBS-hydrazone solution was 
added a solution of N-bromosuccinimide (7 mg, 0.04 mmol) in pyridine (200 µl), and reaction 
progress was closely monitored by TLC. After stirring for 5 min at 0 °C, the reaction was 
judged to be complete by TLC (2% triethylamine/hexanes, desired product has Rf = 0.63). 
The mixture was diluted with ether (1.5 ml) and washed successively with water (0.5 ml) and 
2N HCl (aq, 2 x 0.5 ml), and the organic layer was dried (Na2SO4), filtered, and concentrated 
in vacuo to provide the desired product as a solid (5 mg, 94%). The vinyl bromide was 
typically not purified due to lability, but purification could be achieved by flash silica 
chromatography (triethylamine-deactivated silica, 2% trietylamine/hexanes) to give 
analytically pure material: [!]25D = – 7.82 ° (CHCl3, c = 0.83); 1H NMR (500 MHz, C6D6) 
" 7.37-7.28 (m, 5H), 5.81 (dd, J = 3.03, 1.84 Hz, 1H), 4.56 (d, J = 12.33 Hz, 1H), 4.30 (d, J = 
12.28 Hz, 1H), 3.74 (dd, J = 11.62, 4.93 Hz, 1H), 3.30 (d, J = 8.92 Hz, 1H), 2.99 (d, J = 8.93 
Hz, 1H), 2.28-2.21 (m , 2H), 2.05 (ddd, J = 14.92, 6.78, 3.06 Hz, 1H), 1.98 (dd, J = 12.23, 
3.17 Hz, 1H), 1.87 (ddd, J = 14.92, 13.05, 1.80 Hz, 1H), 1.77-1.56 (m, 3H), 1.50-1.35 (m, 
3H), 1.23 (m, 1H), 1.09 (s, 3H), 0.97 (s, 3H), 0.89 (s, 9H), 0.63 (s, 3H), 0.06 (s, 3H), 0.04 (s, 
3H); 13C NMR (125 MHz, C6D6) " 139.3, 133.7, 132.5, 73.0, 72.8, 72.7, 57.7, 44.2, 43.8, 
40.1, 39.2, 33.7, 30.6, 30.1, 27.8, 26.1, 23.1, 21.3, 21.2, 18.3, 18.0, 12.7, 12.6, 1.3, –3.7, –
5.0; IR (thin film, neat) 2926 (s), 2855 (s), 1734 (m), 1587 (w), 1455 (m), 1385 (m), 1256 
(m), 1092 (s) cm–1; HRMS (ES+) Not found. 
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Aldehyde (–)-2.141: To a solution of dihydroxyaldehyde 2.103 (210 mg, 0.75 mmol, ca. 4:1 
mixture of diastereomers) stirring in methylene chloride (5 ml) at room temperature was 
added, in order, 3,4-dimethoxybenzaldehyde (161 mg, 0.97 mmol), p-toluene-sulfonic acid 
monohydrate (5 mg, 0.026 mmol), and magnesium sulfate (10 mg). The mixture was stirred 
at room temperature for 4 h, filtered, and the filtrate was concentrated in vacuo to an oil. 
Flash silica gel chromatography (25% ethyl acetate/hexanes) gave partially pure material 
(350 mg), which was purified further by crystallization from ethyl ether to give analytically 
pure material (208 mg, 24%) as a crystalline product: [!]25D = – 38.22 ° (CHCl3, c = 0.83); 1H 
NMR (500 MHz, CDCl3) " 9.72 (s, 1H), 7.05 (td, J = 4.17, 1.82 Hz, 2H), 6.85 (m, 1H), 5.58 
(ddd, J = 17.36, 10.49, 7.09 Hz, 1H), 5.49 (s, 1H), 5.04 (m, 2H), 3.91 (s, 3H), 3.87 (s, 3H), 
3.43 (m, 2H), 3.06 (ddd, J = 11.23, 7.30, 4.04 Hz, 1H), 1.83-1.72 (m, 4H), 1.69-1.57 (m, 2H), 
1.52-1.41 (m, 1H), 1.41-1.33 (m, 3H), 1.27 (s, 3H), 1.24 (s, 3H), 1.09 (s, 3H); 13C NMR (125 
MHz, CDCl3) " 208.6, 149.7, 149.1, 139.5, 131.4, 119.1, 116.4, 111.1, 109.4, 102.7, 85.8, 
79.0, 56.2, 56.0, 55.4, 41.8, 41.2, 40.6, 36.9, 32.7, 26.6, 23.5, 20.8, 17.6, 13.8, 10.6; IR (thin 
film, neat) 3080 (w), 2938 (s), 2872 (m), 2722 (w), 1717 (s), 1595 (w), 1518 (s), 1464 (m), 
1415 (m), 1380 (m), 1265 (s), 1237 (s), 1204 (w), 1164 (s), 1137 (s), 1116 (s), 1029 (s), 974 
(w), 921 (w), 759 (m) cm–1; HRMS (ES+) m/z 451.2479 [(M+Na)+; Calcd for C26H36NaO5: 
451.2460]. 
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Enone (+)-2.143: Vinylmagenesium Bromide Addition to Aldehyde (–)-2.141: To a solution 
of aldehyde (–)-2.141 (10 mg, 0.023 mmol) in THF (500 µl) stirring at -78 °C 
(CO2(s)/acetone) under argon was added a solution of vinylmagnesium bromide (1.06M in 
THF) dropwise. The ice bath was removed and the mixture was allowed to warm to room 
temperature. After stirring for 1 h at room temperature, TLC indicated completion (desired 
product Rf = 0.25 in 25% ethyl acetate/hexanes, stains blue in anisealdehyde). The reaction 
mixture was diluted with ethyl ether (1 ml) and quenched by the addition of saturated NH4Cl 
(aq, 200 µl) and the layers were separated. The aqueous layer was back-extracted with 
ethyl ether (2 x 500 µl) and the combined organic layer was dried (MgSO4), filtered and 
concentrated in vacuo to give the crude desired product (11 mg) as a mixture of 
diastereomers and an unidentified impurity. Purification was accomplished by flash silica gel 
chromatography (25% ethyl acetate/hexanes) to obtain the desired product as a mixture of 
diastereomers free of other impurities.  
 
Ring-closing Metathesis/Oxidation: A 10 ml round-bottomed flask equipped with a stir bar 
was charged with allylic alcohol dienes (56 mg, 0.123 mmol) and methylene chloride (2.5 
ml), and the flask was flushed with argon and stirred at room temperature. To this solution 
was added Grubbs 1st-generation catalyst (10 mg, 10 mol %) and stirring was continued at 
room temperature, and after 15 min, TLC indicated complete conversion to a new lower Rf 
spot (0.07 in 25% ethyl acetate/hexanes). During the RCM reaction, the reaction solution 
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turns from purple to a dark green color. The mixture was concentrated in vacuo and the 
resulting residue was dry-packed onto silica gel and loaded onto a column. The column was 
eluted with 40% ethyl acetate/hexanes  to give the pure cyclic allylic alcohol as an 
inconsequential mixture of diastereomers. (Note: It was found that purification of the 
intermediate RCM product 2.142 gave better results than a one-pot procedure, since some 
impurities can be removed at this stage that are difficult to remove at the final product enone 
stage). The RCM product 2.142 was dissolved in methylene chloride (2 ml) and sodium 
acetate (14 mg) and pyridinium chlorochromate (14 mg, 0.063 mmol) were added, in order, 
to the resulting solution. The mixture was cooled to 0 °C (ice/water) under argon and treated 
with sodium bicarbonate (84 mg) followed by Dess-Martin periodinane (84 mg, 0.19 mmol) 
as a suspension in methylene chloride (1.5 ml). The mixture was allowed to warm to room 
temperature and stir for 1 h, and the reaction was judged to be complete by TLC, where the 
new spot has a higher Rf than the RCM product spot (0.17 in 25% ethyl acetate/hexanes). 
The reaction was quenched by the addition of saturated NaHCO3 (aq, 1 ml) followed by 
vigorous stirring for 1 h. The layers were separated, and the aqueous layer back extracted 
with methylene chloride (2 x 500 µl), and the combined organic layers were dried (Na2SO4), 
filtered, and concentrated in vacuo to give the crude desired enone (45 mg). Purification was 
achieved by flash silica gel chromatography (40% ethyl acetate/hexanes) to give the desired 
product (37 mg, 71%) as a white solid: [!]25D = + 57.95 ° (CHCl3, c = 0.38); 1H NMR (500 
MHz, CDCl3) " 7.43 (dd, J = 6.04, 1.82 Hz, 1H), 7.06 (m, 2H), 6.86 (m, 1H), 5.93 (dd, J = 
5.94, 3.14 Hz, 1H), 5.51 (s, 1H), 3.90 (m, 7H), 3.48 (m, 1H), 3.13 (dddd, J = 12.91, 2.79, 
2.79, 2.79 Hz, 1H), 2.29 (ddd, J = 13.32, 2.90, 2.90 Hz, 1H), 1.94-1.81 (m, 2H), 1.76-1.58 
(m, 4H), 1.53-1.42 (m, 3H), 1.23 (s, 6H), 1.14 (m, 3H); 13C NMR (125 MHz, CDCl3) " 212.8, 
162.6, 149.7, 149.1, 132.0, 131.5, 119.1, 111.0, 109.4, 102.7, 86.5, 78.8, 59.26, 56.1, 56.0, 
46.7, 43.0, 39.6, 37.2, 31.3, 23.8, 23.2, 22.6, 20.1, 19.8, 13.1; IR (thin film, neat) 2941 (b,m), 
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2873 (m), 2840 (m), 1701 (s), 1596 (w), 1518 (s), 1454 (m), 1416 (m), 1376 (m), 1331 (w), 
1263 (s), 1234 (s), 1164 (m), 1138 (m), 1113 (s), 1098 (s), 1031 (s), 916 (w), 732 (s) cm–1; 
HRMS (ES+) m/z 449.2314 [(M+Na)+; Calcd for C26H34NaO5+: 449.2304]. 
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Vinyl Triflate Eastern Hemisphere (–)-2.144: To a 2-dram vial equipped with a stir bar was 
added L-Selectride (1.0M in THF, 100 µl, 0.1 mmol) under nitrogen. The solution was 
allowed to cool, and to this solution was added the enone (+)-2.143 (30 mg, 0.070 mmol) in 
THF (100 µl + 100 µl to quantitate transfer) dropwise. The resulting yellow-green solution 
was stirred for 15 min at -78 °C, and then treated with a solution of N-phenyl-bis-
trifluoromethanesulfonimide (50 mg, 0.14 mmol) in THF (200 µl) dropwise. The resulting 
mixture was stirred at -78 °C for 5 min, then allowed to warm to room temperature and stir 
for 30 min further. The reaction was quenched by the addition of saturated NH4Cl (aq, 500 
µl), the layers were separated, and the aqueous layer back-extracted with ethyl acetate (2 x 
500 µl). The combined organic layer was dried (Na2SO4), filtered through glass wool in a 
pipet, and concentrated in vacuo to give the crude product (90 mg), which was 2 spots by 
TLC (30% ethyl acetate/hexanes). The material was dry-packed on silica gel, and 
purification by flash silica gel chromatography (30% ethyl acetate/hexanes) gave two 
products, the desired product (10 mg, 26%): [!]25D = – 35.87 ° (CHCl3, c = 0.15); 1H NMR 
(500 MHz, CDCl3) " 7.06 (m, 2H), 6.86 (m, 1H), 5.57 (dd, J = 3.17, 1.76 Hz, 1H), 5.49 (s, 
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1H), 3.92 (s, 3H), 3.90 (m, 1H), 3.87 (s, 3H), 3.44 (m, 2H), 2.28 (m, 1H), 2.19 (ddd, J = 
14.79, 6.52, 3.31 Hz, 1H), 2.01 (ddd, J = 14.78, 11.02, 1.74 Hz, 1H), 1.88-1.79 (m, 1H), 
1.77-1.61 (m, 5H), 1.46-1.33 (m, 3H), 1.21 (s, 3H), 1.16 (s, 3H), 1.10 (s, 3H); 13C NMR (125 
MHz, CDCl3) ! 158.1, 149.8, 149.2, 131.6, 118.6 (q, J = 320.5 Hz, CF3), 114.8, 114.5, 111.1, 
109.5, 102.7, 86.2, 79.0, 56.2, 56.0, 54.8, 42.9, 42.7, 39.8, 37.2, 31.9, 30.4, 24.4, 24.0, 22.3, 
19.6, 13.1, 12.3; IR (thin film, neat) 2943 (b, m), 2870 (b,w), 1731 (w), 1626 (w), 1519 (m), 
1417 (s), 1213 (s), 1163 (m), 1140 (s), 1101 (m), 1030 (m), 899 (w), 857 (w), 806 (w), 760 
(w) cm–1; HRMS (ES+) m/z 583.1963 [(M+Na)+; Calcd for C27H35F3NaO7S: 583.1953]. 
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The ketone (–)-2.145 resulting from 1,4-reduction (16 mg) was also obtained: ["]25D = – 
47.02 ° (CHCl3, c = 0.30); 1H NMR (500 MHz, CDCl3) ! 7.06 (m, 2H), 6.86 (m, 1H), 5.50 (s, 
1H), 3.92 (s, 3H), 3.89 (m, 1H), 3.88 (s, 3H), 3.45 (m, 2H), 2.34 (dd, J = 19.53, 8.66 Hz, 1H), 
2.29-2.18 (m, 2H), 2.03 (ddd, J = 19.06, 9.55, 9.55 Hz, 1H), 1.54 (dddd, J = 12.49, 12.49, 
9.72, 9.01 Hz, 1H), 1.89-1.78 (m, 2H), 1.77-1.66 (m, 3H), 1.45-1.32 (m, 4H), 1.21 (s, 3H), 
1.08 (s, 3H), 0.97 (s, 3H); 13C NMR (125 MHz, CDCl3) ! 220.8, 149.7, 149.1, 131.6, 119.0, 
111.1, 109.4, 102.6, 86.3, 56.1, 56.0, 55.9, 43.0, 40.2, 39.9, 37.5, 37.1, 31.3, 29.8, 25.6, 
24.0, 23.7, 21.7, 18.9, 13.3, 10.6; IR (thin film, neat) 2942 (b, s), 2878 (m), 1731 (s), 1596 
(w), 1519 (s), 1464 (s), 1408 (m), 1377 (m), 1263 (s), 1236 (s), 1164 (s), 1138 (s), 1119 (s), 
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1087 (s), 1031 (s), 977 (w), 917 (w) cm–1; HRMS (ES+) m/z 451.2433 [(M+Na)+; Calcd for 
C26H36NaO5+: 451.2460]. 
 
Conversion of Ketone (–)-2.145 to Vinyl Triflate Eastern Hemisphere (–)-2.144: To a 
solution of the ketone (–)-2.145 (18 mgs, 0.042 mmol) in THF (200 µl) stirring at -78 °C 
under a nitrogen atmosphere was added potassium (bistrimethylsilyl) amide (0.5M in 
toluene, 200 µl) dropwise. The resulting mixture was stirred for 30 min at -78 °C, and then 
treated with a solution of N-phenyl-trifluoromethane-sulfonimide (36 mg, 0.10 mmol) in THF 
(100 µl). The mixture was stirred for 5 min at -78 °C, then warmed to room temperature. TLC 
indicated complete conversion to a new product (Rf = 0.55 in 30% ethyl acetate/hexanes). 
The mixture was diluted with ethyl ether (1 ml) and washed with saturated NH4Cl (aq, 0.5 
ml), the layers were separated and the aqueous layer was back-extracted with ethyl acetate 
(2 x 0.5 ml). The combined organic layers were dried (Na2SO4), filtered, and concentrated in 
vacuo. The crude product was purified by flash silica gel chromatography (20% ethyl 
acetate/hexanes) to give the desired product (21 mg, 89%), the spectroscopic data for which 
matched the material isolated from the enolate trapping experiment. 
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Alcohol (–)-2.146: To a 5 ml round-bottomed flask was added ketone (–)-2.134 (4 mg, 
0.0083 mmol), 10% Pd/C (1 mg), and ethyl acetate (500 ml), in that order. The vessel was 
was evacuated (water aspirator) and back-filled with hydrogen gas (1 atm, balloon) and 
stirred at room temperature while being monitored by TLC. After 48 h, TLC indicated 
complete conversion to a new lower Rf spot (0.13 in 10% ethyl acetate/hexanes). The 
mixture was filtered through celite, the celite pad was washed with ethyl acetate copiously, 
and the filtrate concentrated in vacuo to give the clean desired product (2.8 mg, 85%): [!]25D 
= – 33.13 ° (CHCl3, c = 0.34); 1H NMR (500 MHz, CDCl3) " 3.62 (dd, J = 11.40, 4.74 Hz, 
1H), 3.49 (d, J = 10.78 Hz, 1H), 3.26 (d, J = 10.76 Hz, 1H), 2.31 (dd, J = 19.32, 7.89 Hz, 
1H), 2.20 (m, 1H), 2.10 (ddd, J = 13.49, 3.43, 3.43 Hz, 1H), 2.00 (ddd, J = 18.98, 9.45, 9.45 
Hz, 1H), 1.80 (m, 1H), 1.75-1.65 (m, 3H), 1.64-1.56 (m, 3H), 1.56-1.47 (m, 2H), 1.46-1.29 
(m, 2H), 1.02 (s, 3H), 0.94 (s, 3H), 0.88 (s, 9H), 0.67 (s, 3H), 0.08 (ad, 6H); 13C NMR (125 
MHz, CDCl3) " 221.4, 73.7, 66.5, 56.2, 43.6, 40.4, 39.3, 38.8, 37.7, 30.6, 27.5, 26.1, 26.0, 
24.0, 22.4, 18.3, 18.0, 12.4, 10.7,      –3.4, –4.8; IR (thin film, neat) 3455 (b, w), 2952 (s), 
2886 (m), 2857 (m), 1731 (s), 1471 (m), 1387 (m), 1254 (m), 1111 (m), 1092 (m), 1072 (m), 
924 (w), 889 (w), 871 (w), 835 (s), 775 (s)    cm–1; HRMS (ES+) m/z 417.2805 [(M+Na)+; 
Calcd for C23H42NaO3Si+: 417.2801]. 
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Aldehyde (–)-2.147: To a 2 dram vial containing a solution of alcohol (–)-2.146 (2.8 mg, 
0.0071 mmol) in methylene chloride (200 ml) was added Dess-Martin periodinane (6 mg, 
0.014 mmol) in one portion, and the mixture was stirred at room temperature while being 
monitored by TLC. After 4 h, complete conversion to a new higher spot was noted (Rf = 
0.25, 10% ethyl acetate/hexanes). The mixture was diluted with ethyl ether (1 ml) and 
treated with sat. NaHCO3 (aq, 200 µl), and the resulting mixture was stirred vigorously for 1 
h. The layers were separated and the aqueous layer was back-extracted with ether (2 x 500 
ml). The combined organic layer was dried, filtered, and concentrated in vacuo to give the 
clean desired product (2.7 mg, 97%) as a solid: [!]25D = – 26.36 ° (CHCl3, c = 0.50); 1H NMR 
(500 MHz, CDCl3) " 9.31 (s, 1H), 3.73 (dd, J = 11.15, 4.75 Hz, 1H), 2.33 (ddd, J = 19.27, 
8.47, 0.84 Hz, 1H), 2.18 (m, 2H), 2.01 (ddd, J = 18.98, 9.34, 9.34 Hz, 1H), 1.85-1.77 (m, 
2H), 1.76-1.70 (m, 1H), 1.68-1.61 (m, 2H), 1.60-1.49 (m, 2H), 1.47-1.33 (m, 2H), 1.08 (s, 
3H), 1.05 (m, 1H), 1.03 (s, 3H), 0.98 (s, 3H), 0.82 (s, 9H), 0.03 (s, 3H), –0.03 (s, 3H); 13C 
NMR (125 MHz, CDCl3) " 220.7, 207.3, 73.9, 56.0, 55.9, 40.5, 39.8, 38.6, 37.5, 30.5, 27.0, 
25.9, 25.7, 24.7, 24.0, 18.1, 17.7, 10.6, 9.5, –3.6, –4.8; IR (thin film, neat) 2953 (b, m), 2852 
(m), 2696 (w), 1730 (s), 1471 (m), 1252 (m), 1115 (m), 925 (w), 873 (w), 836 (m), 776 (m) 
cm–1; HRMS (ES+) m/z 415.2657 [(M+Na)+; Calcd for C23H40NaO3Si+: 415.2644]. 
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APPENDIX 1. Spectral Data for Compounds Shown in Chapter 3 
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X-ray Structure Determination of Compound (+)-2.77 
 
O
O
H
O
H
 
 Compound (+)-2.77, C21H34O3, crystallizes in the orthorhombic space group P212121 
(systematic absences h00: h=odd, 0k0: k=odd, and 00l: l=odd) with a=7.7986(8)Å, 
b=10.6628(10)Å, c=22.343(2)Å, V=1858.0(3)Å3, Z=4 and dcalc=1.196 g/cm
3.  X-ray intensity data 
were collected on a Rigaku Mercury CCD area detector employing graphite-monochromated Mo-
K! radiation ("=0.71073 Å) at a temperature of 143K. Preliminary indexing was performed from a 
series of twelve 0.5° rotation images with exposures of 30 seconds. A total of 254 rotation images 
were collected with a crystal to detector distance of 35 mm, a 2# swing angle of  -12°, rotation 
widths of 0.5° and exposures of 15 seconds: scan no. 1 was a $-scan from 115° to 242° at % = 
10° and & = 20°.  Rotation images were processed using CrystalClear1, producing a listing of 
unaveraged F2 and '(F2) values which were then passed to the CrystalStructure2 program 
package for further processing and structure solution on a Dell Pentium III computer. A total of 
6024 reflections were measured over the ranges 5.28 ( 2# ( 50.06 °,  -7 ( h ( 9,  -10 ( k ( 12,  -
26 ( l ( 23 yielding 3206 unique reflections (Rint = 0.0147). The intensity data were corrected for 
Lorentz and polarization effects and for absorption using REQAB3 (minimum and maximum 
transmission 0.887, 1.000). 
 The structure was solved by direct methods (SIR97 4). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97 5. All reflections were used during refinement (F2 ʼs that 
were experimentally negative were replaced by F2 = 0). The weighting scheme used was 
w=1/ ['2(F o2 )+ 0.0458P2 + 0.2251P] where P = (F o2  + 2F c2 )/3 . Non-hydrogen atoms were refined 
anisotropically and hydrogen atoms were refined using a “riding” model.  Refinement converged 
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to R1=0.0362 and wR2=0.0855 for 2999 reflections for which F > 4!(F) and R1=0.0394, 
wR2=0.0879 and GOF = 1.071 for all 3206 unique, non-zero reflections and 223 variables 6. The 
maximum "/! in the final cycle of least squares was 0.000 and the two most prominent peaks in 
the final difference Fourier were +0.122 and -0.193 e/Å3. 
 Table 1. lists cell information, data collection parameters, and refinement data.  Final 
positional and equivalent isotropic thermal parameters are given in Table 2.  Anisotropic thermal 
parameters are in Table 3.  Tables 4. and 5. list bond distances and bond angles.  Figure 1. is an 
ORTEP7 representation of the molecule with 30% probability thermal ellipsoids displayed. 
 
 
Figure 1. ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
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Table 1.  Summary of Structure Determination of Compound (+)-2.77 
 
Formula: C21H34O3 
Formula weight: 334.48 
Crystal class: orthorhombic 
Space group: P212121  (#19) 
Z 4 
Cell constants:  
 a 7.7986(8)Å 
 b  10.6628(10)Å 
 c 22.343(2)Å 
 V  1858.0(3)Å3 
µ 0.78 cm- 1 
crystal size, mm 0.32 x 0.28 x 0.25 
Dcalc 1.196 g/cm3 
F(000) 736 
Radiation: Mo-K! ("=0.71073Å) 
2# range 5.28 – 50.06 ° 
hkl collected: -7$ h $9;  -10$ k $12;  -26$ l $23 
No. reflections measured: 6024 
No. unique reflections: 3206 (Rint=0.0147) 
No. observed reflections 2999 (F>4%) 
No. reflections used in refinement 3206 
No. parameters 223 
R indices (F>4%) R1=0.0362 
 wR2=0.0855 
R indices (all data) R1=0.0394 
 wR2=0.0879 
GOF: 1.071 
Final Difference Peaks, e/Å3  +0.122, -0.193 
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Table 2.  Refined Positional Parameters for Compound (+)-2.77 
 
       Atom                        x                               y                                z                            Ueq, Å2 
C1 0.5543(2) 0.8576(2) 0.03000(7) 0.0302(4) 
C2 0.6215(3) 0.9605(2) 0.06938(8) 0.0391(5) 
H2a 0.5803 1.0405 0.0546 0.052 
H2b 0.7457 0.9613 0.0673 0.052 
C3 0.5663(2) 0.9449(2) 0.13458(8) 0.0335(4) 
H3a 0.4448 0.9630 0.1380 0.045 
H3b 0.6277 1.0050 0.1591 0.045 
C4 0.6008(2) 0.81206(14) 0.15834(7) 0.0255(4) 
H4 0.5468 0.8070 0.1979 0.034 
C5 0.7928(2) 0.79180(14) 0.16791(7) 0.0262(4) 
H5a 0.8522 0.8037 0.1302 0.035 
H5b 0.8352 0.8541 0.1959 0.035 
C6 0.8329(2) 0.66169(14) 0.19191(7) 0.0259(4) 
H6a 0.7845 0.6525 0.2316 0.034 
H6b 0.9562 0.6511 0.1949 0.034 
C7 0.7588(2) 0.56114(13) 0.15057(6) 0.0200(3) 
H7 0.8030 0.5822 0.1108 0.027 
C8 0.8277(2) 0.42731(14) 0.16319(6) 0.0214(3) 
C9 1.0216(2) 0.4253(2) 0.15230(8) 0.0261(4) 
H9a 1.0465 0.4625 0.1136 0.035 
H9b 1.0786 0.4749 0.1828 0.035 
C10 1.0056(2) 0.2145(2) 0.11339(7) 0.0285(4) 
C11 0.7524(2) 0.34091(14) 0.11531(7) 0.0229(3) 
H11 0.7862 0.3743 0.0762 0.030 
C12 0.5590(2) 0.33732(14) 0.11714(7) 0.0263(4) 
H12a 0.5202 0.3119 0.1566 0.035 
H12b 0.5161 0.2774 0.0881 0.035 
C13 0.4923(2) 0.46922(14) 0.10249(7) 0.0258(4) 
H13a 0.3680 0.4682 0.1043 0.034 
H13b 0.5247 0.4899 0.0618 0.034 
C14 0.5595(2) 0.57376(14) 0.14478(7) 0.0214(3) 
C15 0.5149(2) 0.70957(14) 0.11890(7) 0.0226(3) 
C16 0.5762(2) 0.72543(14) 0.05292(7) 0.0251(3) 
H16a 0.6962 0.7023 0.0503 0.033 
H16b 0.5117 0.6686 0.0275 0.033 
C17 0.7962(2) 0.3764(2) 0.22672(7) 0.0292(4) 
H17a 0.6801 0.3473 0.2299 0.044 
H17b 0.8154 0.4420 0.2554 0.044 
H17c 0.8735 0.3083 0.2345 0.044 
C18 1.0618(2) 0.0853(2) 0.13288(9) 0.0420(5) 
H18a 1.1847 0.0821 0.1344 0.063 
H18b 1.0205 0.0242 0.1048 0.063 
H18c 1.0158 0.0676 0.1718 0.063 
C19 1.0573(2) 0.2409(2) 0.04880(8) 0.0421(5) 
H19a 1.0283 0.3258 0.0388 0.063 
H19b 0.9974 0.1846 0.0226 0.063 
H19c 1.1786 0.2289 0.0444 0.063 
C20 0.4684(2) 0.5574(2) 0.20589(7) 0.0287(4) 
H20a 0.3493 0.5782 0.2018 0.043 
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H20b 0.5204 0.6118 0.2349 0.043 
H20c 0.4792 0.4719 0.2189 0.043 
C21 0.3188(2) 0.7313(2) 0.11762(8) 0.0299(4) 
H21a 0.2781 0.7455 0.1576 0.045 
H21b 0.2632 0.6588 0.1012 0.045 
H21c 0.2935 0.8032 0.0933 0.045 
O1 1.08636(14) 0.29913(10) 0.15379(5) 0.0290(3) 
O2 0.82305(13) 0.21692(9) 0.12043(5) 0.0265(3) 
O3 0.4878(2) 0.87900(12) -0.01810(5) 0.0409(3) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos!+2U13aa*cc*cos"+2U23bb*cc*cos#] 
 
 
Table 3.   Refined Thermal Parameters (U's) for Compound (+)-2.77 
 
       Atom                 U11                   U22                     U33                    U23                   U13                     
U12 
C1 0.0252(9) 0.0381(9) 0.0273(9) 0.0054(7) 0.0001(7) 0.0005(8) 
C2 0.0474(11) 0.0314(9) 0.0385(10) 0.0099(8) -0.0121(9) -0.0015(8) 
C3 0.0370(10) 0.0269(8) 0.0366(10) -0.0021(7) -0.0056(8) 0.0029(8) 
C4 0.0264(9) 0.0261(8) 0.0239(8) -0.0029(7) -0.0004(7) 0.0018(7) 
C5 0.0260(9) 0.0241(8) 0.0284(8) -0.0017(7) -0.0034(7) -0.0045(7) 
C6 0.0211(8) 0.0281(8) 0.0286(8) -0.0009(7) -0.0060(7) -0.0029(7) 
C7 0.0181(7) 0.0232(8) 0.0189(7) 0.0030(6) 0.0001(6) -0.0022(6) 
C8 0.0183(8) 0.0234(7) 0.0225(8) 0.0028(6) -0.0014(6) -0.0028(7) 
C9 0.0191(8) 0.0242(8) 0.0349(9) 0.0037(7) -0.0028(7) -0.0022(7) 
C10 0.0234(8) 0.0282(8) 0.0340(9) 0.0002(7) -0.0019(7) 0.0030(7) 
C11 0.0226(8) 0.0238(8) 0.0223(8) 0.0020(6) -0.0007(7) 0.0011(7) 
C12 0.0238(8) 0.0265(8) 0.0288(9) -0.0031(7) -0.0036(7) -0.0060(7) 
C13 0.0182(7) 0.0294(8) 0.0298(8) -0.0024(7) -0.0043(7) -0.0016(7) 
C14 0.0167(7) 0.0248(8) 0.0227(8) -0.0007(6) 0.0006(6) -0.0021(6) 
C15 0.0182(7) 0.0277(8) 0.0220(7) -0.0013(7) 0.0001(6) 0.0024(7) 
C16 0.0239(8) 0.0297(8) 0.0218(8) -0.0002(6) -0.0024(7) 0.0015(7) 
C17 0.0322(9) 0.0302(8) 0.0252(8) 0.0041(7) -0.0026(7) -0.0029(8) 
C18 0.0353(10) 0.0296(9) 0.0612(12) 0.0028(9) -0.0102(9) 0.0063(8) 
C19 0.0387(10) 0.0476(11) 0.0400(10) -0.0013(9) 0.0077(9) 0.0124(9) 
C20 0.0247(8) 0.0333(9) 0.0281(9) -0.0001(7) 0.0051(7) -0.0019(7) 
C21 0.0220(8) 0.0358(9) 0.0320(9) -0.0011(8) -0.0010(7) 0.0030(7) 
O1 0.0221(6) 0.0259(5) 0.0390(6) 0.0035(5) -0.0052(5) 0.0013(5) 
O2 0.0240(6) 0.0227(5) 0.0328(6) 0.0011(5) -0.0028(5) 0.0005(5) 
O3 0.0437(7) 0.0480(7) 0.0309(7) 0.0103(6) -0.0121(6) 0.0007(6) 
The form of the anisotropic displacement parameter is: 
exp[-2$2(a*2U11h2+b*2U22k2+c*2U33l2+ 2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)]. 
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Table 4.   Bond Distances in Compound (+)-2.77, Å 
 
C1-O3 1.215(2) C1-C2 1.501(2) C1-C16 1.509(2) 
C2-C3 1.528(3) C3-C4 1.536(2) C4-C5 1.528(2) 
C4-C15 1.555(2) C5-C6 1.520(2) C6-C7 1.529(2) 
C7-C8 1.551(2) C7-C14 1.566(2) C8-C11 1.529(2) 
C8-C9 1.532(2) C8-C17 1.539(2) C9-O1 1.437(2) 
C10-O1 1.423(2) C10-O2 1.433(2) C10-C18 1.509(2) 
C10-C19 1.525(2) C11-O2 1.437(2) C11-C12 1.509(2) 
C12-C13 1.535(2) C13-C14 1.552(2) C14-C20 1.549(2) 
C14-C15 1.598(2) C15-C21 1.547(2) C15-C16 1.559(2) 
 
Table 5.   Bond Angles in Compound (+)-2.77, ° 
 
O3-C1-C2 122.0(2) O3-C1-C16 121.6(2) C2-C1-C16 116.37(14) 
C1-C2-C3 112.38(14) C2-C3-C4 112.37(14) C5-C4-C3 110.49(13) 
C5-C4-C15 113.70(13) C3-C4-C15 112.13(13) C6-C5-C4 112.35(13) 
C5-C6-C7 110.44(12) C6-C7-C8 113.86(12) C6-C7-C14 111.42(12) 
C8-C7-C14 115.99(12) C11-C8-C9 105.05(13) C11-C8-C17 111.81(12) 
C9-C8-C17 107.39(13) C11-C8-C7 107.11(11) C9-C8-C7 109.03(12) 
C17-C8-C7 115.90(13) O1-C9-C8 110.86(13) O1-C10-O2 111.01(13) 
O1-C10-C18 105.50(13) O2-C10-C18 105.85(13) O1-C10-C19 111.49(14) 
O2-C10-C19 111.30(13) C18-C10-
C19 
111.4(2) O2-C11-C12 110.96(12) 
O2-C11-C8 110.58(12) C12-C11-C8 112.34(13) C11-C12-
C13 
108.05(12) 
C12-C13-
C14 
114.45(13) C20-C14-
C13 
107.51(12) C20-C14-C7 111.87(12) 
C13-C14-C7 108.89(12) C20-C14-
C15 
108.76(12) C13-C14-
C15 
110.93(12) 
C7-C14-C15 108.90(11) C21-C15-C4 109.31(13) C21-C15-
C16 
105.63(12) 
C4-C15-C16 109.12(12) C21-C15-
C14 
110.97(12) C4-C15-C14 109.76(11) 
C16-C15-
C14 
111.95(12) C1-C16-C15 112.80(13) C10-O1-C9 115.06(12) 
C10-O2-C11 112.89(12)     
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X-ray Structure Determination of Compound (–)-2.134 
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Compound (–)-2.134, C30H48SiO3, crystallizes in the orthorhombic space group P212121 
(systematic absences h00: h=odd, 0k0: k=odd, and 00l: l=odd) with a=8.3845(2)Å, 
b=14.4512(3)Å, c=23.5867(6)Å, V=2857.91(12)Å3, Z=4, and dcalc=1.127 g/cm3 . X-ray intensity 
data were collected on a Bruker APEXII CCD area detector employing graphite-monochromated 
Mo-K! radiation ("=0.71073 Å) at a temperature of 153(1)K. Preliminary indexing was performed 
from a series of thirty-six 0.5° rotation frames with exposures of 20 seconds. A total of 1653 frames 
were collected with a crystal to detector distance of 49.945 mm, rotation widths of 0.5° and 
exposures of 20 seconds:  
 
scan type 2# $ % & frames 
% -25.50 226.51 -345.79 32.61 739 
% -20.50 -35.10 71.57 92.25 69 
$ 22.00 121.61 -214.70 -74.54 69 
$ -23.00 -33.33 -268.05 -98.74 106 
% 27.00 19.96 35.29 69.08 161 
$ -23.00 -27.95 -268.62 -46.47 140 
% 24.50 -22.28 -148.79 55.93 369 
 Rotation frames were integrated using SAINT1, producing a listing of unaveraged F2 and 
'(F2) values which were then passed to the SHELXTL2 program package for further processing 
and structure solution on a Dell Pentium 4 computer. A total of 27880 reflections were measured 
over the ranges 1.65 ( # ( 25.13°, -10 ( h ( 9, -17 ( k ( 16, -28 ( l ( 28 yielding 5078 unique 
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reflections (Rint = 0.0403). The intensity data were corrected for Lorentz and polarization effects 
and for absorption using SADABS3 (minimum and maximum transmission 0.6755, 0.7452). 
The structure was solved by direct methods (SHELXS-974). Refinement was by full-matrix 
least squares based on F2 using SHELXL-97.5 All reflections were used during refinement. The 
weighting scheme used was w=1/[!2(Fo2 )+ (0.0420P)2 + 0.2682P] where P = (Fo 2 + 2Fc2)/3. 
Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding 
model.  Refinement converged to R1=0.0342 and wR2=0.0761 for 4382 observed reflections for 
which F > 4!(F) and R1=0.0460 and wR2=0.0808 and GOF =1.042 for all 5078 unique, non-zero 
reflections and 316 variables.6 The maximum "/! in the final cycle of least squares was 0.000 and 
the two most prominent peaks in the final difference Fourier were +0.156 and -0.194 e/Å3. 
Table 1. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables 2. and 3.  Anisotropic 
thermal parameters are in Table 4.  Tables 5. and 6. list bond distances and bond angles.  Figure 
1. is an ORTEP7 representation of the molecule with 30% probability thermal ellipsoids displayed. 
 
 
Figure 1. ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
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Table 1.  Summary of Structure Determination of Compound (–)-2.134 
Empirical formula  C30H48SiO3 
Formula weight  484.77 
Temperature  153(1) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P212121 
Cell constants:   
a  8.3845(2) Å 
b  14.4512(3) Å 
c  23.5867(6) Å 
Volume 2857.91(12) Å3 
Z 4 
Density (calculated) 1.127 Mg/m3 
Absorption coefficient 0.110 mm-1 
F(000) 1064 
Crystal size 0.44 x 0.30 x 0.04 mm3 
Theta range for data collection 1.65 to 25.13° 
Index ranges -10 ! h ! 9, -17 ! k ! 16, -28 ! l ! 28 
Reflections collected 27880 
Independent reflections 5078 [R(int) = 0.0403] 
Completeness to theta = 25.13° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6755 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5078 / 0 / 316 
Goodness-of-fit on F2 1.042 
Final R indices [I>2sigma(I)] R1 = 0.0342, wR2 = 0.0761 
R indices (all data) R1 = 0.0460, wR2 = 0.0808 
Absolute structure parameter 0.04(11) 
Largest diff. peak and hole 0.156 and -0.194 e.Å-3 
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Table 2. Refined Positional Parameters for Compound (–)-2.134 
 
  Atom x y z Ueq, Å2 
C1 0.4535(3) 0.73421(14) 0.42911(8) 0.0344(5) 
C2 0.5029(3) 0.71195(14) 0.48996(8) 0.0432(6) 
C3 0.6045(3) 0.62409(14) 0.48713(8) 0.0380(5) 
C4 0.5561(2) 0.58191(13) 0.43017(7) 0.0280(4) 
C5 0.6562(3) 0.50563(13) 0.40410(8) 0.0328(5) 
C6 0.5799(2) 0.47544(12) 0.34820(8) 0.0275(4) 
C7 0.5524(2) 0.55685(11) 0.30709(7) 0.0209(4) 
C8 0.5020(2) 0.52548(11) 0.24644(7) 0.0222(4) 
C9 0.4807(2) 0.61179(11) 0.20877(7) 0.0226(4) 
C10 0.3713(2) 0.68382(13) 0.23440(8) 0.0301(5) 
C11 0.4324(3) 0.71473(12) 0.29211(7) 0.0298(5) 
C12 0.4477(2) 0.63477(11) 0.33473(7) 0.0236(4) 
C13 0.5368(2) 0.66505(12) 0.38980(8) 0.0266(4) 
C14 0.6340(2) 0.46600(12) 0.22029(8) 0.0248(4) 
C15 0.9080(2) 0.45918(13) 0.19772(8) 0.0314(5) 
C16 0.9607(2) 0.38328(13) 0.23742(7) 0.0265(4) 
C17 0.9718(2) 0.39886(15) 0.29523(8) 0.0390(5) 
C18 1.0260(3) 0.32966(18) 0.33096(10) 0.0499(6) 
C19 1.0680(3) 0.24492(17) 0.30915(11) 0.0521(7) 
C20 1.0579(2) 0.22903(15) 0.25220(10) 0.0431(6) 
C21 1.0034(2) 0.29734(12) 0.21680(9) 0.0322(4) 
C22 0.3522(2) 0.46458(13) 0.24450(8) 0.0294(4) 
C23 0.6794(3) 0.57051(17) 0.07501(10) 0.0477(6) 
C24 0.4949(4) 0.74816(13) 0.09073(10) 0.0545(7) 
C25 0.3240(3) 0.57546(15) 0.04248(9) 0.0385(5) 
C26 0.3135(4) 0.47018(17) 0.04786(13) 0.0742(10) 
C27 0.3669(3) 0.60109(19) -0.01890(9) 0.0597(7) 
C28 0.1625(3) 0.6174(2) 0.05640(10) 0.0632(7) 
C29 0.2774(2) 0.60256(13) 0.35079(8) 0.0307(4) 
C30 0.6982(3) 0.71329(13) 0.37881(9) 0.0349(5) 
O1 0.3687(2) 0.79769(10) 0.41573(6) 0.0506(4) 
O2 0.78247(14) 0.51473(8) 0.21990(6) 0.0280(3) 
O3 0.42008(15) 0.58399(8) 0.15468(5) 0.0273(3) 
Si1 0.48122(7) 0.61987(3) 0.09247(2) 0.02774(13) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos !+2U13aa*cc*cos "+2U23bb*cc*cos#] 
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Table 3. Positional Parameters for Hydrogens in Compound (–)-2.134 
 
  Atom x y z Uiso, Å2 
H2a 0.4096 0.7018 0.5134 0.057 
H2b 0.5641 0.7626 0.5059 0.057 
H3a 0.5800 0.5826 0.5183 0.051 
H3b 0.7174 0.6387 0.4879 0.051 
H4 0.4491 0.5560 0.4355 0.037 
H5a 0.6623 0.4534 0.4299 0.044 
H5b 0.7636 0.5279 0.3973 0.044 
H6a 0.4784 0.4459 0.3561 0.037 
H6b 0.6482 0.4301 0.3300 0.037 
H7 0.6579 0.5850 0.3021 0.028 
H9 0.5857 0.6401 0.2030 0.030 
H10a 0.2650 0.6582 0.2385 0.040 
H10b 0.3648 0.7368 0.2093 0.040 
H11a 0.3602 0.7608 0.3074 0.040 
H11b 0.5359 0.7437 0.2874 0.040 
H14a 0.6454 0.4093 0.2419 0.033 
H14b 0.6050 0.4495 0.1818 0.033 
H15a 0.9986 0.4986 0.1893 0.042 
H15b 0.8728 0.4316 0.1624 0.042 
H17 0.9428 0.4560 0.3101 0.052 
H18 1.0341 0.3405 0.3697 0.066 
H19 1.1033 0.1983 0.3332 0.069 
H20 1.0880 0.1720 0.2374 0.057 
H21 0.9951 0.2856 0.1781 0.043 
H22a 0.3385 0.4405 0.2069 0.044 
H22b 0.2607 0.5009 0.2546 0.044 
H22c 0.3637 0.4143 0.2708 0.044 
H23a 0.7535 0.5851 0.1047 0.072 
H23b 0.7167 0.5964 0.0399 0.072 
H23c 0.6706 0.5045 0.0713 0.072 
H24a 0.3925 0.7743 0.0994 0.082 
H24b 0.5277 0.7678 0.0536 0.082 
H24c 0.5715 0.7686 0.1183 0.082 
H26a 0.2857 0.4541 0.0861 0.111 
H26b 0.4147 0.4432 0.0384 0.111 
H26c 0.2334 0.4472 0.0224 0.111 
H27a 0.2854 0.5789 -0.0440 0.089 
H27b 0.4671 0.5733 -0.0288 0.089 
H27c 0.3752 0.6671 -0.0222 0.089 
H28a 0.1677 0.6834 0.0522 0.095 
H28b 0.1342 0.6024 0.0947 0.095 
H28c 0.0835 0.5930 0.0310 0.095 
H29a 0.2338 0.6436 0.3788 0.046 
H29b 0.2819 0.5409 0.3659 0.046 
H29c 0.2109 0.6032 0.3177 0.046 
H30a 0.6804 0.7703 0.3590 0.052 
H30b 0.7648 0.6737 0.3563 0.052 
H30c 0.7498 0.7258 0.4143 0.052 
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Table 4.   Refined Thermal Parameters (U's) for Compound (–)-2.134 
 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0449(13) 0.0290(10) 0.0293(11) -0.0041(9) 0.0074(10) -0.0024(10) 
C2 0.0645(16) 0.0392(11) 0.0259(10) -0.0067(9) 0.0079(11) -0.0064(12) 
C3 0.0457(13) 0.0428(11) 0.0254(10) -0.0023(10) -0.0004(10) -0.0045(11) 
C4 0.0299(11) 0.0314(10) 0.0226(9) 0.0026(8) -0.0004(8) -0.0032(9) 
C5 0.0412(11) 0.0285(10) 0.0286(10) 0.0044(9) -0.0031(10) 0.0032(9) 
C6 0.0360(10) 0.0205(8) 0.0259(9) 0.0020(8) -0.0001(9) 0.0031(8) 
C7 0.0202(9) 0.0189(8) 0.0238(9) 0.0007(7) 0.0007(8) -0.0004(7) 
C8 0.0226(9) 0.0193(8) 0.0249(9) -0.0009(7) -0.0002(8) -0.0010(8) 
C9 0.0253(9) 0.0220(8) 0.0205(8) -0.0007(7) -0.0005(8) -0.0002(8) 
C10 0.0358(11) 0.0282(10) 0.0263(10) 0.0059(8) 0.0007(9) 0.0092(9) 
C11 0.0424(11) 0.0199(9) 0.0271(10) 0.0021(8) 0.0057(9) 0.0089(8) 
C12 0.0277(10) 0.0203(8) 0.0227(9) 0.0010(7) 0.0035(8) 0.0012(8) 
C13 0.0322(11) 0.0222(9) 0.0254(10) -0.0001(8) 0.0042(8) -0.0009(8) 
C14 0.0259(10) 0.0194(9) 0.0291(10) -0.0008(8) -0.0016(8) -0.0020(7) 
C15 0.0260(10) 0.0320(10) 0.0361(11) 0.0022(9) 0.0086(9) 0.0076(9) 
C16 0.0183(9) 0.0304(9) 0.0309(10) -0.0002(9) 0.0017(8) -0.0003(8) 
C17 0.0333(11) 0.0458(12) 0.0379(12) -0.0042(10) -0.0010(10) 0.0011(10) 
C18 0.0382(13) 0.0768(17) 0.0346(12) 0.0100(12) -0.0057(11) -0.0029(13) 
C19 0.0331(12) 0.0590(16) 0.0642(17) 0.0307(14) 0.0024(12) 0.0078(11) 
C20 0.0307(12) 0.0352(11) 0.0633(16) 0.0109(11) 0.0103(11) 0.0099(9) 
C21 0.0243(10) 0.0327(10) 0.0397(11) 0.0002(9) 0.0073(9) 0.0040(9) 
C22 0.0281(10) 0.0277(10) 0.0323(11) -0.0009(9) -0.0008(9) -0.0061(8) 
C23 0.0404(13) 0.0668(15) 0.0360(13) -0.0063(12) 0.0053(10) 0.0021(12) 
C24 0.091(2) 0.0308(10) 0.0415(12) 0.0002(10) 0.0137(15) -0.0072(13) 
C25 0.0449(13) 0.0413(11) 0.0293(11) 0.0022(10) -0.0083(10) 0.0008(10) 
C26 0.095(2) 0.0450(14) 0.082(2) -0.0016(14) -0.0489(19) -0.0191(16) 
C27 0.0676(17) 0.0838(19) 0.0276(12) -0.0064(13) -0.0075(12) 0.0007(15) 
C28 0.0415(14) 0.096(2) 0.0518(15) 0.0122(16) -0.0087(12) 0.0063(16) 
C29 0.0273(10) 0.0356(11) 0.0292(10) 0.0006(9) 0.0057(9) 0.0031(9) 
C30 0.0416(13) 0.0341(11) 0.0290(11) -0.0056(9) 0.0026(10) -0.0102(10) 
O1 0.0733(11) 0.0397(9) 0.0388(9) -0.0065(7) 0.0095(8) 0.0194(8) 
O2 0.0217(6) 0.0215(6) 0.0408(8) -0.0028(6) 0.0038(6) 0.0018(5) 
O3 0.0309(7) 0.0291(6) 0.0220(6) 0.0003(5) -0.0033(6) -0.0004(6) 
Si1 0.0353(3) 0.0264(2) 0.0215(2) -0.0020(2) 0.0011(2) -0.0007(2) 
The form of the anisotropic displacement parameter is: 
exp[-2!2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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  Table 5. Bond Distances in Compound (–)-2.134, Å 
 
C1-O1  1.203(2) C1-C2  1.528(3) C1-C13  1.532(3) 
C2-C3  1.530(3) C3-C4  1.530(3) C4-C5  1.516(3) 
C4-C13  1.541(2) C5-C6  1.529(3) C6-C7  1.542(2) 
C7-C8  1.559(2) C7-C12  1.570(2) C8-C14  1.531(2) 
C8-C22  1.534(2) C8-C9  1.542(2) C9-O3  1.431(2) 
C9-C10  1.513(2) C10-C11  1.521(3) C11-C12  1.537(2) 
C12-C29  1.549(2) C12-C13  1.561(3) C13-C30  1.544(3) 
C14-O2  1.430(2) C15-O2  1.423(2) C15-C16  1.508(3) 
C16-C21  1.381(3) C16-C17  1.385(3) C17-C18  1.385(3) 
C18-C19  1.374(3) C19-C20  1.365(3) C20-C21  1.371(3) 
C23-Si1  1.855(2) C24-Si1  1.858(2) C25-C28  1.520(3) 
C25-C26  1.529(3) C25-C27  1.537(3) C25-Si1  1.882(2) 
O3-Si1  1.6385(13)     
 
 
 
Table 6. Bond Angles in Compound (–)-2.134, ° 
 
O1-C1-C2 124.56(18) O1-C1-C13 127.47(18) C2-C1-C13 107.91(17) 
C1-C2-C3 106.54(16) C2-C3-C4 102.76(16) C5-C4-C3 119.91(17) 
C5-C4-C13 111.97(15) C3-C4-C13 105.05(15) C4-C5-C6 108.98(16) 
C5-C6-C7 112.78(14) C6-C7-C8 113.32(13) C6-C7-C12 111.69(14) 
C8-C7-C12 115.97(14) C14-C8-C22 104.94(13) C14-C8-C9 107.79(14) 
C22-C8-C9 110.64(14) C14-C8-C7 109.67(14) C22-C8-C7 114.59(14) 
C9-C8-C7 108.96(13) O3-C9-C10 109.51(14) O3-C9-C8 109.13(13) 
C10-C9-C8 113.34(14) C9-C10-C11 110.81(15) C10-C11-
C12 
113.12(15) 
C11-C12-
C29 
107.99(15) C11-C12-
C13 
111.94(14) C29-C12-
C13 
108.77(14) 
C11-C12-C7 108.32(14) C29-C12-C7 113.68(14) C13-C12-C7 106.22(14) 
C1-C13-C4 100.51(14) C1-C13-C30 101.92(14) C4-C13-C30 111.33(16) 
C1-C13-C12 117.94(16) C4-C13-C12 110.23(14) C30-C13-
C12 
113.95(15) 
O2-C14-C8 110.82(13) O2-C15-C16 113.49(15) C21-C16-
C17 
118.38(18) 
C21-C16-
C15 
120.75(16) C17-C16-
C15 
120.84(17) C18-C17-
C16 
120.3(2) 
C19-C18-
C17 
120.0(2) C20-C19-
C18 
120.2(2) C19-C20-
C21 
119.9(2) 
C20-C21-
C16 
121.3(2) C28-C25-
C26 
109.1(2) C28-C25-
C27 
108.43(19) 
C26-C25-
C27 
109.3(2) C28-C25-Si1 110.66(16) C26-C25-Si1 109.13(16) 
C27-C25-Si1 110.12(16) C15-O2-C14 111.60(13) C9-O3-Si1 126.75(11) 
O3-Si1-C23 110.94(9) O3-Si1-C24 110.79(8) C23-Si1-C24 108.88(12) 
O3-Si1-C25 103.54(8) C23-Si1-C25 110.94(10) C24-Si1-C25 111.70(11) 
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6R1 = !||Fo| - |Fc|| / ! |Fo| 
wR2 = [!w(Fo2 - Fc2)2/!w(Fo2)2]½ 
GOF = [!w(Fo2 - Fc2)2/(n - p)]½ 
where n = the number of reflections and p = the number of parameters refined. 
 
7“ORTEP-II: A Fortran Thermal Ellipsoid Plot Program for Crystal Structure Illustrations”. C.K. 
Johnson (1976) ORNL-5138. 
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APPENDIX 4. X-ray Crystallographic Data for Compound (–)-2.141. 
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X-ray Structure Determination of Compound (–)-2.141 
 
H
O
O
OMe
OMe
H
O
 
Compound (–)-2.141, C26H36O5, crystallizes in the orthorhombic space group P212121 
(systematic absences h00:  h=odd, 0k0:  k=odd, and 00l:  l=odd) with a=7.9383(5)Å, 
b=15.0459(9)Å, c=18.9459(11)Å, V=2262.9(2)Å3, Z=4, and dcalc=1.258 g/cm3 . X-ray intensity 
data were collected on a Bruker APEXII CCD area detector employing graphite-monochromated 
Cu-K! radiation ("=1.54178 Å) at a temperature of 100(1)K. Preliminary indexing was performed 
from a series of thirty-six 0.5° rotation frames with exposures of 20 seconds. A total of 5438 frames 
were collected with a crystal to detector distance of 60.000 mm, rotation widths of 0.5° and 
exposures of 20 seconds:  
 
scan type 2# $ % & frames 
% 99.50 141.56 -9.61 -22.49 739 
% 112.00 11.47 -346.66 30.75 733 
% -53.00 39.28 -1.55 -50.02 600 
% 84.50 63.16 -23.05 -50.02 739 
% 10.950 125.69 -13.00 -30.00 739 
$ -33.00 -81.32 -152.95 -24.38 327 
% 97.00 202.75 -312.84 -65.26 577 
$ 104.50 -21.53 -29.45 45.39 301 
$ 27.00 -34.87 21.06 59.32 72 
$ -40.50 -153.09 -138.29 32.61 279 
$ 102.00 -156.33 28.99 -70.01 72 
$ -13.00 52.46 -91.54 51.77 126 
$ 102.00 17.16 -25.89 21.86 134 
 Rotation frames were integrated using SAINT", producing a listing of unaveraged F2 and 
'(F2) values which were then passed to the SHELXTL# program package for further processing 
and structure solution. A total of 13266 reflections were measured over the ranges 3.75 ( # ( 
67.92°, -9 ( h ( 9, -17 ( k ( 17, -22 ( l ( 20 yielding 3916 unique reflections (Rint = 0.0324). The 
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intensity data were corrected for Lorentz and polarization effects and for absorption using 
SADABS" (minimum and maximum transmission 0.6372, 0.7530). 
The structure was solved by direct methods (SHELXS-97#). Refinement was by full-matrix 
least squares based on F2 using SHELXL-97.$ All reflections were used during refinement. The 
weighting scheme used was w=1/[!2(Fo2 )+ (0.0650P)2 + 0.9222P] where P = (Fo 2 + 2Fc2)/3. 
Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding 
model.  Refinement converged to R1=0.0423 and wR2=0.1168 for 3824 observed reflections for 
which F > 4!(F) and R1=0.0432 and wR2=0.1183 and GOF =1.055 for all 3916 unique, non-zero 
reflections and 286 variables.% The maximum "/! in the final cycle of least squares was 0.002 and 
the two most prominent peaks in the final difference Fourier were +0.748 and -0.198 e/Å3. 
Table 1. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables 2. and 3.  Anisotropic 
thermal parameters are in Table 4.  Tables 5. and 6. list bond distances and bond angles.  Figure 
1. is an ORTEP& representation of the molecule with 30% probability thermal ellipsoids displayed. 
 
 
Figure 1. ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
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Table 1.  Summary of Structure Determination of Compound (–)-2.141 
Empirical formula  C26H36O5 
Formula weight  428.55 
Temperature  100(1) K 
Wavelength  1.54178 Å 
Crystal system  orthorhombic 
Space group  P212121  
Cell constants:   
a  7.9383(5) Å 
b  15.0459(9) Å 
c  18.9459(11) Å 
Volume 2262.9(2) Å3 
Z 4 
Density (calculated) 1.258 Mg/m3 
Absorption coefficient 0.686 mm-1 
F(000) 928 
Crystal size 0.48 x 0.35 x 0.25 mm3 
Theta range for data collection 3.75 to 67.92° 
Index ranges -9 ! h ! 9, -17 ! k ! 17, -22 ! l ! 20 
Reflections collected 13266 
Independent reflections 3916 [R(int) = 0.0324] 
Completeness to theta = 67.92° 96.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7530 and 0.6372 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3916 / 0 / 286 
Goodness-of-fit on F2 1.055 
Final R indices [I>2sigma(I)] R1 = 0.0423, wR2 = 0.1168 
R indices (all data) R1 = 0.0432, wR2 = 0.1183 
Absolute structure parameter -0.1(2) 
Largest diff. peak and hole 0.748 and -0.198 e.Å-3 
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Table 2. Refined Positional Parameters for Compound (–)-2.141 
 
  Atom x y z Ueq, Å2 
C1 0.7157(3) 0.33358(13) 0.15693(11) 0.0249(4) 
C2 0.5880(3) 0.25552(14) 0.14393(13) 0.0325(5) 
C3 0.4556(3) 0.28000(15) 0.08931(14) 0.0364(5) 
C4 0.3591(3) 0.36317(14) 0.11161(13) 0.0325(5) 
C5 0.4804(2) 0.44103(13) 0.12310(10) 0.0237(4) 
C6 0.3899(2) 0.53239(13) 0.13048(10) 0.0249(4) 
C7 0.2978(3) 0.55372(14) 0.06090(11) 0.0282(4) 
C8 0.3738(3) 0.70572(14) 0.07065(10) 0.0261(4) 
C9 0.5284(2) 0.60371(13) 0.13575(10) 0.0240(4) 
C10 0.6465(3) 0.58958(14) 0.19736(11) 0.0307(5) 
C11 0.7368(3) 0.49998(13) 0.18648(11) 0.0288(5) 
C12 0.6153(3) 0.42031(13) 0.18053(10) 0.0253(4) 
C13 0.8297(3) 0.30377(15) 0.21723(12) 0.0327(5) 
C14 0.8261(3) 0.34864(14) 0.09177(11) 0.0294(5) 
C15 0.6800(3) 0.16990(16) 0.12977(15) 0.0416(6) 
C16 0.6633(4) 0.11704(18) 0.07664(18) 0.0537(7) 
C17 0.2594(3) 0.54008(15) 0.18979(12) 0.0330(5) 
C18 0.5374(3) 0.40464(16) 0.25416(12) 0.0369(5) 
C19 0.3036(3) 0.79849(14) 0.06911(10) 0.0249(4) 
C20 0.1423(3) 0.81509(14) 0.09684(10) 0.0252(4) 
C21 0.0777(3) 0.90094(15) 0.09585(10) 0.0268(4) 
C22 0.1770(3) 0.97055(14) 0.06827(10) 0.0268(4) 
C23 0.3337(3) 0.95253(15) 0.04032(11) 0.0290(5) 
C24 0.3965(3) 0.86615(15) 0.04006(11) 0.0278(4) 
C25 -0.1942(3) 0.85167(17) 0.13109(13) 0.0378(5) 
C26 0.1166(3) 1.10081(15) 0.13137(12) 0.0375(5) 
O1 0.24152(18) 0.64469(10) 0.06027(8) 0.0295(3) 
O2 0.45514(17) 0.69119(9) 0.13660(7) 0.0256(3) 
O3 0.9792(3) 0.31397(15) 0.22047(11) 0.0567(5) 
O4 -0.07961(19) 0.92323(11) 0.11779(8) 0.0353(4) 
O5 0.1139(2) 1.05605(10) 0.06474(8) 0.0330(3) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos !+2U13aa*cc*cos "+2U23bb*cc*cos#] 
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Table 3. Positional Parameters for Hydrogens in Compound (–)-2.141 
 
  Atom x y z Uiso, Å2 
H2 0.5275 0.2470 0.1885 0.043 
H3a 0.3775 0.2310 0.0837 0.048 
H3b 0.5098 0.2905 0.0442 0.048 
H4a 0.2980 0.3513 0.1549 0.043 
H4b 0.2779 0.3787 0.0754 0.043 
H5 0.5441 0.4454 0.0789 0.032 
H7a 0.3732 0.5436 0.0214 0.038 
H7b 0.2017 0.5145 0.0556 0.038 
H8 0.4563 0.6991 0.0325 0.035 
H9 0.5963 0.5994 0.0927 0.032 
H10a 0.5835 0.5888 0.2412 0.041 
H10b 0.7282 0.6374 0.1996 0.041 
H11a 0.8128 0.4899 0.2258 0.038 
H11b 0.8042 0.5033 0.1438 0.038 
H13 0.7784 0.2750 0.2550 0.044 
H14a 0.9260 0.3805 0.1052 0.044 
H14b 0.7646 0.3826 0.0575 0.044 
H14c 0.8571 0.2923 0.0718 0.044 
H15 0.7588 0.1530 0.1635 0.055 
H16a 0.5865 0.1303 0.0411 0.071 
H16b 0.7281 0.0656 0.0739 0.071 
H17a 0.3153 0.5541 0.2333 0.049 
H17b 0.2005 0.4847 0.1946 0.049 
H17c 0.1805 0.5863 0.1786 0.049 
H18a 0.6255 0.3941 0.2878 0.055 
H18b 0.4640 0.3540 0.2524 0.055 
H18c 0.4741 0.4561 0.2680 0.055 
H20 0.0791 0.7688 0.1158 0.034 
H23 0.3980 0.9985 0.0215 0.039 
H24 0.5013 0.8543 0.0202 0.037 
H25a -0.1932 0.8114 0.0918 0.057 
H25b -0.3058 0.8750 0.1373 0.057 
H25c -0.1605 0.8207 0.1731 0.057 
H26a 0.0423 1.0711 0.1636 0.056 
H26b 0.0803 1.1612 0.1252 0.056 
H26c 0.2291 1.1002 0.1500 0.056 
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Table 4.   Refined Thermal Parameters (U's) for Compound (–)-2.141 
 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0276(10) 0.0229(10) 0.0243(10) 0.0013(8) 0.0030(8) 0.0007(8) 
C2 0.0319(11) 0.0249(10) 0.0407(12) 0.0013(9) 0.0047(9) -0.0026(9) 
C3 0.0298(11) 0.0273(11) 0.0522(14) -0.0080(10) 0.0012(10) -0.0047(9) 
C4 0.0267(10) 0.0249(11) 0.0460(13) -0.0011(9) 0.0001(9) -0.0024(9) 
C5 0.0237(9) 0.0246(10) 0.0228(9) -0.0015(8) 0.0020(8) 0.0013(8) 
C6 0.0246(9) 0.0249(10) 0.0254(10) -0.0025(8) -0.0012(8) 0.0020(8) 
C7 0.0256(10) 0.0274(11) 0.0317(11) -0.0058(8) -0.0053(9) 0.0022(8) 
C8 0.0257(10) 0.0307(10) 0.0218(9) -0.0008(8) -0.0009(8) 0.0027(8) 
C9 0.0265(10) 0.0214(10) 0.0240(10) -0.0003(8) -0.0017(8) 0.0042(8) 
C10 0.0353(12) 0.0265(10) 0.0301(10) -0.0043(8) -0.0109(9) 0.0024(9) 
C11 0.0307(10) 0.0261(10) 0.0295(10) -0.0008(8) -0.0091(9) 0.0028(8) 
C12 0.0296(10) 0.0256(10) 0.0209(9) 0.0000(8) 0.0012(8) 0.0012(8) 
C13 0.0377(12) 0.0285(11) 0.0320(11) 0.0017(9) -0.0003(9) 0.0074(9) 
C14 0.0305(10) 0.0304(11) 0.0273(10) -0.0017(8) 0.0033(9) -0.0008(9) 
C15 0.0375(12) 0.0292(12) 0.0581(15) 0.0007(11) -0.0025(12) -0.0007(10) 
C16 0.0472(15) 0.0380(14) 0.076(2) -0.0188(13) -0.0066(14) 0.0040(12) 
C17 0.0343(11) 0.0306(11) 0.0341(11) -0.0019(9) 0.0063(10) 0.0055(9) 
C18 0.0503(14) 0.0352(12) 0.0252(11) 0.0035(9) 0.0091(10) 0.0095(10) 
C19 0.0257(10) 0.0307(11) 0.0182(9) -0.0014(8) -0.0032(8) 0.0029(8) 
C20 0.0242(10) 0.0288(10) 0.0227(9) 0.0019(8) 0.0013(8) 0.0013(8) 
C21 0.0252(10) 0.0355(11) 0.0198(9) 0.0020(8) 0.0002(8) 0.0056(9) 
C22 0.0303(10) 0.0280(10) 0.0221(9) 0.0028(8) -0.0043(8) 0.0072(9) 
C23 0.0271(10) 0.0317(11) 0.0282(10) 0.0055(8) -0.0020(8) 0.0006(9) 
C24 0.0218(9) 0.0347(11) 0.0267(10) 0.0020(8) 0.0007(8) 0.0056(9) 
C25 0.0272(11) 0.0521(15) 0.0342(12) 0.0039(10) 0.0082(9) 0.0026(10) 
C26 0.0443(13) 0.0314(11) 0.0367(12) -0.0034(10) -0.0005(10) 0.0078(10) 
O1 0.0272(7) 0.0276(7) 0.0336(8) -0.0048(6) -0.0085(6) 0.0033(6) 
O2 0.0275(7) 0.0248(7) 0.0244(7) -0.0035(6) -0.0047(6) 0.0043(6) 
O3 0.0456(11) 0.0710(14) 0.0536(12) 0.0030(10) -0.0106(9) 0.0059(10) 
O4 0.0266(7) 0.0405(9) 0.0388(8) 0.0045(7) 0.0069(6) 0.0104(7) 
O5 0.0385(8) 0.0289(7) 0.0317(7) 0.0043(6) -0.0022(7) 0.0100(7) 
The form of the anisotropic displacement parameter is: 
exp[-2!2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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  Table 5. Bond Distances in Compound (–)-2.141, Å 
 
C1-C13  1.525(3) C1-C14  1.531(3) C1-C2  1.571(3) 
C1-C12  1.593(3) C2-C15  1.505(3) C2-C3  1.520(3) 
C3-C4  1.527(3) C4-C5  1.532(3) C5-C6  1.557(3) 
C5-C12  1.558(3) C6-C17  1.533(3) C6-C9  1.540(3) 
C6-C7  1.541(3) C7-O1  1.440(2) C8-O1  1.409(3) 
C8-O2  1.423(2) C8-C19  1.503(3) C9-O2  1.439(2) 
C9-C10  1.512(3) C10-C11  1.541(3) C11-C12  1.543(3) 
C12-C18  1.544(3) C13-O3  1.198(3) C15-C16  1.290(4) 
C19-C24  1.372(3) C19-C20  1.406(3) C20-C21  1.390(3) 
C21-O4  1.358(3) C21-C22  1.411(3) C22-C23  1.379(3) 
C22-O5  1.382(2) C23-C24  1.392(3) C25-O4  1.432(3) 
C26-O5  1.431(3)     
 
 
 
 
 
Table 6. Bond Angles in Compound (–)-2.141, ° 
 
C13-C1-C14 107.95(17) C13-C1-C2 106.30(17) C14-C1-C2 110.72(17) 
C13-C1-C12 109.11(16) C14-C1-C12 113.05(16) C2-C1-C12 109.47(16) 
C15-C2-C3 114.9(2) C15-C2-C1 110.76(18) C3-C2-C1 111.83(17) 
C2-C3-C4 110.9(2) C3-C4-C5 110.53(17) C4-C5-C6 113.45(16) 
C4-C5-C12 112.23(17) C6-C5-C12 115.53(16) C17-C6-C9 112.49(16) 
C17-C6-C7 106.90(17) C9-C6-C7 104.43(16) C17-C6-C5 116.38(17) 
C9-C6-C5 106.95(16) C7-C6-C5 109.02(16) O1-C7-C6 110.63(16) 
O1-C8-O2 111.14(16) O1-C8-C19 109.04(16) O2-C8-C19 109.14(16) 
O2-C9-C10 111.75(16) O2-C9-C6 110.44(15) C10-C9-C6 113.25(17) 
C9-C10-C11 107.96(16) C10-C11-
C12 
113.48(18) C11-C12-
C18 
107.65(17) 
C11-C12-C5 108.99(16) C18-C12-C5 112.69(18) C11-C12-C1 110.13(16) 
C18-C12-C1 109.21(16) C5-C12-C1 108.16(15) O3-C13-C1 126.0(2) 
C16-C15-C2 128.1(3) C24-C19-
C20 
120.49(19) C24-C19-C8 119.83(18) 
C20-C19-C8 119.68(18) C21-C20-
C19 
119.73(19) O4-C21-C20 124.36(19) 
O4-C21-C22 116.33(19) C20-C21-
C22 
119.27(19) C23-C22-O5 119.42(19) 
C23-C22-
C21 
120.01(19) O5-C22-C21 120.43(18) C22-C23-
C24 
120.5(2) 
C19-C24-
C23 
119.92(19) C8-O1-C7 112.78(15) C8-O2-C9 108.31(14) 
C21-O4-C25 116.90(18) C22-O5-C26 112.95(16)   
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 'R1 = !||Fo| - |Fc|| / ! |Fo| 
wR2 = [!w(Fo2 - Fc2)2/!w(Fo2)2]½ 
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where n = the number of reflections and p = the number of parameters refined. 
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